INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136997, 14130, 40.0, 40.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dacb052303150c84dd7cf4ed74f49ac04002cd00547', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136998, 14130, 5.0, 10.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c734cc92a2d2e5148c92f4e5548aa5430d5353450c84dd7cf4ed74f49ac542834d635cbcd57484a2c4e4d51c8cf53284e2d2acd55484b2d2aca2cc9cc030058181465', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136999, 14130, 10.0, 10.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c73494d2e4a4d2c4e5548c9071286060ab9e9fad9e9fa2989950a99690ace450a76c6c6aa0a8949f965a90a494075399979a90a8979290a76a13e7e00675513a8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137000, 14130, 20.0, 30.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c3332d0353650c84dd7cf4e5708f057087401002517045c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137001, 14130, 20.0, 20.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c0b2e492c2ab152303250c84dd7cf4e5708f0570874010048620634', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137002, 14130, 40.0, 40.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dacb052303150c84dd7cf4ed74f49ac04002cd00547', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137003, 14130, 5.0, 10.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c734cc92a2d2e5148c92f4e5548aa5430d5353450c84dd7cf4ed74f49ac542834d635cbcd57484a2c4e4d51c8cf53284e2d2acd55484b2d2aca2cc9cc030058181465', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137004, 14130, 10.0, 10.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c73494d2e4a4d2c4e5548c9071286060ab9e9fad9e9fa2989950a99690ace450a76c6c6aa0a8949f965a90a494075399979a90a15460ae5a9a9d9c50067b31411', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137005, 14130, 10.0, 20.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c3334d0353250c84dd7cf4e5708f0570874010024f8045a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137006, 14130, 10.0, 10.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c0b2e492c2ab152303450c84dd7cf4e5708f0570874010048540633', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137007, 14130, 20.0, 20.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dacb052303250c84dd7cf4ed74f49ac04002cb80545', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137008, 14130, 5.0, 5.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c73494d2e4a4d2c4e5548c90712a60ab9e9fad9e9fa2989950a99690ace450a76c6c6aa0a8949f965a90a494065399979a90a8979290a76a13e7e005a34137c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137009, 14130, 10.0, 20.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c3334d0353250c84dd7cf4e5708f0570874010024f8045a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137010, 14130, 10.0, 10.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c0b2e492c2ab152303450c84dd7cf4e5708f0570874010048540633', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137011, 14130, 20.0, 20.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dacb052303250c84dd7cf4ed74f49ac04002cb80545', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137012, 14130, 5.0, 5.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf3cc2b492d2a2a2d285128294a4d2cc94dcd2b51c84c5348cc01f2522a15124b144c1572d3f5b3d3f553122b018923105f', X'789ced5a6d6fdb3610fe2b8700013accae5f12679d5a1470dc976448532f49370c5361d0d259664d911a4925168afef71d65cb916c3776b3146b377f4a28dd1d8fcf3d773c91feb817ea341a4816e39e077b2f70849a19aed574af067ba916eee9d8dac4788dc60d9f60fc58e9c8fdc71b4bc226d02cc170c0acd36937db47f566abde6a5e357ff23a2defa0f5f8e8b07574f4732e8b81e54a1a92fcb8d70d632eb9b19ab967f9238bd3dcca5596a0e7cbaeb43c54167df942191621bc523a361eb4da9d1ab43bcd1a749a4d882308b949501b04cb86bebc50a945036a04d5293c78ab99f0654fc5b19270a55988704e1090c997d30f34ca7d4c8765373fd123b22ad08dfe7c4f23c1e5241fdcfa5b38ba19bc85e4a7f7ce72374c851dd0eab88c2a08acf164ef542b39b06aca036eb3da2018d39807035a9d34a3d4901c131523ed66fdc0e1d39844d07f0bbfbef0e5a565da7ad05e7afc864d3d389c3f6c842c23f0c30fa9b1102a8275984187427afb1afe3aa81fc50a86cc600804a6419dc640c4d0dc724901c34023bd9ce95754f9087a1a9e1f1cec031baa6bcc8d10a808d336dc204e8c2f4f94083d78353707cff2380751e36caf1a0e87e16760914ad64bd0d4434c508628edc08e9960c660cc599dfeaae07105b556b3be0ccf1cb5d63ad4da15d4aaebee34f7b75aeea9b4b4d434b16049dbc6e4a5d36382466106cc42a73cc9323a07053aa034087e8d1a283bdd0b971cafb0112dc37607abefc2f47f47b52d5370c7b587e7da0ed3254cb7df987258fb1872663521f980dbcba05dcdfa7aab0399f2e5f796fe4c86f0fcddd9b92f5b473f7e972b28c8f77536c4a538534acd03fd8f92ab02d37a345c02c9d0e4012a6542a064409ecefab8952cbd67c8bfc9b57c8d8af33576ff5d25f8565650ae045fa15fd995825d29d8116847a01281beb013bd4c30e0b463f455920a765b9c0a46f4354692c920830b7a2b235f7ad07b0a3d963a5908534d0f2129a47c79c6029bdb01cdcdc483b383a770c946683348e544aa1bb9ae165ea0dbb6d634c3f9218ce7cb9eee092ae7f5a3a6070b248d8be2024f2704cfdb53a0e0bb669d54cee0d92129f4940b0397210f98c5d0978bfefb812daf69f84e302138d636fa8bb58db908ebfd341a43cfe5271cdfe5c9b270cf83eeb5e221a4069756f66076bfa0327d9e3a5b9c5eba73cf0597060ed248694eb3cc4ee4fe432c594e80ff1b4dfe5bb9f18545b7c2879592db15027594815510b8d91aee3a600db9842317ad4ad130413d523aa6b4c9bdb7a93b3ce3e4af2bc2be8c33142acc4c42f6087030990cb58ad16d6fd74e298498095ed4f02bea24e2a10a32aba875e0cc97cf3acd5ab349b3cd43063c4e18d76e3baac12a3ce4ed7c83a0bd6abc8d4ad72deab8a2a75db697b42a2fdde69a6aedb6438909f99bf741c0a265c131c6cc2aa1227a1b72a37488ba2420c139474a069e773a99baef2dc3e710de5cf4de5435070b4d9ab774ebb21492cd7657348a5b8d6b771b33b84016ac726f5d69ba44cd555a953bbfc59c7acf392d4ae3d7a70e78a5f59822920f670c9df742344e45e002d18da8534d45eea6e1c4da734cad2e68b74ac4ae74ddab2f71ca487f38b777822cef438432c60597f2975647ff9ea134a01216f0d13cd77c7981b41b11b30a36b854c9f22b2a69a89dbba60510f766e8b8095932ce049b3ae72e7fb9f4e54b9d59c72a88a944719776e8264a27b99fc19c00d7cc04a9207beb4e8166b75c154429bd51e0f56ce7e90e4315e74e12f9c9893e618d5c52b3454baf116ba9298cb9b539d95f70463823bd3967548fe86fc397bf91feac5fbb60664c16cfae4af64fdff617a37beded4b61dbe26e6d49a142ee52cc375b2a0b3f788a94edcda8b6cdb5612e57d12d1372b385b9f420975ef261c1be6d1cb915ae5821da6ed67642d5b92b24dc62fa427e90cb576c9508bcd95059b862a560fa169d642159e5599e1f5b506c2657d12d126ab3f642b2a2efd270b36e2e352bd4bbb2fbcfcbeef256b6abbbbbbabbabbbbbba7b57ddfdd66ac4bd7ef3b4a3d0bf49a1fe98d1b778e0be3ab30a914e9818d5051fa1074feaad238afd1ba4602ac14decc1993b3b7e0abd3ffa879da607eee771f4550e8f9eecfff014debdbef2a0d56dc1a344d3639dfd50a3e101387ab83366da0c5f4e038db31fd3bdc2000d3c39dcafc13bed4e949fecdfe39ce20d066326c9b7811a0dbac1ca4f017b6314ccfd9ccf9d77d720a1aaae1c7c30c2c07dbabb53702c9cbad73949ec3efcab3dd0b160c1048ed5147e675aced2889b095047303f3218312e528df9c73d7dd7df703b86805cd3431e5278ddcf0f35b0e2e0a3744050ea4e4a468bf38b756657cf316a705c839eb3e38e924a66226a50b472e5c1cc1aa19345a7e64ca2a05945766b7a9d83b7a734f355087503898b8140bbaee3d978fc8f38e80aa32a08bb7b25289acafb96a0152377674fe52ecba5d1a74f7f0335eca53d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137013, 12071, 15.0, 20.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c3334d53532c84dd7cf4e57f00c53c8c94f4cc9cc4b5748c92f4e050065280853', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137014, 12071, 750.0, 750.0, 'mg', 'IV', NULL, 'Adult', X'789c333735c84d57f00c030009580230', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137015, 12071, 1000.0, 1000.0, 'mg', 'IV', NULL, 'Adult', X'789c33343030c84d57f00c03000ab70255', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137016, 12071, 1500.0, 1500.0, 'mg', 'IV', NULL, 'Adult', X'789c33343530c84d57f00c03000adf025a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137017, 12071, 2000.0, 2000.0, 'mg', 'IV', NULL, 'Adult', X'789c33323030c84d57f00c03000ac00256', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137018, 12071, 20.0, 25.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c73cc29492dca4b2cc92c4b55c8c94f4cc9cc4b5748c92f4e5548cb2f52284e2dcacc2f2d56c8cc4b4b4d2ec9cccf2bb6523032d03532cd4dd7cf4e57f00c0300dcdc1610', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137019, 12071, 30.0, 30.0, 'mg/kg', 'IN', NULL, 'Adult', X'789c05c1891184400804c05426837b4ce392d87259a054b080f3c9deee9fb7aec6e89e94f081e9bdf16b61484ba4f869d06d0f3fa8a35a30152afccf82950e5a13adf0f94222716a09ccd1750c0ab299a006a35dc2cb2f9db5ee07b373288f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137020, 12071, 500.0, 500.0, 'mg', 'IV', NULL, 'Adult', X'789c333530c84d57f00c53283434ca000017b50385', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137021, 12071, 750.0, 750.0, 'mg', 'IV', NULL, 'Adult', X'789c333735c84d57f00c53283434ca0000180b038c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137022, 12071, 1000.0, 1000.0, 'mg', 'IV', NULL, 'Adult', X'789c33343030c84d57f00c53283434ca00001a2303b1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137023, 12071, 10.0, 15.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c73cc29492dca4b2cc92c4b55d070ccc951084fcd4ccf2829d6b4523034d03534cd4dd7cf4e57f00c53283434020051500ddb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137024, 12071, 125.0, 125.0, 'mg', 'PO', NULL, 'Adult', X'789c0bcd4bcecf2dc8c94c4e2c494db152303432cd4d5708f0572834cb50a8503034d03534514849ac2c060011f70c79', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137025, 12071, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c73cecf2dc8c94c4e2c494db152303530c84d5708f0d7f773572834cb00008a0108db', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137026, 12071, 500.0, 500.0, 'mg', 'PR', NULL, 'Adult', X'789c73cecf2bce4c492d52484c49c9cc4b57284bcc4bcecfad4ccecc53303530c84d57080852283453c84c53000a17e4a496a42a64e6a49616030039b813d2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137027, 12071, 125.0, 125.0, 'mg', 'PO', NULL, 'Adult', X'789c0bcd4bcecf2dc8c94c4e2c494db152303432cd4d5708f0572834cb50a8503034d03534514849ac2c060011f70c79', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137028, 12071, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c73cecf2dc8c94c4e2c494db152303530c84d5708f0d7f773572834cb00008a0108db', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137029, 12071, 500.0, 500.0, 'mg', 'PR', NULL, 'Adult', X'789c73cecf2bce4c492d52484c49c9cc4b57284bcc4bcecfad4ccecc53303530c84d57080852283453c84c53000a17e4a496a42a64e6a49616030039b813d2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137030, 12071, 125.0, 125.0, 'mg', 'PO', NULL, 'Adult', X'789c333432cd4d5708f0572834cb50a8503034d03534514849ac2cd65128c948cd033233732a8112e6c8828546bac6603e50c248d742a13c1b00e5741505', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137031, 12071, 500.0, 2000.0, 'mg', 'PO', NULL, 'Adult', X'789c333530d035323030c84dd74f49ac5408f05748c92ccb4c494d512834d3b5c850a85030d735345000ca15030006770c60', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137032, 12071, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c73cb2c2a2e5170c92f4eb552303530c84d5708f057a85030040060ed071f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137033, 12071, 15.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3334cd4dd7cf4e57f00c53283432c9000022d0045a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137034, 12071, 15.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034cd4dd7cf4e57f00c53a850300400734207f1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137035, 12071, 10.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3334d03534cd4dd7cf4e57f00c53283434d235b4c800003b6c057b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137036, 12071, 10.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d03534cd4dd7cf4e57f00c53a8503004008850087f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137037, 12071, 10.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3334d03534cd4dd7cf4e57f00c5328b4d03534ca0000363e054a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137038, 12071, 10.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d03534cd4dd7cf4e57f00c53a8503004008850087f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137039, 12071, 15.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3334cd4dd7cf4e57f00c53283432c9000022d0045a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137040, 12071, 15.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034cd4dd7cf4e57f00c53a850300400734207f1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137041, 12071, 10.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3334d03534cd4dd7cf4e57f00c5328b4d03534ca0000363e054a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137042, 12071, 10.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d03534cd4dd7cf4e57f00c53a8503004008850087f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137043, 12071, 15.0, 20.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3334d53532c84dd7cf4e57f00c5328b4000022ff0453', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137044, 12071, 15.0, 20.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d53532c84dd7cf4e57f00c53a850300400886d0880', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137045, 12071, 10.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3334d03534cd4dd7cf4e57f00c532834d3b5c800003130051d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137046, 12071, 10.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d03534cd4dd7cf4e57f00c53a8503004008850087f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137047, 12071, 1.0, 1.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb0523054482f4acc5528482d5248c92f4e0500420b06ab', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137048, 12071, 1000.0, 1000.0, 'mg', 'IV', NULL, 'Pediatric', X'789c33343030c84d57f00c53283434ca00001a2303b1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137049, 12071, 1000.0, 1000.0, 'mg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230343030c84d57f00c53a8503004006735074b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137050, 12071, 10.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b1523034d03534cd4dd7cf4e57f00c532834340200456e05f8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137051, 12071, 1200.0, 1500.0, 'mg', 'IV', NULL, 'Pediatric', X'789cf3cc4bcbb752084a2d484d2c5148c92fcecc4b57c84dac54284a2d2ccd2c4a55282d5028c95730343230d035343530c84d57f00c53283434ca50c82f523004f2f5b3214216009810171c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137052, 12071, 40.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3331c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d3b5c850a85030d735345000ca150300ff4f0c41', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137053, 12071, 10.0, 13.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d03534ce4dd7cf4e57a8503004006f7307be', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137054, 12071, 500.0, 500.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac50303530c84dd74fc92f4ed55130328070122b0167fb07d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137055, 12071, 40.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3331c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d3b5c850a85030d735345000ca150300ff4f0c41', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137056, 12071, 10.0, 13.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d03534ce4dd7cf4e57a8503004006f7307be', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137057, 12071, 500.0, 500.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac50303530c84dd74fc92f4ed55130328070122b0167fb07d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137058, 12071, 40.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3331c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d3b5c850a8503034d0353451004a1603000acc0c6f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137059, 12071, 10.0, 13.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d03534ce4dd7cf4e57a8503004006f7307be', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137060, 1832, 0.5, 0.5, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494c5230d033cd4d07005e590773', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137061, 1832, 0.25, 1.0, 'mg', 'PO', NULL, 'Adult', X'789c33d03332d53554c84d5708f05730aad02fcf0600272c04b2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137062, 1832, 0.25, 0.25, 'mg', NULL, NULL, 'Adult', X'789c0b2e492c2a5130d03332cd4d5730aad02fcfd651c8cc4b2e4a4d2c4e55283429cf5648aa4491060084690f6f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137063, 1832, 1.0, 1.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb0523054c84d5730aad02fcf060022d30481', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137064, 25848, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65230343050c84dd7513002d30080ec082c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137065, 25848, 200.0, 200.0, 'mg', 'IV', NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4eb55230323050c84d57f00c53484cc9cdcccb2c2e492d4a4d51c8cf534849ac54300400581a0eee', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137066, 25848, 100.0, 100.0, 'mg', 'IV', 1, 'Adult', X'789c1dcb310e83400c05d1abfc3248445a8a34dc80226d7a8b35594bb046b64904a707d1ced3bc496a70a53a32b23af7e852c2f2c5f0412699774c6ac89b518856e884a2be4ad02cc79d5a5cbead08c5ebd9a56bda1d8f7f91b1f08f0de2f0a2166ccd09f90f25a6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137067, 2094, 2.0, 2.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652704e2cb05230ca4dd75130c94db75608494c427001201f0cc3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137068, 2094, 2.0, 2.0, 'mg', 'PO', NULL, 'Adult', X'789c0b2e492c2a5130ca4d5708f057a830040028cd04bd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137069, 2094, 36.0, 36.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052305648c92f4e2dd63732c950282d5028c9573036cb4dd74f49ac0400989109c1', X'789ced586d6fdb3610fe2b0703fd66c72f71b242dd17d7d9900e4d6bc4eeb0170d064d9d242214a9929463a5c87fef51761ccb71eb38c3b676c8378bbe7b782fcf1d79fcd4884c914c15cbb0114063226e98129150d86842a330d22fa6cee53668b7afc5156647da24fe9768d7652d372cc768ca9c57e9757aa7ad4eb7d5ed4c3a2f83ce71d03f393aee1ef77fe856b2c89dd0ca92e4a7c620ca8412d619e6d7aa25878b0a6552e618c04561b9443028d9822917aa336d5982f0b336990d60c8f2007a59d2847e96bc82099bdd7f86ea52170e2de818eafb04f0de3019aaa1ce32ad60625884f08ea240887f30c562898bcad462b669ed2d2d393693e8bffefc8bbea45057cb0fffdf202aa49b928142253557766035c639b34e70e1ca9ae81b1589b9880a26c50d42a42dc2e83d7c3c6dbd4c21372a5463c78cf33efaf5453754176c11c071256adbbd7e0a450e4ec3f16996b42356866a42a9314ba85eab0fcb652f72d61e828809564bad128ca0b05536377cbcdde7f337ecc681d91b6124983382efcae098c5e8ca36c6b1e08c97a0b403b41e4ed894b6140af23b7dc88964a89c7d8211e31cb960723ad27921d93d5bbec6a491c14431c5cbe925696c193e24291151e09874681409cc291f8521398ad84a3154236dad98f94213f6ca170cb9cb24a4cc64db8ca0cfb78cbbcab8a917dfbfdf752a087a6690b81223c549253bb6142aa60a078b51850d4c459096b9764890d41c1eda71898a62b5235d552552773043093ff64e023843ee775f527107d239faa4ed4cfd0aeb1d653cc2981a5e74688dfc0b09dae6c473860ecad07f16aeedbc7d27f1fa1b666e7bfc8fda7930f881ed9ac841570a41871ddfd1ac0752a249aa338a4b666ddbdfb64235986b11019b992277702d5c1a1976cde4932e1c733416a797c8f8e3ce8a311aa18bba5c1524edf4a23ac643f59aae432567868eb3503543b541593ab74bc5758ea13a6752165ca8a5dfe49562795ad22d4dd84a6bec704e4aad5f74aa2c91df962a323a23cd26e022d652ac5a1d9a8c7e39af3658c6840ef4002e71a60b2a98f3c9bb2638c6d395494d5f42689c5682eda0fdf24a57f3ef3734da3a9d7977c63a535aa2e2482646e2e686126fbdc1a0d0cc2932cbcf0f93377ecd7761664a880d7e2cb0eac3be1d3891575e577efe4ac0aeaaffb3d25e79b887767d258f5f4ac3fe1bf8963ced718fb591c2fd409bc23594ad5eb5c79c0de11aca8a31fb11ee046bda759a3dc28cba7c0d6b83a2fb813685ebfe7c81d88f70b0ae395d6bd6f0d7acdc0f78b616ad21107bf7eb7aa19ad626b3f7abd7a46b387705b11f632d79bbbcfbfeef7ad376f77d6e4ecfcde9b9397d97cde99b29ddc75f119fb3d618f9f998712d75527f9fa24a8c5b52c41840efe8045213aa0b1aa867d4fa6d16c05beafee6150c7f1ff54f3a0174073df071f7cf877448fcb4a09966f98ef881328970da79d1a4819ca3855ee7c5132ef217c853a668eba98ea703fee02df4358d18b69a23d00f1c9286d13c65ad1eb0c820312c111c0ced9f3b6d6c9306cf6ae85a3d215025b39ca620c8a8211b226461a83308958a9958cfa50623df9912b0eb073d22e5723759829f2f96f13fc4b3dbdbcf0520aa04', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137070, 2094, 2.0, 4.0, 'mg', NULL, NULL, 'Adult', X'789c0b492c482d5248c92f4e5530d23551c84dd74f49ac5428c95770d17756c84c532828cacfc9cf4b4f4d51282d4e05004f020efb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137071, 3846, 1.0, 2.0, 'mg', 'IV', NULL, 'Adult', X'789c33d435ca4d57f00c5328282dce000018bd0404', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137072, 3846, 0.07, 0.08, 'mg/kg', 'IM', NULL, 'Adult', X'789c33d033305728c95730d033b050c84dd7cf4e57f0f4d551282d2e4dcc5148c92f4e5530050a2ba4e5172998192800650b4a006b740ec7', X'789ce5576d6f1a3910fe2b23a4935a29c0420249e97da170d7462a5194b4914eb727647607d68ad7dedade244b95ff7e33bb2c6fcd352957dd97fb04d833e3c7f3cccc63be36629b2fa65aa4d81840632263b1344aa48d2368e456f15ae27de606edf6bdbcc5b465ec82bfc9f68ea98bacc8309e0acf1edda0db6f069d6627f8149c0e7aa783ee9b56a7f3e6f8a45bda62e4a5d18e2cbf36ceb5b7a6fce6f1a174be460c7564a597915010098bf02597d12d589ca3451dd1f6dc5860dc101b870e6605dca35c24be15eaf2847cb67dc8232d793153c8bffefc8b7e29a96fab1fbcf71e355aa176507c2a321c84fa1deaa589a558622635ba508f8d130b84df8d4ddd00ce6f423d32696a347cb22246b8a03cd2fa0d5a87f18f41d99cbd77e8f354ec3b3c96d71ac6b9f253022cf562e76e43fd208d2a9ca4fbb4434d4805030c355db8d3eca60bba1764b94b421db48253f006e8f30cd245fb96f6264790bb9cb8e1e4438f9681f9e80740bb990ff535ca656eb18a1770b8499b33753efa0cd7abc368eba311f1003a41b317a45115fa06a49ee7ae043311527bd482081f4037a0620aa0b26b2776cbee3381b8973e01e7858e858de51263a82f059935de44469518bdf4b65c3e949a3aecf39cd4176d50dcede22e53f312f7cab0a2f212895d6f65f4149dffb26136d5d0761b72faa969f60a3b60e67bcda0d5a9d9af2ba3dfec7457fb5d36087afb16dcda420b27d476499043b7b6bc8058dec998e89aa1bf47d4a08da36b2a2acc4b6b228c73eacb3597a52f1dd57f89ffe65aecd6dbb8bc4ac54355ba1d2aa8c5eb434be1bb197f9ee0d1ca7dcaeed3d27dba71ff1945739d6124e9804b93e54a6c466e1df6d2e282dbab802bdad50b2667cc7de7d16aba574e297289b15e15945faa20841895bc435b8070ce50704fa92f7b6fae4c9615dc95427b70858ead4989ee8f22f22beec692a999e5ec2335cc2c0ae72195eaf6a83caa8c1389bc1a4557c810aa6aa7722c6719c5c088dd900bb817fc52f6b4434284947a76980ba9ca3a5b774ca83f604610a26f82518529a317042752282c0f1a0616496b13530ec77590436b643fc5cf53386635ae8cdd54eae93ac28ad491e1ae923aa6daf996d2a1526817054fec4811476deef903147118dfb1824daf5044df9ef24440aa512b4dbe8726d32828ff456636df68a457737b4cb564659e86fa08ee13ea5d2a82b864345b139371d4d8312d2c1e0e7d9dc52df4555a5884774e1f5b73ef580e89c80b41c145fbcea4f2a9002fe2b2c6fb020e6bcb9d2e7e02c3f7c3ec3bacbafa3f4ef43ed1ff9f4cfff84d0f19113f09ec65226c2ae89d6316c5ee9447710b389f132e1a7de793018c12a9621a97f4f6eaf1a4382619949ae6b27b0be56824c5a435dae9af77c8f36600a5f9e9d6da5ae107a598d6ebe3dcae5e94ec754d281596923b805fbb9098dc3a78c5bf9b3166a863d4fef5519e9547aeb62b35d88c6206fe79dbe22d4c50d01d56f176c16c5df18c7d4e3a1b701f849a37959c13984eebacd96f9d406249f690a8324aba7400f5f7652555a5e6b1e48cfeb83c1e9e70401e8b7708e9cad0238479703cebd08337d4cda420f97b28d2fa1f52a87f7b20e1aa74b054363e2f4a84a6e3c0cc6118557ba38b6bd2d8cc5281918eb678dd81f0f07ef86e480a1761e6f9156b08d54a08e716bfe4c80a4361a244194bef21e0d01a1518ca2e65ff887595c50f12fa5b6333c264e5b27a1fd39b995fce33a9ea150aa431b786f534c5744659c5d6012242efd2e950b9dd7f771b9660fb2d7d48e7fc43a8ef77cfc669ba76aa3ae8aa7e7cedced6898cf82913e3c38fa6e0f1f16f095b43ae', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137073, 3846, 10.0, 10.0, 'mg', 'IM', NULL, 'Adult', X'789c3334c84d57f0f4d5f70c03000eb302ba', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137074, 3846, 10.0, 50.0, 'mcg/kg', 'IV', NULL, 'Adult', X'789cf3c94f4cb1523034d03535c84d4ed7cf4e57f00c53c8cc4b2b2dcecccf030080c20950', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137075, 3846, 20.0, 100.0, 'mcg/kg', NULL, NULL, 'Adult', X'789cf34dcccc2b49cd4bcc4b4eb5523032d035343050c84d4ed7cf4ed7cf2852c8cc4b2b2dcecccf0300f3980cca', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137076, 3846, 0.05, 0.1, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33cbcdd735ad2cb25230d03330d535d03354c84dd7cf4e57f00c5328282dce000085ee08cd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137077, 3846, 0.025, 0.05, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d33534aa2cb25230d0333032d50592a60ab9e9fad9e90a9e610a05a5c519007ee00885', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137078, 3846, 0.2, 0.2, 'mg/kg', 'IN', NULL, 'Pediatric', X'789cb35230d03352c84dd7cf4e57f0f45348c92ccb4c494d51484a2d294f4dcd53c8cb2f2e29cacc290600e9fe0d38', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137079, 3846, 0.2, 0.6, 'mg/kg', 'IN', NULL, 'Pediatric', X'789c0b28ca4f4e4d292d4acc51284e4d492cc9cccfb35230d033d235d03353c84dd7cf4e57f0f45348c92ccb4c494d51484a2d294f4dcd53c8cb2f2e29cacc29060097cc1581', X'789ce5576d6f1a3910fe2b23a4935a29c0420249e97da170d7462a5194b4914eb727647607d68ad7dedade244b95ff7e33bb2c6fcd352957dd97fb04d833e3c7f3cccc63be36629b2fa65aa4d81840632263b1344aa48d2368e456f15ae27de606edf6bdbcc5b465ec82bfc9f68ea98bacc8309e0acf1edda0db6f069d6627f8149c0e7aa783ee9b56a7f3e6f8a45bda62e4a5d18e2cbf36ceb5b7a6fce6f1a174be460c7564a597915010098bf02597d12d589ca3451dd1f6dc5860dc101b870e6605dca35c24be15eaf2847cb67dc8232d793153c8bffefc8b7e29a96fab1fbcf71e355aa176507c2a321c84fa1deaa589a558622635ba508f8d130b84df8d4ddd00ce6f423d32696a347cb22246b8a03cd2fa0d5a87f18f41d99cbd77e8f354ec3b3c96d71ac6b9f253022cf562e76e43fd208d2a9ca4fbb4434d4805030c355db8d3eca60bba1764b94b421db48253f006e8f30cd245fb96f6264790bb9cb8e1e4438f9681f9e80740bb990ff535ca656eb18a1770b8499b33753efa0cd7abc368eba311f1003a41b317a45115fa06a49ee7ae043311527bd482081f4037a0620aa0b26b2776cbee3381b8973e01e7858e858de51263a82f059935de44469518bdf4b65c3e949a3aecf39cd4176d50dcede22e53f312f7cab0a2f212895d6f65f4149dffb26136d5d0761b72faa969f60a3b60e67bcda0d5a9d9af2ba3dfec7457fb5d36087afb16dcda420b27d476499043b7b6bc8058dec998e89aa1bf47d4a08da36b2a2acc4b6b228c73eacb3597a52f1dd57f89ffe65aecd6dbb8bc4ac54355ba1d2aa8c5eb434be1bb197f9ee0d1ca7dcaeed3d27dba71ff1945739d6124e9804b93e54a6c466e1df6d2e282dbab802bdad50b2667cc7de7d16aba574e297289b15e15945faa20841895bc435b8070ce50704fa92f7b6fae4c9615dc95427b70858ead4989ee8f22f22beec692a999e5ec2335cc2c0ae72195eaf6a83caa8c1389bc1a4557c810aa6aa7722c6719c5c088dd900bb817fc52f6b4434284947a76980ba9ca3a5b774ca83f604610a26f82518529a317042752282c0f1a0616496b13530ec77590436b643fc5cf53386635ae8cdd54eae93ac28ad491e1ae923aa6daf996d2a1526817054fec4811476deef903147118dfb1824daf5044df9ef24440aa512b4dbe8726d32828ff456636df68a457737b4cb564659e86fa08ee13ea5d2a82b864345b139371d4d8312d2c1e0e7d9dc52df4555a5884774e1f5b73ef580e89c80b41c145fbcea4f2a9002fe2b2c6fb020e6bcb9d2e7e02c3f7c3ec3bacbafa3f4ef43ed1ff9f4cfff84d0f19113f09ec65226c2ae89d6316c5ee9447710b389f132e1a7de793018c12a9621a97f4f6eaf1a4382619949ae6b27b0be56824c5a435dae9af77c8f36600a5f9e9d6da5ae107a598d6ebe3dcae5e94ec754d281596923b805fbb9098dc3a78c5bf9b3166a863d4fef5519e9547aeb62b35d88c6206fe79dbe22d4c50d01d56f176c16c5df18c7d4e3a1b701f849a37959c13984eebacd96f9d406249f690a8324aba7400f5f7652555a5e6b1e48cfeb83c1e9e70401e8b7708e9cad0238479703cebd08337d4cda420f97b28d2fa1f52a87f7b20e1aa74b054363e2f4a84a6e3c0cc6118557ba38b6bd2d8cc5281918eb678dd81f0f07ef86e480a1761e6f9156b08d54a08e716bfe4c80a4361a244194bef21e0d01a1518ca2e65ff887595c50f12fa5b6333c264e5b27a1fd39b995fce33a9ea150aa431b786f534c5744659c5d6012242efd2e950b9dd7f771b9660fb2d7d48e7fc43a8ef77cfc669ba76aa3ae8aa7e7cedced6898cf82913e3c38fa6e0f1f16f095b43ae', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137080, 3846, 0.5, 0.5, 'mg/kg', 'IN', NULL, 'Pediatric', X'789c73ccabc8cccfa92cce2cb65230d03355c84dd7cf4e57f0f453d0c84dac5048c92f4e553034008a6a02001bbd0cc4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137081, 3862, 80.0, 80.0, 'mg', 'IV', NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494cca492d2956c82f52484e2c282ecd4905b2d3140c0d74148c80d804882d0c72d3f51402f2cb53528b4072f9b9a905458955f939a90ac5f92999a5b90a6940dd9e617a0044871d98', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137082, 3862, 20.0, 20.0, 'mg', 'PO', 1, 'Adult', X'789c3332c84d5708f057c8cf4b4e554849cccca9d4512849cc4ecd53484cca2f2d513054c8c82f2d52484a4dcb2f4a55c84d4dcc290600b35c117c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137083, 3862, 40.0, 40.0, 'mg', 'PO', 1, 'Adult', X'789c3331c84d5708f0574849cccca904001a33042b', X'789ced586d6fdb3610fe2b077f6a503bb19597b5de30c048d236d8920a6e3a60ab0ae12c9d252e14a991541ab5c87fdf51f2ead8d11627088660eb071be2f1782fcfbde8c42fbdd45459acb0a0de187a6f0b2a0d7ed6927a7de855467a62ee5c69c73b3b9fc40515dbda64fe49ecacf2dac46049698cce1f0986c1c160381a8c86e7c3efc6fb2fc6bb2fb77783dd9707a386971227b4b2ccf9a537490ba18475063dad2139ba6aa49cd7258d23151aedb482b22a4a102a1733e1b489d4b3303cd98ad491b69811bcd2a6b06338c7992467411b48b0b495247e9ec368d887807f7bfc7b312cb26d08f5a7948cdfd35ffd00ab53511530e7d327bf6c476aaa2bd70a58b5720ce1db3eb344ea501705db766e3025386314d986d008a9d9c7c6d56a76d3db6b26396fa25f7df8c82b29d445b358badde9efddf1688fc5fe58bc3c76fdd1eb9ca4957431432554b60271878dbdd7c7d3a315a68011638f41ab84204521eb3e38bc20053863846004b9ae0ccc8881232808a5edad3aea6d08a97422892b9990b12bf2f716f21bd11d277fd39261cac8c4c7fc60d9495babd4e8266797620e1662fe783108f6f27539ff007da3e4b1bc5e47f389bb7d0ff3d63dfb57ec7bb092cd2b6f81432ad01986e21e5512072b6c3f8ca02634637887737235a04a81e67391605283d20ec87a1384cd298dd43e7747b8c8c6b00f0bdb8fb08ed46838085a3a6fdfdcf871410e6e923bd2e6d8b00397141f5b5de6980927ecba95dcb25cbea199938c52581c01a761e164a4769bd57e6bd376e3446be87ecb76c3b9961e554170b03fbae95cbbd1aa188c0e1ac9b64bc20d789abd6e885a0d9be0b44937781ad15dcfbb6fe17d84f07e0371b36cbb0bc777252502651ceab292b84cd2e528439942c5984d795765118f4e8791fa1913d7708311f6c2134fb1e6372994862c29c7630f14425e74e5ff94142bec68d2671a30fdbdb2ae60091d7df10d95e8bafbfb1907d4ba2a1594de2393fedecdbb87b5233f75b7cc96a7b5f8ab841e2b5c0a5e05ea6eb15ff963cf1f27e828d346b0f1ed1cb83978ebb03f3a7af78cc93d13f3904bd1a0502957ecedb49c484926ab7d952412adddf11f410fd032492f796aa2784a98dcd6d205e33b3242576bd66406552575523b86814bfb9561711597421fb475a44beddb951d18e21af3fda6818da7fd2b9108c7351d72e61862479d3f7ea21c5be517284151999b963ecd7196eaa2d6b266691d15d27eccacd8f68630c524a73ea4e2f367a1c8b2a033ac2ce1cea52e844f60bf87c6e4847d6834084e322819fd3eccd962fe08e3119af7129102e77965b8e13651e943c2c0385136ab48bd9f9e785295e56c2d5afe7f8dd60f6550b2d125ab9e48ddb41c7e72867b376f650d8bbbedd19dcdeb49c5623d53fe67c1f80fb87bdf2f8e1c4d8189963aab57fd46391f4831a7b17fe16f07cd7726ebff30fa18a95362999a078f620c8bee09cf0e7f0d83c3d1cb3ef0c3ee646f8b7903e63dbee24c6cef2bde1bc6ef01469e5292a3626db19ec793e4d6154d189e7c0f33eeb3d637d337cf777e7a3ea02b7f26e3e8c0e43c444bf0ac5c5e696cf9977bf617b4c82f27c7114b484a2e31aeb34afab87a265b957e1eb0fef5a7e73043cb8c7e10e3a81555537e6d5cd9a1d6cf874c3044f1445abd36b6787307b76f601e7e9dd3216c93eb9cc1edeb9cebeb3f01156a87e5', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137084, 3862, 60.0, 60.0, 'mg', 'PO', NULL, 'Adult', X'789c3333c84d5708f05728b4d03532c900001c3b03be', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137085, 3862, 5.0, 5.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33d5353450c84eb7523055c84d5708f057287449ac040037cc05a7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137086, 3862, 10.0, 10.0, 'mg', 'PO', NULL, 'Pediatric', X'789c3334d0353250c84eb752303450c84d5708f057287449ac0400402b0600', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137087, 3862, 20.0, 20.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb3333250c84eb7520052b9e90a01fe0a852e899500391405b1', X'789ced586d6fdb3610fe2b077f6a503bb19597b5de30c048d236d8920a6e3a60ab0ae12c9d252e14a991541ab5c87fdf51f2ead8d11627088660eb071be2f1782fcfbde8c42fbdd45459acb0a0de187a6f0b2a0d7ed6927a7de855467a62ee5c69c73b3b9fc40515dbda64fe49ecacf2dac46049698cce1f0986c1c160381a8c86e7c3efc6fb2fc6bb2fb77783dd9707a386971227b4b2ccf9a537490ba18475063dad2139ba6aa49cd7258d23151aedb482b22a4a102a1733e1b489d4b3303cd98ad491b69811bcd2a6b06338c7992467411b48b0b495247e9ec368d887807f7bfc7b312cb26d08f5a7948cdfd35ffd00ab53511530e7d327bf6c476aaa2bd70a58b5720ce1db3eb344ea501705db766e3025386314d986d008a9d9c7c6d56a76d3db6b26396fa25f7df8c82b29d445b358badde9efddf1688fc5fe58bc3c76fdd1eb9ca4957431432554b60271878dbdd7c7d3a315a68011638f41ab84204521eb3e38bc20053863846004b9ae0ccc8881232808a5edad3aea6d08a97422892b9990b12bf2f716f21bd11d277fd39261cac8c4c7fc60d9495babd4e8266797620e1662fe783108f6f27539ff007da3e4b1bc5e47f389bb7d0ff3d63dfb57ec7bb092cd2b6f81432ad01986e21e5512072b6c3f8ca02634637887737235a04a81e67391605283d20ec87a1384cd298dd43e7747b8c8c6b00f0bdb8fb08ed46838085a3a6fdfdcf871410e6e923bd2e6d8b00397141f5b5de6980927ecba95dcb25cbea199938c52581c01a761e164a4769bd57e6bd376e3446be87ecb76c3b9961e554170b03fbae95cbbd1aa188c0e1ac9b64bc20d789abd6e885a0d9be0b44937781ad15dcfbb6fe17d84f07e0371b36cbb0bc777252502651ceab292b84cd2e528439942c5984d795765118f4e8791fa1913d7708311f6c2134fb1e6372994862c29c7630f14425e74e5ff94142bec68d2671a30fdbdb2ae60091d7df10d95e8bafbfb1907d4ba2a1594de2393fedecdbb87b5233f75b7cc96a7b5f8ab841e2b5c0a5e05ea6eb15ff963cf1f27e828d346b0f1ed1cb83978ebb03f3a7af78cc93d13f3904bd1a0502957ecedb49c484926ab7d952412adddf11f410fd032492f796aa2784a98dcd6d205e33b3242576bd66406552575523b86814bfb9561711597421fb475a44beddb951d18e21af3fda6818da7fd2b9108c7351d72e61862479d3f7ea21c5be517284151999b963ecd7196eaa2d6b266691d15d27eccacd8f68630c524a73ea4e2f367a1c8b2a033ac2ce1cea52e844f60bf87c6e4847d6834084e322819fd3eccd962fe08e3119af7129102e77965b8e13651e943c2c0385136ab48bd9f9e785295e56c2d5afe7f8dd60f6550b2d125ab9e48ddb41c7e72867b376f650d8bbbedd19dcdeb49c5623d53fe67c1f80fb87bdf2f8e1c4d8189963aab57fd46391f4831a7b17fe16f07cd7726ebff30fa18a95362999a078f620c8bee09cf0e7f0d83c3d1cb3ef0c3ee646f8b7903e63dbee24c6cef2bde1bc6ef01469e5292a3626db19ec793e4d6154d189e7c0f33eeb3d637d337cf777e7a3ea02b7f26e3e8c0e43c444bf0ac5c5e696cf9977bf617b4c82f27c7114b484a2e31aeb34afab87a265b957e1eb0fef5a7e73043cb8c7e10e3a81555537e6d5cd9a1d6cf874c3044f1445abd36b6787307b76f601e7e9dd3216c93eb9cc1edeb9cebeb3f01156a87e5', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137088, 3862, 2.5, 2.5, 'mg', NULL, NULL, 'Pediatric', X'789c335628c957b03155c84eb75230d23355c84d57287449ac040046b1064c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137089, 3862, 5.0, 5.0, 'mg', NULL, NULL, 'Pediatric', X'789c335528c957b0313450c84eb7523055c84d57287449ac0400411b061a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137090, 3862, 10.0, 10.0, 'mg', NULL, NULL, 'Pediatric', X'789c7bd4b9d4d040213bdd4a0148e5a62b14ba245602004d3906c2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137091, 3862, 5.0, 5.0, 'mg', 'PO', NULL, 'Pediatric', X'789c335528c957b0313450c84eb7523055c84d5708f057287449ac0400536606d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137092, 3862, 10.0, 10.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33345028c957b0313250c84eb752303450c84d5708f057287449ac04005da70732', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137093, 3862, 20.0, 20.0, 'mg', 'PO', NULL, 'Pediatric', X'789c7bd4b9d4c840213bdd4a0148e5a62b04f82b14ba24560200619d0783', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137094, 3730, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137095, 26576, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137096, 592, 5.0, 5.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65230cd4dd751303400914660d204480200c7c40a65', X'789ced59d96edb4816fd950b3fd9804489d42e377aa0c85bd27662481ee4210a8c3259222ba68a4491b4a33432df3ee716b5b7a6bd74d03383ee179a6255dde5dcbdfceb41608af0568b993ce8d3c11ba9c537991a151f54e8a030317f8cf23ccdfab5daa3ba9733273121bfa9daf6decc372295c1adc8f98857f7dad5ba5b75eb37f54ebfd9ed37ba4eafd36a755dbb57fab94a74869dbf1e0c8299d22acb8de06ff6532ebf5a2a37f354f6277a303c25a52375a7f2c44cf449928950d2596266599f5ab3b0426e9d9f9e7d36f19ce85152e432a3644adbf4fb74fd61a287c96c9668ba312290f41eba83d065924b9d296d052cee3665fc8e4fb9b88b25fffaf419bf62a5efed8fb5b05b523e8d1eb6dfaeb77fffcc3c064111e7b7d04fe9700b08afda8556101d1c28d1921243f963428150f19c822483642f12dbb2bb968112b951fe3e963fb7e7499fea8e57ad3bed5958bb0f4b6e159a89af16e45a20e6afe03a4ea5af447c7b9da4452cd67eb064bc87e4c1b591a116da9fdf8e706247d2a1c8659898399dd0e154e62226a3b27b0a244c6ccd2e83a3836da1588e4be1e796fd2d6fdfa2f8564f85ce4b322a23f69f9988f7d0182104e27de8594bf6e9fc6c443f35ea6caea1a19f1b70d72a43574239d12b0bf4492760287d38a6d4810c484d97a7f7f0bd902944df6bb705e7f72027333ea6b248065bac76d676e93fe9363fc218bb16fedb1aafb4c6ab80db45ff2f89dc9fa6f42edaff55ad7f38f317a6ff61a29106940e94bf27f90fe2589a704e79427e2cb2acc6dd093a001daa442289088a50ca915fb8866b00ae7276710171ee95919a8a4c728d84c077126a122b2b759e6def8749612e7ca7c39f1aede888b4ed63e680645dc3333a944ee85026fc021fb0be2f733da5ef2078902693b72329fce715bbb1342a297670590130d115125aa4d13c06c14405d0a4a43cd1e3776360151aa18b38f1e7394c9cf1fe4f9fb42c7293a4522b1058b80094f60d6fa940671f543278eee5d90d8ed8d020354b853270e97c4fe8962dd4969027eadb37a565c63c998b08841f4946be08a3893e03d3b0902f70d87dfa3fa3b35aef05ed350da0f3f461deb4756a07ce67b0df39b0456d05d1d374d65bb7282c617d9ac06ae7d6796b8ca70f97dbcab6f47fd42177e3e66f8ffccb78e41f32f56b86bbff4b94ae236166c24fe2249c6f617521e269355653d9a745cd77eb55d78d2a94ae4bfdbf5a80ed0a2dfc5d82ea3aeb535446e9449f7e457096c3b4e1b8acd09d8a9530af9906afa41f098ce7b3db647a3bf07f7305b03555f797af19f989e6ba8aed3ce30b0eb0727ca7b7dc3c6c7d785ba1c748f911a69032ab64f420b2243530123a014e560f2a9fe350804e02d3742e0d0fd9cb85d70cb952de0ee22cd9867d9e4a6385e2dcb8a5d90bc7f7fd349fe15a9bbbb793ca6fa479c1f545b670b8919c4a78842f776ac5e5e5c5e0863e4ca7ca87cd2ccec3243181d2c2f65953bece88242d360e933886d7f185cd83a491cca430b0deb9498ab44293c2abbbfe95f882431f8a1c3d1dec09335fa830aa8e78d6596b89e3d78b069046608bfeef1b6a0a1c64b07690ead0fa128fb274aabfcd6792de2e35b3cdbf887d55cc680847d532a637c8a4f7d2d0434627aae04840b4dcb0f83a57d1266f56f452a52aa85e268f28a260700307ccb982b11098a41ff815116f721ae4b9f0efb143a1d41d96581c55acba01bd1b5c0df886abeee1d9ed1e7a8da3bed7ebbad55ec7a14fd7c5dd15f472bd66a7d769373ec3bb66e0e70b6dc194a1e428f97007cfe6e056429756389fa3e4727e40538d767730fc707e54a11b0110cf12e3e394a64d9f619c57e3bff39ba574bd349269029dc0d51af6e5d258bd7bcf97a524b7a4e1002ab771ec7ade61eba8efe22ff25bc35d43e535dd16c0ecd0265627766a803b0d9018201787225039191c39ebb5a130d292ef1d37bdc3ac48d398dca3fed8ad8edd5ec399688e18048ccffb82c5a92f49619029331b40c85dd021af35bdda988f4bf6875b77a21d1af8081e6e7bdea16223a32231572c2f87c5e4c41488199dc2153e4a1dc209dfff52a13786c72978f87985240f43c77b0187e081b2c560637de17a1bfa6e237e6d380be2fdbc50818cb9b01dd3189b2512e6d4460753453ef58b589832aed06fa01db4367d0b550d3b3967b5f54988731321c27d747de3c284d2aeaea4da94c73201632cc4884139e3bbdcb9b54093061703a4a221854be956b964869e34b4c832b3e518488f2a8f30aeebeaf8a62a63f950f2c084974bd414a47d063d9bebc024f65658a0c43de5c96b606b7f0457fa94168bb99a453165292091a6a06553dc3bb0b78c972c4b148edbcd43af897cd0711b553c9a9f9da7b64ab7d1ab4acfeb3a14248aebbfe3d6dd76ed8bf345f8bec35b9d7acfa9bb1bd9c56b79ed7ac7ed72c4e81cf8d2e9550506bf93341ee225e6d8a477e385132e3335cc53839936155ddae86acb46ab4cfd916d04fb9caeec73354f7c56031ec0975aa644a64aa75f252cc7a9765ccc66301d1a9a67a49e1f65b0c38f46d9b2c1fda8ca732939ab8fe483caa465eef67abd972a3eb0beb857e35535182ae32f2ecf6d516856c875eb9cea5add6eb5dd6823933c081573f740225fe5a4c7c747c75f9f1591281352a85649695ac4710dc46aad1a684df4aab6b4bc6eafd1ddb1fe05c7387b81417242f48474fd71c7fe10af0318fd82d3da3fd340e472659b856bb0063fde3f9c3fd31756757a37eeac7dba156ab9871e42148d76b3b751b1bb6ecfed34db8c2ae04ba6533a1f21a34b741a794e1faff8dda03eaec20a95c8142157becc37685200393243391f9fc1e46848fa545eeeed426a7bfd45fb15a93840abe6500b58cac0a16b7c11d89d464a54e87ad0df8bd67534cfca8a7dcc7a755096de887b83e2737ec9354919ba1a395bdd95bfeeae64d95dadfac6aa58400c2456c9d866ba4c1a745cdcade32014e8f305761ee121c8177cc9c70a81341a4afd0fb81ffa435b6ae00bac0d64ab1fbb6d1b12ed6eabda46655e835eef78cd7aabf599858fa728cd68af2a749e08fae5d2a1f5ff35d983d0a229f9c8baf3d8912e46aa60aec50cb58bb15c7ebb879cf6ca91ef35a0309cc2aec3f3f85fa305af49ee81853f671da3cd668637429d5066369d45d603a7a53d4b93670ea713979b0ef47e2dd7adb61a3dc7661bf9b8a15cc7ab37ba4de83644f42024fe435bb32aa9fb12dbe9579bcb57690db17cf0fbe4b8ddfa7d9acba05e34bd4ba5b7637c451bf85886a23239e03704d672cd36448d0a355a87e365f7e5563dd7735e3aa87dfffe6fef2769fe', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137097, 592, 2.0, 80.0, 'mg', 'PO', 1, 'Adult', X'789c33d2b530c84d5708f057c8cc53c8cf4b55c82f522829cf574849cccca95448c92f4e2d0600bef70ba0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137098, 592, 0.2, 0.6, 'mg/kg', NULL, 1, 'Pediatric', X'789cb333abccb75230d033d235d033cb4dd7cf4e574849cccca9d451c84dac503031000aa524560200d0c60b67', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137099, 592, 5.0, 40.0, 'mg', NULL, 1, 'Adult', X'789c734c29cd29b15270770b52b0313650c82f52702e52b033b65230d53531c84d574849cccca90400c45a0a81', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137100, 27251, 30.0, 30.0, 'mEq', NULL, NULL, 'Adult', X'789c0ba92c48b55208c948ccb552303650c8752dd4373400d23e0a1aa6605a53213a27b124b54221ad283535160040ea0db7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137101, 27251, 3.6, 10.8, 'g', NULL, NULL, 'Adult', X'789c15ca410a02310c05d0abfca56eca9482889e40d04364a61909b40da6a9e0ed9daedf7b3471a172438c11ae4829a13ea13b9690f042d7325cb4e194c26586b8842bdee73b2867994205547534efa8f4c3ca30fe0c31ceb36fdadcf4289b64edd241bbb381ccb8fb31bf6c9d73f80323542d04', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137102, 883, 16.0, 16.0, 'mg', NULL, 1, 'Adult', X'789c0b4a4dcecfcd4dcd4b494d514849cccca95448ccc9c92f4fcc4b4eb5523034cb4dd74f49ac54d000aad0d451303481f1cbf34122009db814a9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137103, 883, 250.0, 6000.0, 'mg', 'PO', 1, 'Adult', X'789c737674d151f0f071b152303235d035333030c84d5708f0574849cccca954c8cc5330d2355648c92ccb4c494d5148c92f4e2d060048970e77', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137104, 883, 150.0, 500.0, 'mg', 'PO', 1, 'Adult', X'789c0b48cdc9494c2f4ab452303435d0353530c84d5708f0574849cccca954c8cc5348c92ccb4c494d5148c92f4e2d060044b70ecf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137105, 120, 15.0, 15.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652704e2c282ecd495548cc4b5108494cca492db1563034cd4d5750533036c84d070064db0ea3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137106, 120, 15.0, 30.0, 'mg', NULL, 1, 'Adult', X'789c3334d53536c84d574849cccca9040017a003fe', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137107, 120, 15.0, 15.0, 'mg', NULL, 1, 'Pediatric', X'789c734c4f5530d4353454a84c4d2c2ad651284fcd4ccf2851b03136c84eb7523034cd4d574849cccca90400f3c50c5e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137108, 120, 15.0, 30.0, 'mg', NULL, 1, 'Pediatric', X'789c734c4f55b03354a84c4d2cd251284fcd4ccf2851b03336c84eb7523034d53536c84d574849cccca90400f6070c2c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137109, 7520, 50.0, 200.0, 'mg', 'PO', 2, 'Adult', X'789c3335d035323050c84d5708f05748ca4c01001ef40427', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137110, 7520, 12.5, 100.0, 'mg', 'PO', 2, 'Adult', X'789c3334d233d535343050c84d5708f05748ca4c010025880487', X'789ccd56dd73e23610ff5776780e0e90e368fdc691a6e9cce5ca00cd4b7de311f262ab91258f2487f86ef2bf77257324e6d2908f97be8024efe74fbfddd5f75e66ea3c55acc45e0cbd2b74ba325a6ad93b815e6da43f2c9cab6c7c7aba15375846dae47e254ebbb2961b56619632e7554683d1c7fe60d81f0e5683493c9ec4a3b3e8e387d12f1fc64116b9135a5992fcdefb1d151a26c3dae15d505f3515c689fa848ec15a6a7e83c626ea5c5b96235c6853da18566c2dd1c5301a43999fc0d9246a17e341f89b8cfdef70e07711fc711dc32d33c2eb246aa6cb522b581996217ca1d4c9dc67ca05add5260458af1fc7784f47ceabfadddf5f692785ba099b87983bc11e47cf8ba77bf1fbafdec734aba54b294da1f20e1e4fc4d4bb248c8c4365e9a4233c1ef447216d98ff096b91f5bad17b47b3cb8b8eca70148dfbc3234a5722374c284ce9d2aba291ec4ed88e95d1111bcfc0181c2c2be482c974aeab5ab2874c7fd89f1bcc1553bc81057d5579a2629825ea33e32e48136316a8988416c144053c63f8a28165ffd4d695a81c28e474cfcc34899a63269833823f2373891519e73fdb7490e186e0c8a0d05bbc45039c0216192d0c6635a70f99b608598de034143b3b25ddfb5a4b61cb03ffefb6f756e21ec27a9cbbe7be65b4c236152add5bd8f178a695f354c9047fe21aa752a2c91b9f0497ccda53df8112b514aab6b0a69a6c3833040c617ddd1614d57e865c9715b19d390282f1da21108b131564758e8ab0b0050927aa682afda3305e85c9ae08097b8be90219ff39f8a72a718946e8ba2b17627b32197fac152fb4ad587b6987c519ba53c7da8660cc6bea5c99f8f68d38620322a1615114b46e6ca590bda2e03a911ebf712fd4deed7b933d04efff9dedfba27b25f3e6053325e33451f3a6e3f292c94d5f8a0dc670d69f507fa8fd38bcda573e4d2f41a44dd46f77dc606885103aa117e2055324037a0353de7e5ba2f461dd22f829d41f52eb337e0ae75443865a5fe5b401a61ccb35a9ba37a4b2444ca7d2ea6ee12b27983145e38a5270ca60c624177509330a51a1844fed388495be135c38eabe53ea8ed4d02fc4da08d9ce04d80a57c0e27ad17d1f503b6995deda060fa23bce924305f2f2886747527b01095b0be9ce42bab390ee2d74fc3d07d40b5209dae963edd46ba75ebbe3e73f217ff96b27ddabb535b6c00d12fd38769bcac3f332063f7040a80dbdfc427011fc55adf439cd8208b6db6d54136333bfa3211111cdfdf4a63131ad281d189dc06830fc357a2d8defefff0593a6c789', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137111, 7520, 25.0, 100.0, 'mg', 'PO', 2, 'Adult', X'789c3332d535343050c84d5708f05748ca4c01001f020428', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137112, 4666, 20.0, 40.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c3332d03531c84dd7cf4e57f00c53c8c94f4cc9cc4b5748c92f4e050064f30851', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137113, 4666, 500.0, 1500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530d035343530c84d5708f0d7f70c53283434cad003003b3f0574', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137114, 4666, 1000.0, 1000.0, 'mg', NULL, 1, 'Adult', X'789c0b2e492c2a513035305028343452c82f52303400b2035d741432f39215922ac1fcdc74fd94c44a8542a3f26c0043650d97', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137115, 4666, 3000.0, 3000.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac5030363030c84dd74f49ac04001e63044b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137116, 4666, 1500.0, 1500.0, 'mg', 'PO', NULL, 'Adult', X'789c33343530c84d5708f0d7f70c53283434ca50c82f020036300585', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137117, 4666, 1000.0, 1000.0, 'mg', NULL, NULL, 'Adult', X'789c0b2e492c2a5130353050283434d251c8cc4b5648aa5430343030c84dd74f49ac5428342acf0600cc210b00', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137118, 4666, 3000.0, 3000.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac5030363030c84dd74f49ac04001e63044b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137119, 4666, 60.0, 60.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c3333c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5148ca4c010070a308b0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137120, 4666, 20.0, 20.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c0b2e492c2a513032c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5148ca4cd151c8cc4b5648aa44515268549e0d0021ae12c4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137121, 4666, 3000.0, 3000.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac5030363030c84dd74f49ac04001e63044b', X'789ced586d6fe24610fe2b2ba47e83f092404e4e5589865c933697e3487a5fea135aecc1deb29ef5edae09ce29ffbdb3b62140489323d25595f209efeebc3ef3cc78cdb75aa8b3688c3c819ac76a9730072b340fc0f2a45667b54c4bb71f5b9b1aafd9bc1533480e948edc93683e123781e62984636e9d56a7d5e9355aed46bb75d33af6ba3dafd33de8f48e8e0f7b852c0456283424f9adf61b20682e8b670b8b42fd264fc1f3b18f56040ae799341cadf171a00c8f80bd573a311e1b7e649d6e2b89eaacdb2a7e8ecb55bbe59627e52e3b1b5507f474c22e3ebbe3246a26973e9eaa2451c86e340f815d111064f40f4853cd8b28b3c97aa0f7b465f944825bfdf5855652e0ac583c04be15f1f3386e2bdc7f717efa6126ed98b215186d00736db9cd0c3b4b858494343302a5d36a1cb98c6691cb4e2a1e92160b95011f875c5bc1a58f06c45da681c4eb8c877f6718581f09a046bb4469f8b149ca5fdb9df8c047f2a2ad83cf6d30a50b44d9a7419d090cd824af106e863c675f3bb7331f3ff0053b5c6dfa581555dc41c8ac4211b040ba9f270279140439dd0ae3a5bef7addc63649f2f5ea9335ed7215f0f3697b9bec0d252f2d5fa057f86100a6eb5087671a8e2045b5a5fabc311d181e5cac75e49a802656ab350cc4548a59c88705996ce9312ab4aad8beca6c92fed5ee1eec7137157f6bdff28fb4799ff10ea1744b94e21202e8c872acd247f18ca2bae6888906390b3119d62e4a3c74e7dbce4812da43d966a35210739337c4a03670448d42a594703dccd319ab3fa5452328d772d8f15a52e422e1bfd8286b25b373ae5e6a701cde94ae5b0d5e8920a0df94639c1571a6b845957f8f9b012efae1c9cac7bac64cf079b71748e9cd53acd4c86cab2cc4021b6eaa2a5f56eab4e721e0b21d0c049ca0d59b2f4d3668acfa4f36fb1ef881552423aa820f528c082b0c6268076df61b75dd6e707ccc0dd154a613316385e59a826cea942abb9c050043b68d497127494530752fb71639aeeeab1075dfbe11cb481f10878f0d8cb0e83b56bd042659b720348a9f10dc910bcca582185a576ec4751b13d07368198cf857b070d4d1ec4043dbdafae3311889097c29790cd540a28b88f579059bd5c38a098e62666b7c2c60c5cd9541a930fce3886cce4c642e206d0c2b5395da3d0347e57311a17ce8d5ad011a4344d74428d84c43425f3c2ff99ce6d0c096709359598d21d88facd390935bf5d9be74c4c199fe82cb534974c10731d416d13d8b262eef2b379bb50092a091890e1be216745469f5522cade3f071ef220a6d33f471745027d541a164eea02a725ee1b98be27324419388cf49cea8004306124eeeec4f2916b1d0319f8b5c29c32a198317257840bad05855d191b12bf5c9944397b089144b907d2902ba1f5e25e716a659701d01b2fa249dbb7bc08f6c9eaf57121c099213e4fb3d24a3fa1508b43a98a71b90de68b5a6e99e80b5a6d295976d61b83570cde6eee370aff3f28fc56a7d7d4699f17fcdea51a52b3253c505245f946c1ceb99c36a49882c77a8d777445fd405ffe132585493c16e761d5e42c1128a8ef252576b6a06b52794bcc3415c1e938bc4985a929eb07e5192ce865ce92d551863354b7b8cf6d1660dc97466d32ad1c2a3bfe4dd8dc6092269934c588d3507d46effd35593a7df187dbe677dfebff4578dada93697e8f877169644c46c60f464a068d600ada35f6e62b0b5215686ecb8fd9efa9ebfdfd3fd1427614', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137122, 4666, 500.0, 1500.0, 'mg', 'PO', NULL, 'Pediatric', X'789c333530d035343530c84d5708f0d7f70c53283434cad003003b3f0574', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137123, 4666, 1000.0, 1000.0, 'mg', NULL, 1, 'Pediatric', X'789c0b2e492c2a513035305028343452c82f52303400b2035d741432f39215922ac1fcdc74fd94c44a8542a3f26c0043650d97', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137124, 4666, 3000.0, 3000.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac5030363030c84dd74f49ac04001e63044b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137125, 4666, 60.0, 60.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c3333c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5148ca4c010070a308b0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137126, 4666, 20.0, 20.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c0b2e492c2a513032c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5148ca4cd151c8cc4b5648aa44515268549e0d0021ae12c4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137127, 4666, 3000.0, 3000.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac5030363030c84dd74f49ac04001e63044b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137128, 4666, 1500.0, 1500.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33343530c84d5708f0d7f70c53283434ca000026f40484', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137129, 4666, 1000.0, 1000.0, 'mg', NULL, NULL, 'Pediatric', X'789c0b2e492c2a5130353050283434d251c8cc4b5648aa5430343030c84dd74f49ac5428342acf0600cc210b00', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137130, 4666, 3000.0, 3000.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac5030363030c84dd74f49ac04001e63044b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137131, 6488, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137132, 16063, 400.0, 400.0, 'mg', 'PO', 1, 'Adult', X'789c333130c84d5708f057284c51a83034504849ac2c0600395605e7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137133, 16063, 400.0, 400.0, 'mg', 'PO', 1, 'Adult', X'789c333130c84d5708f057284c51a83034504849ac2c0600395605e7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137134, 16063, 400.0, 400.0, 'mg', 'PO', 1, 'Adult', X'789c333130c84d5708f057284c51a83034504849ac2c0600395605e7', X'789ced5a6b6fdb3816fd2b1701064851db89f3e86edcc1028e933eb6496ac469d1c1b830688ab6b991489594d27806f9ef7b48f925478d5cb58b7676f2a5b5a57b0f2fef8bf730fe732b30e978a05824b65ab4d511a3440ed344a8ad1a6da526740f274912dbd6cece67792da2863663f749eee4652d372c16c180254e656f77ef597db7596fee5eedfea375b8dbdadd6f1c1dec3f7b76e065054fa45616927f6ebd144a1816facf89b8f5ea57d358b468df0434f66f9d745f71114f58a86dac8dc4d7136dd958d00b6d22db22ce629b86a2461a6064531b0b65bdda4cae9718a1c6c96429dba283dddd68fc7c5da5454778bc73189dd5a8f9cfd9c7bebad4d8ab253da2761049256d9219d6a2eedbbeeae828d28aae0c0b045dc09d58a7230276eb379c0e57f77c8747091b86c27dfbfd23be85525dfb2f4b1fe476bb493456c5ef3eba35da411a2603ec5faa71cebf05366d7526462bc90743fcc7273291b636601c5b1e885bc68519facde660bcfbb07bfa14d06d73970236b55bf9bd3933de260e6d108940b219661598ee8499a91a3bac9d2b582dc330b312811071a2b9e67c2d8f36417e20187ed9efe8977597ffb51d53d5fa752ffc20f3bfe3b29b9777b6b2f3586290531b966681a7077b39ad671469aa53b349535da35f0f0eafc77d7544685dd7eb06f7d539bbf5adcfbdc693be6aee3df57affcaf4be6bdafd0c862a91a2373bdfb92e9d2a994ceb8c7f4aa511c18fb5ae428dfd0887562bd9c7d0ffeffbd34f910d7f6127ff5ca67fe541d28b0597c881ae8ed3902d0332b7b96bc45831c5a77489b70a0bb7e8b8afce184fe693abd1432c3025cb460223ae509884b353a9affcf888c9d67442dadfad1f1cb568cf1bfe29983da5c3fa1e9e36d79e12fd7ad8a20b9d5020465209bc7875329bb6898d126148303e2134b5706a251cd63d71f298c1e3381491505876714ae62d38681cce9cfe29a851c46e339b3237af1ab5d7d85b976cae4b7ec1d0a34cadc0d20c27a30d1ea7c0f057228677f9ba1b73abac6c6ee57955aab01ee772b670e2485f266c07520d160833e6d0d10aec46aa40f282bc7a057a66ac234b89bc41c550a28987ccda1d4726e15c96faf4822f0a24bb9d8b79a6c92866d2646ec3923c35e06809297019a3137d0b2f82bab9b73d21ff488d4020ac3681300e813b59a64042a586c3eb3040a31e121110d7be5956a8a97670e32c1e5c22eef7775ed4fe7ac2489de6e5da6128ccf89e63209a466425bf56c2da7a88a090992d84b789b881abeaffd61365c125ed54054647a8cbd3db11368448dcc003c244cc8f05786ea6c944448c22a4981c810943f8cafb4dc4d24b86f026377a5667af1552da3a6dff026ece807a29e224d548cc4ce934e0e9d14872190a5afab58f8460c64c045b4404b9ecf226d120cf92151cc11931ce79e782a5d6419c2cc04e4371e30377fceec255100b50756ee3ae86743c91d83de4a7a0e8b1751fdfeb48662dad3d0cf0d965137209a6b79588ee1bb2511d7d2900e5f5b4a639586862dd257e41b8caa1e74a8315a51cea3c241b54fd5c32a73f0be4069b9c09e6b4d7a3ff30444e3a8793e54439c24c2ea77bf28d1e98e75bb9fe42321fd7952cdd20a0abd2399c795297632c2473faf952284759c80fbc7c1e6b51462518995c766c3cb6c27c31dcbb637bec858fbdf0b117fe2d7ae18fabf52a14e231e5fe0f52ce5d19450cdc478fa779c2c6c2118ed891002daeef81414fcc736aee370ef081e4883c1b76b4b9afce05720527ac8d5af416cdd6b823971b91dd17bcc3c928e8f0d92f357a01fe6569ffe817a7c3274c41c5ff718c67a2c738cb71907219b0f0394935014d4b2c711186f499e19f28e5687e7182c3d99d2e58cb56636c0b0638e82d98a614e5c4ed8dc87ba9d75736b5dc9984d576e6b455d0766a53583c7d82a9a1afa41b1cfc8d6c825737ccc8ec066545d5b8ad24a0a6d0b8ecabc557dad6861408bf18f9f902d81c9b01c9ced07b4f61c254615e823c2697cf3299ac786cc97531a7bc83e8c2421c85f4eeea3569054bb6953faf6d82d4e0b4186580ffa1d9574a53c012b4920f7b7dc53223a422f8cce81a0dd3c41b882a0f566c83f4fe03d24bc1959d399b5e1a9dc6d4267f6749f1f24a93f0726199a520156e403c6dd0880900b941ecc3419515672bcdeff51e9e7dd000bd852efa2f0d8ba8ab33873ab5b766ec933a9b8680da986fa746c735ead4e8e5969f7917b71b5e32abe305ec179016178fa200e37509c67b695055709bdf6c01c0e5664630c44269242e8d8b503e344b604e5d25f88b6840cc0357c19c7b38328daad873deebb52b2c7f7e5949add3ae57d4ec252c9e34e834e32532a8e434f092ff081c06c5be2ad33e6b10d24fbb01d4fdc46213037c815c88b1e75e761df0a2416300e278d7a252520320c228ecdb43b147ca10ceb561b768968c381a1c2cf9423a9695e8ab866b4d612ad41f853b29d3471773f78f1534df846268a5db822d2ac80d17de59c2d069eff8ec699592bc87f4a6dba904e46b7be887011bd7a81dc51dd0ed7185f81642c5ba4af1f484713fde297673991d73658a98c10cc4a15da55bf5588812ac1cecde448e2b2b778d4e049a6d240d1bca6a6532c7b849c33186a08a1037e8818ac399366e544040cde38b4fd06280d236eae68a2ca7686444aa025954b95f031348f72784b48a435661aa39a48d12415a310c075512a3cd31e0270f9b50e68bae15693033820993fa218355003a4ecdf544873824911f18ae19974530e52397c0c868c0f96646452c4c56f8e2575af51b828be19391988d2dee4f4dbc8a612f0c43ea5b9fbd491a32e3d42bf5926393f2078aa054ff4c8ca5fe9632ea32d08dd478047739a71defab62c92b26221f9bd4b10210cf69513996c2bc974323b5eb4d4a8e242f2cc67b20e7d2f27b15390959340dbc49acb8a6cae7d229982e3a75b4e42545734529cea5e4d72249acfc1643b2d2c6d448ec66c339bbad983b78ef0f7d8eeb2b1d4d79e100599eb5de148d130063bf61e32f1c44a5b967c40d8e229f7a22c463e566dae2922cb5a9136ab02a4ca070d0e2deff5b81b61d655da03da902f722b52ba1f37fc8403f33d58852d7fd8068e57744a97da0717cbc7fe5f27873f2f7b839f9dadf230931688756e77263793d6769fb9c49f5a4ea1d753152d9fde8426730d3b9fb787777f75f2b5d35f9', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137135, 16063, 9.0, 9.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789cb354c84dd7cf4e5708f057284c51a83034504849ac2c0600493306ad', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137136, 16063, 400.0, 400.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230313050c84dd74f49ac040021dc0476', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137137, 16063, 400.0, 400.0, 'mg', 'PO', 1, 'Pediatric', X'789c333130c84d5708f057284c51a83034504849ac2c0600395605e7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137138, 16063, 9.0, 9.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789cb354c84dd7cf4e5708f057284c51a83034504849ac2c0600493306ad', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137139, 16063, 400.0, 400.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230313050c84dd74f49ac040021dc0476', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137140, 16063, 400.0, 400.0, 'mg', 'PO', 1, 'Pediatric', X'789c333130c84d5708f057284c51a83034504849ac2c0600395605e7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137141, 16063, 9.0, 9.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789cb354c84dd7cf4e5708f057284c51a83034504849ac2c0600493306ad', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137142, 16063, 400.0, 400.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230313050c84dd74f49ac040021dc0476', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137143, 16063, 400.0, 400.0, 'mg', 'PO', 1, 'Pediatric', X'789c333130c84d5708f057284c51a83034504849ac2c0600395605e7', X'789ced5a6b6fdb3816fd2b1701064851db89f3e86edcc1028e933eb6496ac469d1c1b830688ab6b991489594d27806f9ef7b48f925478d5cb58b7676f2a5b5a57b0f2fef8bf730fe732b30e978a05824b65ab4d511a3440ed344a8ad1a6da526740f274912dbd6cece67792da2863663f749eee4652d372c16c180254e656f77ef597db7596fee5eedfea375b8dbdadd6f1c1dec3f7b76e065054fa45616927f6ebd144a1816facf89b8f5ea57d358b468df0434f66f9d745f71114f58a86dac8dc4d7136dd958d00b6d22db22ce629b86a2461a6064531b0b65bdda4cae9718a1c6c96429dba283dddd68fc7c5da5454778bc73189dd5a8f9cfd9c7bebad4d8ab253da2761049256d9219d6a2eedbbeeae828d28aae0c0b045dc09d58a7230276eb379c0e57f77c8747091b86c27dfbfd23be85525dfb2f4b1fe476bb493456c5ef3eba35da411a2603ec5faa71cebf05366d7526462bc90743fcc7273291b636601c5b1e885bc68519facde660bcfbb07bfa14d06d73970236b55bf9bd3933de260e6d108940b219661598ee8499a91a3bac9d2b582dc330b312811071a2b9e67c2d8f36417e20187ed9efe8977597ffb51d53d5fa752ffc20f3bfe3b29b9777b6b2f3586290531b966681a7077b39ad671469aa53b349535da35f0f0eafc77d7544685dd7eb06f7d539bbf5adcfbdc693be6aee3df57affcaf4be6bdafd0c862a91a2373bdfb92e9d2a994ceb8c7f4aa511c18fb5ae428dfd0887562bd9c7d0ffeffbd34f910d7f6127ff5ca67fe541d28b0597c881ae8ed3902d0332b7b96bc45831c5a77489b70a0bb7e8b8afce184fe693abd1432c3025cb460223ae509884b353a9affcf888c9d67442dadfad1f1cb568cf1bfe29983da5c3fa1e9e36d79e12fd7ad8a20b9d5020465209bc7875329bb6898d126148303e2134b5706a251cd63d71f298c1e3381491505876714ae62d38681cce9cfe29a851c46e339b3237af1ab5d7d85b976cae4b7ec1d0a34cadc0d20c27a30d1ea7c0f057228677f9ba1b73abac6c6ee57955aab01ee772b670e2485f266c07520d160833e6d0d10aec46aa40f282bc7a057a66ac234b89bc41c550a28987ccda1d4726e15c96faf4822f0a24bb9d8b79a6c92866d2646ec3923c35e06809297019a3137d0b2f82bab9b73d21ff488d4020ac3681300e813b59a64042a586c3eb3040a31e121110d7be5956a8a97670e32c1e5c22eef7775ed4fe7ac2489de6e5da6128ccf89e63209a466425bf56c2da7a88a090992d84b789b881abeaffd61365c125ed54054647a8cbd3db11368448dcc003c244cc8f05786ea6c944448c22a4981c810943f8cafb4dc4d24b86f026377a5667af1552da3a6dff026ece807a29e224d548cc4ce934e0e9d14872190a5afab58f8460c64c045b4404b9ecf226d120cf92151cc11931ce79e782a5d6419c2cc04e4371e30377fceec255100b50756ee3ae86743c91d83de4a7a0e8b1751fdfeb48662dad3d0cf0d965137209a6b79588ee1bb2511d7d2900e5f5b4a639586862dd257e41b8caa1e74a8315a51cea3c241b54fd5c32a73f0be4069b9c09e6b4d7a3ff30444e3a8793e54439c24c2ea77bf28d1e98e75bb9fe42321fd7952cdd20a0abd2399c795297632c2473faf952284759c80fbc7c1e6b51462518995c766c3cb6c27c31dcbb637bec858fbdf0b117fe2d7ae18fabf52a14e231e5fe0f52ce5d19450cdc478fa779c2c6c2118ed891002daeef81414fcc736aee370ef081e4883c1b76b4b9afce05720527ac8d5af416cdd6b823971b91dd17bcc3c928e8f0d92f357a01fe6569ffe817a7c3274c41c5ff718c67a2c738cb71907219b0f0394935014d4b2c711186f499e19f28e5687e7182c3d99d2e58cb56636c0b0638e82d98a614e5c4ed8dc87ba9d75736b5dc9984d576e6b455d0766a53583c7d82a9a1afa41b1cfc8d6c825737ccc8ec066545d5b8ad24a0a6d0b8ecabc557dad6861408bf18f9f902d81c9b01c9ced07b4f61c254615e823c2697cf3299ac786cc97531a7bc83e8c2421c85f4eeea3569054bb6953faf6d82d4e0b4186580ffa1d9574a53c012b4920f7b7dc53223a422f8cce81a0dd3c41b882a0f566c83f4fe03d24bc1959d399b5e1a9dc6d4267f6749f1f24a93f0726199a520156e403c6dd0880900b941ecc3419515672bcdeff51e9e7dd000bd852efa2f0d8ba8ab33873ab5b766ec933a9b8680da986fa746c735ead4e8e5969f7917b71b5e32abe305ec179016178fa200e37509c67b695055709bdf6c01c0e5664630c44269242e8d8b503e344b604e5d25f88b6840cc0357c19c7b38328daad873deebb52b2c7f7e5949add3ae57d4ec252c9e34e834e32532a8e434f092ff081c06c5be2ad33e6b10d24fbb01d4fdc46213037c815c88b1e75e761df0a2416300e278d7a252520320c228ecdb43b147ca10ceb561b768968c381a1c2cf9423a9695e8ab866b4d612ad41f853b29d3471773f78f1534df846268a5db822d2ac80d17de59c2d069eff8ec699592bc87f4a6dba904e46b7be887011bd7a81dc51dd0ed7185f81642c5ba4af1f484713fde297673991d73658a98c10cc4a15da55bf5588812ac1cecde448e2b2b778d4e049a6d240d1bca6a6532c7b849c33186a08a1037e8818ac399366e544040cde38b4fd06280d236eae68a2ca7686444aa025954b95f031348f72784b48a435661aa39a48d12415a310c075512a3cd31e0270f9b50e68bae15693033820993fa218355003a4ecdf544873824911f18ae19974530e52397c0c868c0f96646452c4c56f8e2575af51b828be19391988d2dee4f4dbc8a612f0c43ea5b9fbd491a32e3d42bf5926393f2078aa054ff4c8ca5fe9632ea32d08dd478047739a71defab62c92b26221f9bd4b10210cf69513996c2bc974323b5eb4d4a8e242f2cc67b20e7d2f27b15390959340dbc49acb8a6cae7d229982e3a75b4e42545734529cea5e4d72249acfc1643b2d2c6d448ec66c339bbad983b78ef0f7d8eeb2b1d4d79e100599eb5de148d130063bf61e32f1c44a5b967c40d8e229f7a22c463e566dae2922cb5a9136ab02a4ca070d0e2deff5b81b61d655da03da902f722b52ba1f37fc8403f33d58852d7fd8068e57744a97da0717cbc7fe5f27873f2f7b839f9dadf230931688756e77263793d6769fb9c49f5a4ea1d753152d9fde8426730d3b9fb787777f75f2b5d35f9', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137144, 1160, 50.0, 200.0, 'mg', 'PO', 3, 'Adult', X'789c3335d0353230c84d5708f05708f17401001c0503b9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137145, 19886, 1.0, 1.0, 'mg', 'SC', NULL, 'Adult', X'789c33cc4d570876d6f7f4d5f70c53a850300400255f0438', X'789ce5566d6fdb3610fe2b077f5a81d896dd79ed846e809bae498026c8e2a05faa40a0294a224c1e35924a2d14f9ef3d4a761a3bc6121bc150605f6c893ade3df7dcebb75e66eb2245a6452f86de89aa392b0cf68ea0575b158e4aef2b170f875fe542e881b1457892c387928e5b56892c653e5c1847e3dffad1a83f8aaea337f1e4753cf97d30198da3d1a49515dc4b838e24bff54e040acb54fbecc5b2bd7edd54228653fab5856ab8d0921f25c8d0cbcc7891e007e35821e0a3b1dac5091e1bad0dc2b56599800b72c3c5d06223ddadbd7afed0e41d1d79365722bc7db9a1372571d1befc80b036f6340bd3b5e4dd4dd03ccd6ae5534228b1d8706a07921eb968561eb20de1912e60763c3c3b1f9e7d86258c123c670d585109e6e19f71045a225c5e5df4367d0900de0bcffa7365f842d8d49ba5e4d2375f4637e98681091920d573a36a07e65658302882d63a107c25ba0f32073464d655845800cb3d098e22124bf02c0791e7c19b5b7104ce33eb41625e3bf20e08e5b84f3686a5dd01f1a33159da5a48a5ae584bc823f73bc7b76fff4bf05ad52fc2e87698fedf94eea9faf9d5d66abf149964de4a7e48cda4e30df16810bd26821604e77c38fb7b1569f845b325fc0104f35582534584230b1427f86e1c2d8a046388069347f9f1e7fae37352e7b985983e4e9b48f380f96552e4cd4adb8e2cd9a7747e2e629f558f3f31b3b34a70c9547a69aa5ab11f7eac815e5a51d078e30d5cd1576cb9799fe027aab5567a35ce68d4127c0f6cee8c9d8b8ce0c1c919784b72e00cd4a86834a906bc01ceeae060466d88feade8cad6852be4144db7400a32055dd551f8c2dc4af082f467229728b204ef6b73ebfc5454848b1f70f7d071bccdd0d363f943d8693a61ea5b98de6b58cde96383449cc44cf21d11992a45bb47c7a462ce0dc38a94a04457133aa3598255290c2fadd186379e4e0ee87dd32e3ce9d53a3c4f36bf99b0d2d49b7265d8939c40272975a910eea31d562656958d624be91224395a5330e4f38e6ed52d511b8a2f420e316098c1add1b2cbccf2c156c6f62e849783bfcdcc7f82ff6023fb0ec59259cdb851a66836ac9d3295f795cc693d3efb1cc3dbfee8ed6ac37000d49c63f875b23ea06e4a7d921a9f743a864fd4d6ec112c6486a249f0af25b7a2eb2d352ed07cc520ce4b86240d268729efbecebcd4a16991817255f6c131530834aa71d20d420f72da185f82ae1d57a1dd50cc04fa7d3dbfbbfb0ed0ad3504', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137146, 19886, 5.0, 5.0, 'mg', 'IV', NULL, 'Adult', X'789c33cd4d57f00c5348cacf292d56c82f4b2d52c8cf4b55c8cdcc2b2d49050088ef09fe', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137147, 19886, 2.0, 5.0, 'mg', NULL, NULL, 'Adult', X'789cf34c53484d4b4b4d2ec92c4bd551282e492c2a51c8cc4b2b2dcecccf53482c5130d235cd4dd7cf28020025cb0e0c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137148, 19886, 1.0, 1.0, 'mg', 'IV', NULL, 'Adult', X'789c33cc4d57f00c53a8503004000f9e02ae', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137149, 19886, 0.03, 0.03, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c33d03330ce4dd7cf4e57f0f4d50f0ed4f70c53a8503054d0c84dac50b05530cc4dd704009e2e0910', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137150, 19886, 0.5, 0.5, 'mg', 'SC', NULL, 'Pediatric', X'789cb35230d033cd4d570876d6f7f4d5f70c53a85030040032f904f4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137151, 19886, 1.0, 1.0, 'mg', 'SC', NULL, 'Pediatric', X'789cb35230cc4d570876d6f7f4d5f70c53a8503004002b950492', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137152, 19886, 50.0, 50.0, 'mcg/kg', NULL, NULL, 'Pediatric', X'789c3335c84d4ed7cf4e07000ae3029e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137153, 19886, 70.0, 70.0, 'mcg/kg', NULL, NULL, 'Pediatric', X'789cf34c53484d4b4b4d2ec92c4bd551282e492c2a51c8cc4b2b2dcecccf53482c513037c84d4ed7cf4ed7cf280200539e0f43', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137154, 6400, 5.0, 20.0, 'mg', NULL, NULL, 'Adult', X'789c05c1cb0980301005c0565e010a12f0620796f1301b13c88fddf590ee9db9bb2b3b8d153695ebc2b98703edddd0b8a032858e384c5012b230f2c982296ac5dcc0e4a208c8e353fb0111b91b12', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137155, 6400, 50.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c458ec10dc23010045bd92748280a117c420579206a3839676c298ea3b30da4040aa1312ac14e40fc5633b7abbb080d2dbad1465bc2b146f4d8d735dc157e545ca1d3b0ab46ef03e34e01134901c30cd69a55b437861718a69e946108ab2461074773ce135304aded4d0a692906728c3ca5ad84b8b82d484716bc9faf06c6e7810a677a5897dce2dbdf5f533e2ae084e60f9ac3b7f301bde147de', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137156, 6400, 5.0, 5.0, 'mg', 'IN', NULL, 'Pediatric', X'789c05c1d109c0300805c055de0281b6100ad9465044880a9a9f6edfbb39ee179f50f5c2741dcfe50a62b7b03e52c2b0408620b24fd90635086da15bc0d9f203bd871654', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137157, 6400, 3.0, 6.0, 'mg', NULL, NULL, 'Pediatric', X'789c33d3353457a84c4d2c2ab65230d635cb4d5728cecc4bcf495548c92f4e05007ef60941', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137158, 28911, 900.0, 900.0, 'mg', 'PO', 2, 'Adult', X'789c73f60d53c8cc4b4b4d2ec9cccfb352b0343050c84d5708f05770f2740100813a085b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137159, 28911, 900.0, 900.0, 'mg', 'PO', 1, 'Adult', X'789c73f60d532828ca2fc8a8cc49acc82cb652b0343050c84d5708f0574849cccca90400b2230aa3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137160, 28911, 17.0, 17.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789cf34bcdcf4b2c49cc5170f60d53c8cc4b4b4d2ec9cccfb352303457c84dd7cf4e5708f0574849cccca95470f27451a850303452284f4dcd2ed65128c948cd432883a829cd2bc9cc513054a84c4d2c52c84f53484c4f0500052f1f65', X'789ccd554d6fdb3810fd2b039fed5af63a9b44e8c5b5b79b004d1ab8de5eaa40185363896b8a14482a8d50e4bfef5072eada0912d4408bbd0822e771e6cdf7b75e66eb3cd558522f86de6754396a21853277d2f6fad0abad0a82c2fbcac5c3e157b9a1f28db179f893c3a778272c5694a5e8c3b37134fe73108d06a368199dc5d1249e9cbd393b391d9f9fb658125e1aed18f9ad37cd4aa9a5f316c35d7be5e9bed5b26c2a8a133dd55eb21554899e1b8739c17b634bc79285a93d39306bd8d712c3c7163e336569342c2d6604d7ecab8b5bfbf5ea470a0f7ce571a5289cbedcf24949bd690f3b2edf49bc1e9c1df4e136e89e66b5f22953973adff36f76f519a45e775462388f222873b8f908ef2ee74c9ea5953555d128bc97ee47798652353fe749cbe4863289de4af11c9b6b321a3d2a38a0353a65abc3cdce70a007f7301ac357a28deb832f48ef601da6e62028184143684382386d4710fe549190a8d21b53d50a7745f3c8f9c652aeb9101b58b054e709f39da1a7dcd806667d585370c84ab701815a1b0f2b025b2bca804b27d11f50f8566d8b8983dba8fd0b0f16a45961d6468f5364670a26d1e0e41cca0f43aec01826276d92ba0c06f1f864f0c713b1d182ba406d51a368309e1ca2e88ed88d31031bb7c5bd65e416068603abe1621e43e0694970b593ce284bf40555ec96d8123dbae80fc3fb7aedcfc354a91e9fa5a2cb85642b5d2fcc8ce61e953a93e299744e95229b37e00d0885ce0dc3903aa26ca61947ce51ba20144fad3ca3b0f789ac34f5011b4da5c421564c250413db731f14d51b53910effbeb0a65c19d1f8c79b2a38be3df5f6797601082369bff1b07684c33b53ca10e43e70935a5b1026fa6f8beb90da7f3bae21b198a12828d1ff2c2ef9b3e4cffb5027895e5a2a8d3d34f96a87fd32c70f43fc7ff3fc77f0f9d9f95ca02d511865f2668fd805aaf540c935f16ce0a55a24fa8a27dbca28e9ca18b6dd9ee8bfee85a56e6ab783ea080a57240ae44d5aa6669d4ec5939d7ca90bb992de41bbe1607e3d05d768de004eba63063c513a55ce1ceec56327d6f6e9cb432a80781c3d3cfc07b891049b', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137161, 8332, 10.0, 30.0, 'mg', NULL, NULL, 'Adult', X'789cf32f4accb1523034d03536c84d572834c928520808f203004908065d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137162, 8332, 5.0, 15.0, 'mg', 'IM', NULL, 'Adult', X'789cf3f4b55230d53534cd4d07000d0c028d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137163, 8332, 0.1, 0.1, 'mg/kg', 'IV', NULL, 'Adult', X'789cf30cb35230d03354c84dd7cf4e5748cacf292d5648cbcfc9c92f4f4d5148aa04ca199842250b0d4d758d0c147233f3144af34a3273140a1281cce4fcbc9222a086d414006eac1866', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137164, 8332, 4.0, 8.0, 'mg', NULL, NULL, 'Adult', X'789c73f4f5b45230d1b5c84d572834d53534cdcdcc530808f2030047ea064c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137165, 8332, 2.0, 4.0, 'mg', NULL, NULL, 'Adult', X'789c732eca2cc94c4eccc9a954c8ccc9b15230d235c94d572834d435ca2852c82f5230d1b500f18d754d80fc80203f007f970ecb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137166, 8332, 0.8, 10.0, 'mg', 'IV', NULL, 'Adult', X'789c73cecf2bc9cc2bcd2f2d56c8cc4b2b2dcecccf53f00cd3510876b65230d0b3d03534c84dd7cf2852d0282d5028c957b0807035010a0e117d', X'789ced58616fdb3610fd2b07030312c076643b6e53b718e039db626cc98c24eb06cc85414bb4c4452255524ae214d96fdf3b4a49e4369bd37c2b900fb628f2783cbe7b7747ea532bb265bcd02293ad11b58e8dcd13a565ab4dadd2a6dc951445ee467b7b57ea42665d63636ea9bda6a40badc865b410054fe807fd579da0d7e905e7c1ebd1a037da7fd33de8efa3d7cbcab050463b487e6afd2cb5b422f5ed425efbe9e7eb5c8ee6fab75c1915b9b93e344ec4927e323673231ab6a917e087671fcf017efb680ff17c85df6bb40ff07cc33201ffb1549f5b4177b897a5e8f1ff7dffbf8fff2e55fd07d568503daabe7ef518faceb99e982c339acead88249d003218347685151983d1a6f1fbe9c98d68d36179df35d5abb26efe222225749b8ecf2834ba50dac3512e9b88dca2ab10cb54f2db5f1ff0962a7de15f1e10aaa1d9eea33bc1db0fac771c9569b1009c4ac71b888fc3b290940ba569e7d844f0085e0b434e5e4a2b77d91970d208d874064116d3c7fdc4d2ecf464aea7c7f048a737cce2b986df5428d2744dda14646508b0a48e644451e9d5490bc52a24b1740084b70c052b2a0b95aa1b19b5318f00156413a1c96849d3638a8c93e41253a6112d25c5ea5202c25a6391488a848ea525b3a279cb1522bcc0eee62d3fcfd14e26d6944a11b1b4952e5730c1d8351c90e5d664cac95d18f17e0476f4288bf72e625a9ab474b432696aae60fc728db160580f7eec0d3bfd80324055c28569851abbd362828ce6fac8c0d25569619badad5819bbb1782473bc3a0f00dc814544181a1bc172b6534552a430235ad395547152ccf5f8783aa2fdce0183eff1c6a2de0113ab8a1a7595c245fdce3ecbf43a7db808cbd673069d7b974d3cf54a833d2a7093ada0e9fb369d4d188403442d760ae19d3267630eaad7ddc7961a5463733d9b8c39bc3afdeeb0b630b8b7f0c75c450887947666d8b4b497e0c0a5a495950cfd19f69c4a8fd308c18c89411632d28f1aca16f63b4177bf5eb72192a9d09a07b941d71b11930185a98fddbb3615aab8a3b65cad1075cc8f6bfa87f7c134d03c9cc8f049c682309d60d0cde2ff3383cd6d9a4120b275f5b2fd6ad953185247573fb877d6d7e5061fdf3389fc5258153e16e39344a591959abe7f851456248e848ee8dd3060a8b72480bbf8c79687407f5087428354d3e33b0201946e3fab3c58c555f0e81cdae12cc19eb80e2522c0d38e91ddfd0fcf57c9c773a3c1b980d70b2aed7ebadf56d0e87c169467b90c954817339397a978a8577768821db1163a5cd32946917060e064ae7f157065e1cdfd5117129e5e5a295c015aa417ec690d6a55cee1789aa4bcab613042d9fa8e3398468d8304efa31e7fd7c3e830f872f4e8102bb24f79b44d82733b275011fd5dba0289175963d69481c2d3d3f3bb0e46c9cf71bc36d4c9dce7e6cab8119d3435515c956944fe4ea8ac4d20e428143ef139a4ab2ad13566ec3eb7b47d0eecf61a77c8c7974ad82d945edc6ba8ab1e93c982d91172d7978e1c2369db78cd440c53e1dc1e9f869e41987184487172712a45f8e52a8f286c9d49abc0f0cd20553664be6d16091c3c5000431008ad50a04e0814518b51f8f8079c45d65527c62959e7a690baaa2d9393b38d5ad3464047a22abce35c4b9c549a65a952b9d79c31d6224fd6a9b856489fa9b06b1d1b970b97b536f1a880e6c3d1c67e0e65ce27001d82b0e3c323ac865aec6465666c340e442e430db4e60ab4c3a2a8eceae6a66e825c55f0431e255c8409d4cc6cc97508e7c23fa535ae400d175ed4152af77b6bd3253aaba8fcdd2a0dabb13040a9363e636e14068631627f4871c1ab210260d235771d291c2350bee483b9a8e6608fe5d1f14a2dbd2370d4481ac0cb486682fd9300439f4a21bb8c6009c73cbf7f0ed993e2c13b7e7b109c7931687c98b94994ed2a2695fca296dfd0d520d976454de10d2d9b747c824527678b86fc862e76c3760d5e6a635ec36bdba79f378437b1bd77f21376c1b20b2f5b25a46f3ff03f4f652f91ff12f92f91bf3df25fe2647b9c3ce7d0f80d536296081cea43939a78bd418c2391ae3aa95ae1a639cd327fb3bb879b6ff9b8d0bea5f1a5d237a2badebeadbf2f51afd7e90dd031d7c712d099140c1a517dc0c77dfc3a84affd1d857d5f5d987019967e4298080d79be6e8cbd1746a834383c3b3e211bff39893fedc81c85836f678450e59b73a2960a7709e142d099bf63f8cb24964caec41a9ac7a9bf0ee5d2f25cfee6c0cb721182a3fd5db322c4cc9aa8842df465caf89a13f9ededbf3fc6209d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137167, 8332, 2.0, 30.0, 'mg', NULL, NULL, 'Adult', X'789c732eca2cc94c4eccc9a954c8ccc9b15230d23536c84dd7cf28020073be086b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137168, 8332, 0.5, 2.5, 'mg', NULL, NULL, 'Adult', X'789c0b70765430d033d535d233cd4d572834d53534c8cdcc530808f20300552c06c6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137169, 8332, 30.0, 100.0, 'mcg/kg', NULL, NULL, 'Adult', X'789c0bcecc4bcf495548c92f4eb5523036d0353430c84d4ed7cf4e07006ad807e1', X'789ced58616fdb3610fd2b07030312c076643b6e53b718e039db626cc98c24eb06cc85414bb4c4452255524ae214d96fdf3b4a49e4369bd37c2b900fb628f2783cbe7b7747ea532bb265bcd02293ad11b58e8dcd13a565ab4dadd2a6dc951445ee467b7b57ea42665d63636ea9bda6a40badc865b410054fe807fd579da0d7e905e7c1ebd1a037da7fd33de8efa3d7cbcab050463b487e6afd2cb5b422f5ed425efbe9e7eb5c8ee6fab75c1915b9b93e344ec4927e323673231ab6a917e087671fcf017efb680ff17c85df6bb40ff07cc33201ffb1549f5b4177b897a5e8f1ff7dffbf8fff2e55fd07d568503daabe7ef518faceb99e982c339acead88249d003218347685151983d1a6f1fbe9c98d68d36179df35d5abb26efe222225749b8ecf2834ba50dac3512e9b88dca2ab10cb54f2db5f1ff0962a7de15f1e10aaa1d9eea33bc1db0fac771c9569b1009c4ac71b888fc3b290940ba569e7d844f0085e0b434e5e4a2b77d91970d208d874064116d3c7fdc4d2ecf464aea7c7f048a737cce2b986df5428d2744dda14646508b0a48e644451e9d5490bc52a24b1740084b70c052b2a0b95aa1b19b5318f00156413a1c96849d3638a8c93e41253a6112d25c5ea5202c25a6391488a848ea525b3a279cb1522bcc0eee62d3fcfd14e26d6944a11b1b4952e5730c1d8351c90e5d664cac95d18f17e0476f4288bf72e625a9ab474b432696aae60fc728db160580f7eec0d3bfd80324055c28569851abbd362828ce6fac8c0d25569619badad5819bbb1782473bc3a0f00dc814544181a1bc172b6534552a430235ad395547152ccf5f8783aa2fdce0183eff1c6a2de0113ab8a1a7595c245fdce3ecbf43a7db808cbd673069d7b974d3cf54a833d2a7093ada0e9fb369d4d188403442d760ae19d3267630eaad7ddc7961a5463733d9b8c39bc3afdeeb0b630b8b7f0c75c450887947666d8b4b497e0c0a5a495950cfd19f69c4a8fd308c18c89411632d28f1aca16f63b4177bf5eb72192a9d09a07b941d71b11930185a98fddbb3615aab8a3b65cad1075cc8f6bfa87f7c134d03c9cc8f049c682309d60d0cde2ff3383cd6d9a4120b275f5b2fd6ad953185247573fb877d6d7e5061fdf3389fc5258153e16e39344a591959abe7f851456248e848ee8dd3060a8b72480bbf8c79687407f5087428354d3e33b0201946e3fab3c58c555f0e81cdae12cc19eb80e2522c0d38e91ddfd0fcf57c9c773a3c1b980d70b2aed7ebadf56d0e87c169467b90c954817339397a978a8577768821db1163a5cd32946917060e064ae7f157065e1cdfd5117129e5e5a295c015aa417ec690d6a55cee1789aa4bcab613042d9fa8e3398468d8304efa31e7fd7c3e830f872f4e8102bb24f79b44d82733b275011fd5dba0289175963d69481c2d3d3f3bb0e46c9cf71bc36d4c9dce7e6cab8119d3435515c956944fe4ea8ac4d20e428143ef139a4ab2ad13566ec3eb7b47d0eecf61a77c8c7974ad82d945edc6ba8ab1e93c982d91172d7978e1c2369db78cd440c53e1dc1e9f869e41987184487172712a45f8e52a8f286c9d49abc0f0cd20553664be6d16091c3c5000431008ad50a04e0814518b51f8f8079c45d65527c62959e7a690baaa2d9393b38d5ad3464047a22abce35c4b9c549a65a952b9d79c31d6224fd6a9b856489fa9b06b1d1b970b97b536f1a880e6c3d1c67e0e65ce27001d82b0e3c323ac865aec6465666c340e442e430db4e60ab4c3a2a8eceae6a66e825c55f0431e255c8409d4cc6cc97508e7c23fa535ae400d175ed4152af77b6bd3253aaba8fcdd2a0dabb13040a9363e636e14068631627f4871c1ab210260d235771d291c2350bee483b9a8e6608fe5d1f14a2dbd2370d4481ac0cb486682fd9300439f4a21bb8c6009c73cbf7f0ed993e2c13b7e7b109c7931687c98b94994ed2a2695fca296dfd0d520d976454de10d2d9b747c824527678b86fc862e76c3760d5e6a635ec36bdba79f378437b1bd77f21376c1b20b2f5b25a46f3ff03f4f652f91ff12f92f91bf3df25fe2647b9c3ce7d0f80d536296081cea43939a78bd418c2391ae3aa95ae1a639cd327fb3bb879b6ff9b8d0bea5f1a5d237a2badebeadbf2f51afd7e90dd031d7c712d099140c1a517dc0c77dfc3a84affd1d857d5f5d987019967e4298080d79be6e8cbd1746a834383c3b3e211bff39893fedc81c85836f678450e59b73a2960a7709e142d099bf63f8cb24964caec41a9ac7a9bf0ee5d2f25cfee6c0cb721182a3fd5db322c4cc9aa8842df465caf89a13f9ededbf3fc6209d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137170, 8332, 0.2, 0.4, 'mg', NULL, NULL, 'Adult', X'789c73cecf2bc9cc2bcd2f2d56c8cc4b2b2dcecccfb35230d033d235d033c94dd7cf280200cf660b49', X'789ced58616fdb3610fd2b07030312c076643b6e53b718e039db626cc98c24eb06cc85414bb4c4452255524ae214d96fdf3b4a49e4369bd37c2b900fb628f2783cbe7b7747ea532bb265bcd02293ad11b58e8dcd13a565ab4dadd2a6dc951445ee467b7b57ea42665d63636ea9bda6a40badc865b410054fe807fd579da0d7e905e7c1ebd1a037da7fd33de8efa3d7cbcab050463b487e6afd2cb5b422f5ed425efbe9e7eb5c8ee6fab75c1915b9b93e344ec4927e323673231ab6a917e087671fcf017efb680ff17c85df6bb40ff07cc33201ffb1549f5b4177b897a5e8f1ff7dffbf8fff2e55fd07d568503daabe7ef518faceb99e982c339acead88249d003218347685151983d1a6f1fbe9c98d68d36179df35d5abb26efe222225749b8ecf2834ba50dac3512e9b88dca2ab10cb54f2db5f1ff0962a7de15f1e10aaa1d9eea33bc1db0fac771c9569b1009c4ac71b888fc3b290940ba569e7d844f0085e0b434e5e4a2b77d91970d208d874064116d3c7fdc4d2ecf464aea7c7f048a737cce2b986df5428d2744dda14646508b0a48e644451e9d5490bc52a24b1740084b70c052b2a0b95aa1b19b5318f00156413a1c96849d3638a8c93e41253a6112d25c5ea5202c25a6391488a848ea525b3a279cb1522bcc0eee62d3fcfd14e26d6944a11b1b4952e5730c1d8351c90e5d664cac95d18f17e0476f4288bf72e625a9ab474b432696aae60fc728db160580f7eec0d3bfd80324055c28569851abbd362828ce6fac8c0d25569619badad5819bbb1782473bc3a0f00dc814544181a1bc172b6534552a430235ad395547152ccf5f8783aa2fdce0183eff1c6a2de0113ab8a1a7595c245fdce3ecbf43a7db808cbd673069d7b974d3cf54a833d2a7093ada0e9fb369d4d188403442d760ae19d3267630eaad7ddc7961a5463733d9b8c39bc3afdeeb0b630b8b7f0c75c450887947666d8b4b497e0c0a5a495950cfd19f69c4a8fd308c18c89411632d28f1aca16f63b4177bf5eb72192a9d09a07b941d71b11930185a98fddbb3615aab8a3b65cad1075cc8f6bfa87f7c134d03c9cc8f049c682309d60d0cde2ff3383cd6d9a4120b275f5b2fd6ad953185247573fb877d6d7e5061fdf3389fc5258153e16e39344a591959abe7f851456248e848ee8dd3060a8b72480bbf8c79687407f5087428354d3e33b0201946e3fab3c58c555f0e81cdae12cc19eb80e2522c0d38e91ddfd0fcf57c9c773a3c1b980d70b2aed7ebadf56d0e87c169467b90c954817339397a978a8577768821db1163a5cd32946917060e064ae7f157065e1cdfd5117129e5e5a295c015aa417ec690d6a55cee1789aa4bcab613042d9fa8e3398468d8304efa31e7fd7c3e830f872f4e8102bb24f79b44d82733b275011fd5dba0289175963d69481c2d3d3f3bb0e46c9cf71bc36d4c9dce7e6cab8119d3435515c956944fe4ea8ac4d20e428143ef139a4ab2ad13566ec3eb7b47d0eecf61a77c8c7974ad82d945edc6ba8ab1e93c982d91172d7978e1c2369db78cd440c53e1dc1e9f869e41987184487172712a45f8e52a8f286c9d49abc0f0cd20553664be6d16091c3c5000431008ad50a04e0814518b51f8f8079c45d65527c62959e7a690baaa2d9393b38d5ad3464047a22abce35c4b9c549a65a952b9d79c31d6224fd6a9b856489fa9b06b1d1b970b97b536f1a880e6c3d1c67e0e65ce27001d82b0e3c323ac865aec6465666c340e442e430db4e60ab4c3a2a8eceae6a66e825c55f0431e255c8409d4cc6cc97508e7c23fa535ae400d175ed4152af77b6bd3253aaba8fcdd2a0dabb13040a9363e636e14068631627f4871c1ab210260d235771d291c2350bee483b9a8e6608fe5d1f14a2dbd2370d4481ac0cb486682fd9300439f4a21bb8c6009c73cbf7f0ed993e2c13b7e7b109c7931687c98b94994ed2a2695fca296dfd0d520d976454de10d2d9b747c824527678b86fc862e76c3760d5e6a635ec36bdba79f378437b1bd77f21376c1b20b2f5b25a46f3ff03f4f652f91ff12f92f91bf3df25fe2647b9c3ce7d0f80d536296081cea43939a78bd418c2391ae3aa95ae1a639cd327fb3bb879b6ff9b8d0bea5f1a5d237a2badebeadbf2f51afd7e90dd031d7c712d099140c1a517dc0c77dfc3a84affd1d857d5f5d987019967e4298080d79be6e8cbd1746a834383c3b3e211bff39893fedc81c85836f678450e59b73a2960a7709e142d099bf63f8cb24964caec41a9ac7a9bf0ee5d2f25cfee6c0cb721182a3fd5db322c4cc9aa8842df465caf89a13f9ededbf3fc6209d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137171, 8332, 3.5, 10.0, 'mg', NULL, NULL, 'Adult', X'789c0dca310a80300c05d0abfc514145ad2eae9e444aaa199a409a8a9367d737bf5dc559aad682ccd19425d5c22a1bc2b0f6d3984fe84d8679b9ac7470763b9ce00a4a89a2a3c9c78337fcb1fd00188f1a43', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137172, 8332, 0.2, 10.0, 'mg', NULL, NULL, 'Adult', X'789c73cecf2bc9cc2bcd2f2d56c8cd4c2ecacfcc4b2b2dcecccfb35230d033d23534c84d57c82f4b2d52303251c8c82f2d2a56d0c84dac50a833024a68020093011467', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137173, 8332, 10.0, 20.0, 'mg', NULL, NULL, 'Adult', X'789c0b4a4d2e49ccb1523034d03532c84d572834d635c92802004ca50679', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137174, 8332, 0.15, 0.3, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf32f4accb15230d03334d535d033ce4dd7cf4e572834d635c928520808f203007f55084f', X'789ced58616fdb3610fd2b07030312c076643b6e53b718e039db626cc98c24eb06cc85414bb4c4452255524ae214d96fdf3b4a49e4369bd37c2b900fb628f2783cbe7b7747ea532bb265bcd02293ad11b58e8dcd13a565ab4dadd2a6dc951445ee467b7b57ea42665d63636ea9bda6a40badc865b410054fe807fd579da0d7e905e7c1ebd1a037da7fd33de8efa3d7cbcab050463b487e6afd2cb5b422f5ed425efbe9e7eb5c8ee6fab75c1915b9b93e344ec4927e323673231ab6a917e087671fcf017efb680ff17c85df6bb40ff07cc33201ffb1549f5b4177b897a5e8f1ff7dffbf8fff2e55fd07d568503daabe7ef518faceb99e982c339acead88249d003218347685151983d1a6f1fbe9c98d68d36179df35d5abb26efe222225749b8ecf2834ba50dac3512e9b88dca2ab10cb54f2db5f1ff0962a7de15f1e10aaa1d9eea33bc1db0fac771c9569b1009c4ac71b888fc3b290940ba569e7d844f0085e0b434e5e4a2b77d91970d208d874064116d3c7fdc4d2ecf464aea7c7f048a737cce2b986df5428d2744dda14646508b0a48e644451e9d5490bc52a24b1740084b70c052b2a0b95aa1b19b5318f00156413a1c96849d3638a8c93e41253a6112d25c5ea5202c25a6391488a848ea525b3a279cb1522bcc0eee62d3fcfd14e26d6944a11b1b4952e5730c1d8351c90e5d664cac95d18f17e0476f4288bf72e625a9ab474b432696aae60fc728db160580f7eec0d3bfd80324055c28569851abbd362828ce6fac8c0d25569619badad5819bbb1782473bc3a0f00dc814544181a1bc172b6534552a430235ad395547152ccf5f8783aa2fdce0183eff1c6a2de0113ab8a1a7595c245fdce3ecbf43a7db808cbd673069d7b974d3cf54a833d2a7093ada0e9fb369d4d188403442d760ae19d3267630eaad7ddc7961a5463733d9b8c39bc3afdeeb0b630b8b7f0c75c450887947666d8b4b497e0c0a5a495950cfd19f69c4a8fd308c18c89411632d28f1aca16f63b4177bf5eb72192a9d09a07b941d71b11930185a98fddbb3615aab8a3b65cad1075cc8f6bfa87f7c134d03c9cc8f049c682309d60d0cde2ff3383cd6d9a4120b275f5b2fd6ad953185247573fb877d6d7e5061fdf3389fc5258153e16e39344a591959abe7f851456248e848ee8dd3060a8b72480bbf8c79687407f5087428354d3e33b0201946e3fab3c58c555f0e81cdae12cc19eb80e2522c0d38e91ddfd0fcf57c9c773a3c1b980d70b2aed7ebadf56d0e87c169467b90c954817339397a978a8577768821db1163a5cd32946917060e064ae7f157065e1cdfd5117129e5e5a295c015aa417ec690d6a55cee1789aa4bcab613042d9fa8e3398468d8304efa31e7fd7c3e830f872f4e8102bb24f79b44d82733b275011fd5dba0289175963d69481c2d3d3f3bb0e46c9cf71bc36d4c9dce7e6cab8119d3435515c956944fe4ea8ac4d20e428143ef139a4ab2ad13566ec3eb7b47d0eecf61a77c8c7974ad82d945edc6ba8ab1e93c982d91172d7978e1c2369db78cd440c53e1dc1e9f869e41987184487172712a45f8e52a8f286c9d49abc0f0cd20553664be6d16091c3c5000431008ad50a04e0814518b51f8f8079c45d65527c62959e7a690baaa2d9393b38d5ad3464047a22abce35c4b9c549a65a952b9d79c31d6224fd6a9b856489fa9b06b1d1b970b97b536f1a880e6c3d1c67e0e65ce27001d82b0e3c323ac865aec6465666c340e442e430db4e60ab4c3a2a8eceae6a66e825c55f0431e255c8409d4cc6cc97508e7c23fa535ae400d175ed4152af77b6bd3253aaba8fcdd2a0dabb13040a9363e636e14068631627f4871c1ab210260d235771d291c2350bee483b9a8e6608fe5d1f14a2dbd2370d4481ac0cb486682fd9300439f4a21bb8c6009c73cbf7f0ed993e2c13b7e7b109c7931687c98b94994ed2a2695fca296dfd0d520d976454de10d2d9b747c824527678b86fc862e76c3760d5e6a635ec36bdba79f378437b1bd77f21376c1b20b2f5b25a46f3ff03f4f652f91ff12f92f91bf3df25fe2647b9c3ce7d0f80d536296081cea43939a78bd418c2391ae3aa95ae1a639cd327fb3bb879b6ff9b8d0bea5f1a5d237a2badebeadbf2f51afd7e90dd031d7c712d099140c1a517dc0c77dfc3a84affd1d857d5f5d987019967e4298080d79be6e8cbd1746a834383c3b3e211bff39893fedc81c85836f678450e59b73a2960a7709e142d099bf63f8cb24964caec41a9ac7a9bf0ee5d2f25cfee6c0cb721182a3fd5db322c4cc9aa8842df465caf89a13f9ededbf3fc6209d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137175, 8332, 0.1, 0.2, 'mg/kg', 'IM', NULL, 'Pediatric', X'789cf3f4d5510876b65230d033d435d033ca4dd7cf4e07002fce04f4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137176, 8332, 0.05, 0.3, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf30cb35230d03330d535d033ce4dd7cf4e572834d635c928520808f253d0c8cb2f5128c95748ad484e4d4d51303400aa48c92f4ed50400950c0fe1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137177, 8332, 10.0, 30.0, 'mcg/kg', NULL, NULL, 'Pediatric', X'789c73cecf2bc9cc2bcd2f2d56c8cc4b2b2dcecccfb3523034d03536c84d4ed7cf4ed7cf280200e9fc0c4f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137178, 8332, 0.01, 0.03, 'mg/kg', NULL, NULL, 'Pediatric', X'789c0b70765430d03330d40512c6b9e9fad9e9fa29f9c5a90a8979290a064882194500ebfd0bc0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137179, 1691, 5.0, 5.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652f02f4acc5128cecf292dc9cccf53d030cd4dd7cff5d15448cc4b5108494cca492d018a29e4a6eb2898eb81684d00968a13a5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137180, 1691, 2.5, 2.5, 'mg', NULL, 1, 'Adult', X'789c33d233cd4d5728c957308730ca33935315521233732a0167bb086a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137181, 1691, 2.5, 2.5, 'mg', NULL, 1, 'Pediatric', X'789c732f4a4d2c492d5228c948cc533031c84eb75230d233cd4d5728c957308730ca33935315521233732a014eeb0eaf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137182, 1691, 0.05, 0.05, 'mg/kg', NULL, 1, 'Pediatric', X'789cf3492d2e5628c948cc533031c84eb752082e492c2ac9cc4b5748c92f4e55c82c5630d0333055c84dd7cf4e572829cf4c4e554849cccca9040000e0126d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137183, 1691, 0.2, 0.2, 'mg/kg', NULL, 1, 'Pediatric', X'789c3353c8cdcf2bc9285628c9573054a84c4d2c52c84dacc8cc2dcd5548c92f4e55d05530d033ca4dd7cf4e572829cf4c4e554849cccca90400f0ed123f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137184, 1691, 0.3, 0.3, 'mg/kg', NULL, 1, 'Pediatric', X'789c33b451a84c4d2c52c84dacc8cc2dcd5548c92f4e55d05530d033ce4dd7cf4e57282d5028c95730d733cd4d572829cf4c4e554849cccca90400efba1200', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137185, 1227, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137186, 5358, 200.0, 200.0, 'mg', 'PO', 3, 'Adult', X'789c0b294a2c4bcd492d522f5648c94c2c2aca484dd45170d55348cecfc9d4cdcc4b294d4e4db152303230c84d5708f05728c94c51a830564849ac2c06004ba4134b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137187, 5358, 550.0, 550.0, 'mg', 'PO', 2, 'Adult', X'789cf3482d482cc94c5648cd4b4e2dc848ccc90772332aad144c4d0d72d31502fc1592325300f43c0c8a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137188, 5358, 550.0, 550.0, 'mg', 'PO', 3, 'Adult', X'789cf3740ad65148c94c2c2aca484dd42d284a4dc9cfcdcc4bcc2bb152303535c84d5708f05728c94c51a83034514849ac2c06008c230fef', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137189, 5358, 200.0, 200.0, 'mg', 'PO', 3, 'Pediatric', X'789c0b294a2c4bcd492d522f5648c94c2c2aca484dd45170d55348cecfc9d4cdcc4b294d4e4db152303230c84d5708f05728c94c51a830564849ac2c06004ba4134b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137190, 3008, 25.0, 25.0, 'mg', 'IN', 1, 'Adult', X'789c45ccc10ec2201084e15799078044a9c4444f267af5ea19d94d45659b165a834f2f78d0eb3f99ef3c88667997c80842b30fd2e3703ac2d17d169fd30e17e607d6da28181b7b8ce48ac2abc54e6f14ecea17f38da52a7e629798702dff11bcf0541af3bda63da20b92599c7886315677dba6930bcf520d18505802558686c4e903f3de36c4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137191, 3008, 25.0, 25.0, 'mg', NULL, 1, 'Adult', X'789c358cc10dc23010045bd9026cc909c907fa80f7e15b8121b9806340ee1e8ce03bb3b37b996e799142885e1e16cb1607f28acef70efd389f705fd4e1d5d8c60f7fa6521dca9986643153562a8ef523fd187e1e7c32d776f4add71d664956686291e842f043685b9534d53788ab2b4c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137192, 3008, 50.0, 50.0, 'mg', 'IN', 1, 'Adult', X'789c35cc3b0ec2301084e1abcc011cc9793550219133503bde5558c08b889d20737a9c08da5f33dfa09f1c18a2b478d109a7e10c47b7457d3ae0c27c475d3506bd0d135ee4b2c17b8b6dd5fde2286490aeacc5f033bbc88431a3b6ff0778e5396fcc7e8d4704279a589d7a466b6dd5ef5b72f2c80541039255a838f48c1cbf9b953473', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137193, 3008, 25.0, 25.0, 'mg', NULL, 1, 'Adult', X'789c5d8e3b0ec2301044af320770a47c014185042d2df5e25d8540b216b10398d393a48294fbf466664f4e13d14fec048df2601badb13f1e407c1bd406bfc559e48e2cc90df2aaabf1608a06af0916496950a5ffb032c8d2055b8d6ce9adc7bea5b70129e322d1291bb0f3d353b617f2e2e1af6e6819ea02e46d45f8670714e686368e8120fd935abf4347d3a1a45650a46952ce3e53d3c62f18dc5035', X'789ced586b6fdb3614fd2b8481000d60397ec4ceea0203bca6eb036d1a24d903980b8316af653614e9929413a5c87fdfa16427b2e33c1b0c1bb02fb1445197e79e7bee43f95e13364b469aa754ebb3da479e1a6f652235d5eaac96591556a7decf5c7f67e74c9e52da3036095772676db38b2d9f9118711fde6937dbbda8d98a5acd93e65ebfdbeb375f367a2f7bad66b7d84bb197463becfc5e7b4b9a2c57c5b5a7f3e2f5937c46fda11e682f63a3e799725c7b37d4fbc6f184d8afc6a6aecfba695267ede26fb719feb69ae54f79d70e7743fddaa4a9d1ecc47241ec009ee24d6097b1e78abdf8bc7f5267c79e5b4fb6cefe3cda2ef065e32ac44b2c793e5614eefefa823b25f56971730d790debfdfcadbf70f9259c331099f223f82975b242c947d2da9c476f79e63ccf7c9f7db601fffb342521b92766491177c4262027533ca0df1eea03a323d217794a4c6a91c530cb066ff619175f331d7b70f107d1296b45ed924af64df0bccecec26227da2d995d2cfa296958896d3847b0717efd90d19c6c1ecc14afba572ce5527bd25cc7c4daed6ed4d90bd605972a870dd66642cea58019611c21b4bf7335b32638b28076139911556015b43781e1c007628366a2dda09412db50bfb99dad2aa40a2f6b648da5d804a910e703007500a87b0d68235987d0ab44f81dc98bcc92635c0b36b332e5b09b9409252fb0df1b2de32856e1e76af750dfa99a3e73c812c65d58646bba0b08c00a683a07e000699385e7d55db1d8ad57185cacf516b95e5ddb5b247e75eda7829f31e546233481c3abd038e6a626538269e3199dc7048f2a91e2beb05084011562ced58668adc8e74774bc7474dda7de06dff736f8beee27bc7b2e3fc169d4ee3e539adc70a6bb2168701ae4aefbbcfb0fc6166745bdebd83eae3314d5fcb0c8322be34d15fdfd5575b0d29d3233610285419959a0d39195268307a7c87fcbdd34a46d28f9686853a98445796947ad36cb895b64d39d19fdb8746c363a69b2739aecac45add9e855d66f16b8eaf3bb4bdc6ea31bed35ba57bbefc99a66a3d5bd0551e71e449d07226a4555340fd4f62a21157937da77c2aa3ebf1b56376a55710d8481d462c2b8c07ebe8efd114dc8a2d40323868745857e825a8f6714a3ab8c0ecd6c211cb722d8434b49c095b3233c0d4da0cf5e0ff5478e51aa6c1cdde616a3904c8e8d83bf9ea5529d36d860a689233bad39033672aece6606cdc56531f49d3486fa081e2b5666499fedd3922e514e7c29981a13a3c924f833a757c869b84bdf32680619ec7c262409187a4733808917a686fa1392a55feefe8a1696021e168d885c609ed899f428121eed2e963ecc86cbb3cb3162ebc6e6cd3be1f95327c7755aef1f1df7c3d05e6e7623a94757161643e46ba3bd858c848c378471a014d9240f828915776e277c033c412e03014e1c8d8e88c7374fd960b0765c16b5957dc72b856e692acce4a05cbbe883996a87f9fd38d7904f984b50ee4fcc3942fc668699c8a6d0cd01226154ee248ae471266329b088878beaf70e9f1340aa9d8476a4cfafcea9adba5872173e1756201e60f609f29d9b5406ceeb8c8f05ae836267a039946482d6cbeb3a234129c79005dca9967831fc227391d1753601a624c385901717452e40fca8eff8b8c91dd469ac9d12de3e9a4a8dd3f0f41795599488b97485338708b4cfbd99116caf3bf020c15da3bd5f6ac5de51b1b7d4d6bf3286eb42fb3f887707f1bfc7cf530aeb0f517438e590656c9449f215a2de713589949c503f7c65763a0cedc3c2834f0440464997f6d9b209059ddbd0d9c2f7129a45d9257fb3a084bd78b9bbb50daa28c6a0faa2bdb51d4cc453ae61210c8383b8dcfd5e4fe558a2e3272af33cad8e78c1bc5c3e9e1be5d12aa3658e1022226496b2605393724f9908884603e5cc5ab6179f911bfe3db3bac0541867dd820465b878f45872e3d0fb03b9dc08abcff9cf99dbadddeae6634e189546463032ba3602255e5efe0d5c67b5cf', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137194, 3008, 25.0, 25.0, 'mg', NULL, 1, 'Adult', X'789c5dcd610ec2200c05e0abbc03b084a153a3f7d0df95363a65a083a9dc5eb668a2fbd77e69dfdb93bbf5819280f832789bb638885c515746c134dd09f7c00acfd116d5f26b4cf9838d42a3ff69a550eb99ad8bcdef3620cf384a0ebe54709088d6db5e2896299ec3e0183e24c8cb8af04f26284d092e978724fd835cdca1a371f1e4adc0685d99a98fa975f90dc3974a91', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137195, 3008, 50.0, 50.0, 'mg', NULL, 1, 'Adult', X'789c5d8e4b0e82401044af52071812fe1a5d99c8195cb7d31d44a12732a08ea7d761a52ceba57e8dbec320e89467db698b437304f175563bed7012b9214b72832a1d5adc9982c133c222290db274452b837ccd6a83224dffd0c6a05cdbb620659c25386503763e7eb2a390170f7f7173cf5037415e56847fa641d3d2d0876f6092f141bddf63a02894d44adc4aeac5cfd4f5e1031b924e0a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137196, 3008, 0.3, 0.3, 'mg/kg', NULL, NULL, 'Pediatric', X'789c55cc410ac2301484e1abcc019a546daba02b41b76e5dc76488b1e415da5489a7d7b810ddfe337ca74114e5992311c4cd3688c7fe788071b7596c9ab638933d966a5561a19be8ebded7cee40a8fd21bd596befee9e94a795b76a499e870c97f3b78e7988bf701a61da2099228462cd1ea4e6d74f77dbf00e71d32dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137197, 3008, 0.15, 0.15, 'mg/kg', NULL, NULL, 'Pediatric', X'789c558d410e82301405aff20e504004367a0f5d7fdb17a8c8d7942ae9eda16e94ed4c327391c72b3c2512e2ee6fb5f1842b39a22e8e0687b2eea6be1afbca493258b2688a368be68fc7810aaf3650663adcd2ce831f869483dfc07cc6245e2355d472c3bfc30a50792d2f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137198, 3008, 0.6, 0.6, 'mg/kg', NULL, NULL, 'Pediatric', X'789c55cc410e82301484e1abcc015ab0282e74650267705dda49ada46f0145534f2fb830bafd67f2f5f22a8988e2171725e0d277b0febe88cb275cc91146370abbea98423d86dadba2f0dcfa5e1f144cd5fcf47ca3ac949b68677a0ce56f071f9ccae67d80f98c64a3648a1547b4dab4dfeb1b30523059', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137199, 493, 500.0, 500.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303530c84dd751b0300553860620aeb5826b104cc21c590200fc300ff4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137200, 493, 850.0, 1000.0, 'mg', 'PO', 2, 'Adult', X'789cb33035d035343030c84d5708f05748ca4c01002340046e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137201, 493, 500.0, 500.0, 'mg', NULL, 1, 'Adult', X'789c0b2e492c2a51303530c84d5770f27451c82f52b0300571025d0072a207ce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137202, 493, 500.0, 500.0, 'mg', NULL, NULL, 'Adult', X'789cf3cc4b2e4a4d2c4e55303530c84d57282ccf56c82f52b03005738ccab301aeba0a5e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137203, 493, 2550.0, 2550.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac5030323535c84dd74f49ac04001eae0454', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137204, 493, 1000.0, 2000.0, 'mg', 'PO', 1, 'Adult', X'789c33343030d0350212b9e90a01fe0a812e00210e03f9', X'789ced586d6fdb3610fe2b843fc78dedc54de00203dca45d8a2d8be7741f86a91068f22c11a64895a4926845fffb8ea4dfe4684d6c6c6981f593add3e98ef73cc7bb233f75b8a9b254d1023a23d2b90237d7a610aa73443a95915e963b57dad1f1f19d5840f1429bccff13c70d55cb0c2d81a7d4f92f06bdc1cb6eafdfedf7def74e47c3d3d1a0f76230383be9ff10748139a19545cd4f9d31470bc23a43bd2c881cdc072befeb124689ba1074060e2c29800b16d450a82dcd80bcc505d81119f67a457644ce86e1a7dff38fafc89be9eac5e9f68b444d75e5ede939697a1f91c975a2ce75516845de1bca81fc8ab8a003f4e3f09f3b223fc98ae93247e7e13fcafea247642a34fe0bc155b3edf83ea3c8d19904fff4e7077c92422dc2c326d096081f877ff551baf5d1e70fdedf9857d2a58890505903d096f5ad7da75720a570954d1dc29e0e9a4cd005903be1725c21953651975a72727246725d194b300d88d05c28ea8013a615e2695da2de157e6d28245390402d240a29ea461a106b32133c51378e1a179922afdf5d1034168824bf5da009c58cff72f9fee3dd62f3fee3e06e91a82b7a4f06432f38e6b44ed49b7b078ae33ad63ebdbfee60edd49bddf6d9ee265163e9080f20be5a664e5cef98f3a59a58c767a2af8884c2c4f95845b12d1168f0f94a94768499cae63e0296c35da7991b9eba899635abad132cbdbea5465095ded48a1b1d76e76384ecc1430cc08578b6e2dca227c4bac6855aa20010d627013edc00eed16d0b7e692728793bbb607c61e304a4bee7ed57cddbdd32f23d719f9ab8ff6fa49ede1e235821288358b5b4b3fd103acf85e40614c1d6cd716374fb67a4066ac21c80b27d9ae34e99f1586c43fae55deaa120700ba626fdee80dc012cec7f550d9f65a17b727a53021354a6135d56926ec05e2d7262205354b19a4cf1adc2796d445e27ea17ca5cd02646d885174e8c9ea19f9a583a6fa56f0a0afdb4644e989046e43c248750617ec2a438373ff65f9c6021247328280640a85a4a875e5af8bdb14ec91139c4404bd3bf8492baf6145f2e747cab058fa99e4765ace12515a600e51a4bfaa2e61e59f5cf743c6132f5078aa86c53a1d2b5850e3adc186e12fab8d9b57eeaf5538f78a68dc0c5c7b1f75b657b372bbf45ba9f3f0ff72c1a0dec1f948cb19460b29a384d98a4d61efb332d967c2c6698854201094c459a7c7b0a14f907ac67807eb5c40552267c93c41a77f1f338169c86f45d4b57b9ac4b7d0f85a0f811e43537cbf3e90d94e19b9bca64584051b105af735a45edf3cbb7d8642507236bdfad99ceb5247456f956eb5d643833442fabbd72c83913dd3cbecdbc52639f6efb7ffcf386f6ea3c8a3dc4423a05ca1e72d7b6456ec0085d35f5d6d70d5d245833118890bb1c5d4146a59e611204b95a2d7aa7e4c6337ec33eb650637240881545dc69d8ccb7ba10b107bdc5565549500c7c9be422031bb91bcf382a61e9215c58a60b5c24523b56dac0bd27ec1228a7380e256a4a6d9ea8ebdb65d7c3299b576c75d8dfbb2e3f058f3d2e71b6aca4d14abab6d24887154e4fbaa1889a310dfe7d5277d3e63babcfcfeab787f981377087853fc9a92928d352677503844b2ae75d29e630222f97d70d38129498c34504a47fba11cfa4d67cd38a6c81d3ca1f939361cf1fbd70248f9793bf1bec6407f4ce2b6039556835d5f374cc1edcb35e409cfaedba5567fe92138f01a5d14b60c39285729e2bcf109d596dcac8dbead4e043b115fa26169445b66f853be88000908ea5d507548a969b547b684e7cc5add81ac3ded7c19bc1780ec6efb766ed7d536a86e30aec091016b2cf7f03807e4c8c', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137205, 493, 500.0, 500.0, 'mg', NULL, 1, 'Adult', X'789c0b2e492c2a51303530c84d570874010022b1044d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137206, 493, 500.0, 500.0, 'mg', NULL, NULL, 'Adult', X'789cf3cc4b2e4a4d2c4e55303530c84d57282ccf06003b380627', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137207, 493, 1000.0, 1000.0, 'mg', NULL, 2, 'Adult', X'789c73cc295148c92fcecc4bb75630343030c84d5748ca4c010052f00705', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137208, 493, 500.0, 500.0, 'mg', NULL, NULL, 'Adult', X'789c734c4951303530c84d57c8cccd4d4dc94c2c4955284acd494d2c4e5548cb2f52c8cc4b4c492d2c85081717e4e715a70200c8f1129a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137209, 493, 500.0, 500.0, 'mg', NULL, 3, 'Adult', X'789c333530c84d5728c94c01000c5902cb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137210, 493, 850.0, 1000.0, 'mg', NULL, 2, 'Adult', X'789c73cc295148c92fcecc4bb756b03035d035343030c84d5748ca4c01006d6407cf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137211, 493, 2550.0, 2550.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac5030323535c84dd74f49ac04001eae0454', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137212, 493, 1500.0, 2000.0, 'mg', NULL, 1, 'Adult', X'789c33343530d035323030c84d57087401001634033f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137213, 493, 2000.0, 2000.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac5030323030c84dd74f49ac04001e59044a', X'789ced586d6fdb3610fe2b843fc78dedc54de00203dca45d8a2d8be7741f86a91068f22c11a64895a4926845fffb8ea4dfe4684d6c6c6981f593add3e98ef73cc7bb233f75b8a9b254d1023a23d2b90237d7a610aa73443a95915e963b57dad1f1f19d5840f1429bccff13c70d55cb0c2d81a7d4f92f06bdc1cb6eafdfedf7def74e47c3d3d1a0f76230383be9ff10748139a19545cd4f9d31470bc23a43bd2c881cdc072befeb124689ba1074060e2c29800b16d450a82dcd80bcc505d81119f67a457644ce86e1a7dff38fafc89be9eac5e9f68b444d75e5ede939697a1f91c975a2ce75516845de1bca81fc8ab8a003f4e3f09f3b223fc98ae93247e7e13fcafea247642a34fe0bc155b3edf83ea3c8d19904fff4e7077c92422dc2c326d096081f877ff551baf5d1e70fdedf9857d2a58890505903d096f5ad7da75720a570954d1dc29e0e9a4cd005903be1725c21953651975a72727246725d194b300d88d05c28ea8013a615e2695da2de157e6d28245390402d240a29ea461a106b32133c51378e1a179922afdf5d1034168824bf5da009c58cff72f9fee3dd62f3fee3e06e91a82b7a4f06432f38e6b44ed49b7b078ae33ad63ebdbfee60edd49bddf6d9ee265163e9080f20be5a664e5cef98f3a59a58c767a2af8884c2c4f95845b12d1168f0f94a94768499cae63e0296c35da7991b9eba899635abad132cbdbea5465095ded48a1b1d76e76384ecc1430cc08578b6e2dca227c4bac6855aa20010d627013edc00eed16d0b7e692728793bbb607c61e304a4bee7ed57cddbdd32f23d719f9ab8ff6fa49ede1e235821288358b5b4b3fd103acf85e40614c1d6cd716374fb67a4066ac21c80b27d9ae34e99f1586c43fae55deaa120700ba626fdee80dc012cec7f550d9f65a17b727a53021354a6135d56926ec05e2d7262205354b19a4cf1adc2796d445e27ea17ca5cd02646d885174e8c9ea19f9a583a6fa56f0a0afdb4644e989046e43c248750617ec2a438373ff65f9c6021247328280640a85a4a875e5af8bdb14ec91139c4404bd3bf8492baf6145f2e747cab058fa99e4765ace12515a600e51a4bfaa2e61e59f5cf743c6132f5078aa86c53a1d2b5850e3adc186e12fab8d9b57eeaf5538f78a68dc0c5c7b1f75b657b372bbf45ba9f3f0ff72c1a0dec1f948cb19460b29a384d98a4d61efb332d967c2c6698854201094c459a7c7b0a14f907ac67807eb5c40552267c93c41a77f1f338169c86f45d4b57b9ac4b7d0f85a0f811e43537cbf3e90d94e19b9bca64584051b105af735a45edf3cbb7d8642507236bdfad99ceb5247456f956eb5d643833442fabbd72c83913dd3cbecdbc52639f6efb7ffcf386f6ea3c8a3dc4423a05ca1e72d7b6456ec0085d35f5d6d70d5d245833118890bb1c5d4146a59e611204b95a2d7aa7e4c6337ec33eb650637240881545dc69d8ccb7ba10b107bdc5565549500c7c9be422031bb91bcf382a61e9215c58a60b5c24523b56dac0bd27ec1228a7380e256a4a6d9ea8ebdb65d7c3299b576c75d8dfbb2e3f058f3d2e71b6aca4d14abab6d24887154e4fbaa1889a310dfe7d5277d3e63babcfcfeab787f981377087853fc9a92928d352677503844b2ae75d29e630222f97d70d38129498c34504a47fba11cfa4d67cd38a6c81d3ca1f939361cf1fbd70248f9793bf1bec6407f4ce2b6039556835d5f374cc1edcb35e409cfaedba5567fe92138f01a5d14b60c39285729e2bcf109d596dcac8dbead4e043b115fa26169445b66f853be88000908ea5d507548a969b547b684e7cc5add81ac3ded7c19bc1780ec6efb766ed7d536a86e30aec091016b2cf7f03807e4c8c', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137214, 493, 500.0, 1000.0, 'mg', NULL, 2, 'Pediatric', X'789c333530d035343030c84d5748ca4c0100176a03a7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137215, 493, 500.0, 500.0, 'mg', NULL, 1, 'Pediatric', X'789c0b2e492c2a51303530c84d570874010022b1044d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137216, 493, 500.0, 500.0, 'mg', NULL, NULL, 'Pediatric', X'789cf3cc4b2e4a4d2c4e55303530c84dd74f49ac54482d4b2daa5430d43552284f4dcd2e0600c8280b5b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137217, 493, 2000.0, 2000.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac5030323030c84dd74f49ac04001e59044a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137218, 151, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137219, 1413, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137220, 22166, 375.0, 375.0, 'mg', NULL, NULL, 'Adult', X'789c33363755c84dd7cf050008b30230', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137221, 3433, 10.0, 10.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db6523034c84dd7513002932640120095e10910', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137222, 3433, 20.0, 80.0, 'mg', 'PO', NULL, 'Adult', X'789c3332d0b530c84d5708f0572874f40500199803aa', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137223, 3433, 20.0, 20.0, 'mg', 'PO', NULL, 'Adult', X'789c0b2e492c2a513032c84d5708f0572874f4050032230543', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137224, 3433, 20.0, 60.0, 'mg', 'PO', NULL, 'Adult', X'789c3332d03533c84d5708f0572874f40500198203a8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137225, 3433, 20.0, 20.0, 'mg', 'PO', NULL, 'Adult', X'789c0b2e492c2a513032c84d5708f0572874f4050032230543', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137226, 3433, 60.0, 60.0, 'mg', 'PO', NULL, 'Adult', X'789c3333c84d5708f0572874f4050012370319', X'789ced5a5b73da3814fe2b1a663a93ce4202e45a765f686836ed342d1bb2bbb3b3def108fb006a64c9956482d3c97fdf235f203610204dbb6d97170f96cef9f49d9b6ee653c557d1d01534804a8b54ce7824276098804a955422c56de3c89850b7f6f66ed83504bb520ded2fb65794d59ea221f82e3556a5596f1ed5ea8d5aa37e553f6e1deeb7f6ebbb272f8e9b07cd44163cc3a4d028f9a9d2f6032698368adab6a4c9c02441b98a436891b630cc875081d654184774a4a64320675205ba451af5605825cde479804f475ccac8802672408ad02df25e51ee8853190452902b457d20efd07044e92a794bbd845bd4bf4fef0e9b0ced73b06f7fff836f9c89ebf4c5f6b5fd881b172931312c705f8055b9a01fa472335bd8185c9f69a97c5005cd66bd76828690ee7bf2b17de1889ea1ca2416664d9522274be33d0e9440d6d0ba30e2097a6709fad1a6e82f23ce02465d016a8cce2fe01d3da8d9a58279cb883c38240b25a76aeaa1aa6b93c17d5db6e53047e92e4239a586861c26f1032e28abad8af81306b19c1fdb287eb5283eb1abcb91dcfafafa518957f6e30fe88df54d9a4baa6fd6a647322b1bf825a8ad8bb9e1badf059f51a36c243f73ed779bc582a81d93583aa25127193fdf1127b5c649d65a6bce3a36dd0894863aae35d2b1126f3c843a1f5f93c4b70488ec6688870f2316e7843250f3a7f588bd165a0682d1253456baab7bd5eb2cf6c94ad59ef418e56e5b4c18987871411fe6663c0434cdd0921332652472b05cffd1bb95cf4cbb8db62edbbcfbdfe5dd13e5c3ea25709b10df47423c41e4566cb2b7a1fb52a17ba49fcbf1da3a7a85a33776d0dc71e947f7d02606969df37d58f878964b4f535f82e6c6e01b9eaf7a21247ee84adc3cd09951f9385d0543418517934bec154347b4c8e9cfe494465696507fcc34f88409b2af7c8207b500b401e588b7d433091e514c5fa31222337430a11cfb05768d81dc8c1807d25740b519001ef5f080b7c0c3972090e2820360722bdc72c43b894c3e44da04606faea787c672d782243b8710b92c3c5ee6e81df02c4320bec4875464a0e06304e894e250cbe53688fa72d7affe52d0b19f18c25ccdf5a881a1540c47b94b6c7d523f9683f4ad39f2eb4677c3b2c36a308a32e1336f41d1b53907358c8991c4e354eb3dfbedc81159d1b5eca715e1454a6124c8e9bb1e997db521910647b4b9274792a72f5da3c92fa47998cc17af389620b7964d93ab54b799c7080b42ca54960712cd3dfdabdbec1c9100d02ec9d9ad157ec9d3a24d6adc11bf5d9150492ec530310a799e9f21621cca80e2726b9d96fe18316da4421aedb1643ea17d158586dc3033f215bda1fc511f88c6a034b89740bd798f2e5ca740311915e57a11f3984f3933b18d787a9ab796c0847aa0fa995d5393f692e79ce55547a07d9afaa0313824944c18d08ec021a59102674b1d0b5fc9c0064bd07014733a612850b5f7de3006a16b6fe408b72982f4a69255f24ac56604012501e62e1b48659b11340a8866deb540b68ef8836a0f779226c123dd88075250159301eb2b2c036cfd95d3c843036c3f15430e358f4b1da9048cdde28f948a3513676a0581b5d1727bddee9ca7ed431e7b697b57311a321d20bd092675182b1a581fa28d416864a0172dedc9b7c182ebf34d194e351413371d702c03962e3bf882b5a8d4c8f69c03f5a93782acf9f696a5a6b785543061d49a95aceb55926ca6239df56b749fb0fd762cc9b17a139b2711d2f5633d88849746b813eb10426de9b4fb881a5801acff00512ea91e39e24f60c39121e8b83903d79ade67d9b5c6c43e9345ec19c682245b0d769529b93eb8b95201753e4b57834e75dca94e01f35e96af06bb2f5c64b6a436d6e057d4747b0b59ce4a6735e23dd902465e5cab11a69225efa715b88ecf33c982fefda25d8d51902ef2b0b5be0689446c8e413e3dacc7602a5dc049e781d508995c41379f38d688632e59d0cfe79a356a33972cfa209ba1d6b03f972c8d9f4d6aeb10c8450b0876965aad9c48a5bbc3ed7af815d7c3b943e47641dc2e88db0571bb206e17c46f6641fcf1e6e4f5cfd4dba4fb8f92ae3ba218470ff74ec3e25f69ce291fd4381b408b1cd48e884f63b213d2e40ec85e0f3dc76cf2c98bdd7ddba3c98ebd0519c3f4bac6c073475c642f3a6891b7d8abaac9adce69e345a29cddf0ec848a05b841428557134f41fa9fdedf155a474eeacfc84ea3b17bf48c60168e70b304fef32a39030fd7dcc6e1b3475cdc5c80c5414eae1cb86d6feecfc93de090d8c263c2c488f599d1444f5764055168e8356c3af2ddddbf413df4fc', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137227, 3433, 20.0, 20.0, 'mg', 'PO', NULL, 'Adult', X'789c3332c84d5708f0572874f40500120b0315', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137228, 3433, 20.0, 50.0, 'mg', 'PO', NULL, 'Adult', X'789c3332d03535c84d5708f057280cf00500199503b6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137229, 3433, 20.0, 60.0, 'mg', 'PO', NULL, 'Adult', X'789c3332d03533c84d5708f0572874f40500198203a8', X'789ced5a5b73da3814fe2b1a663a93ce4202e45a765f686836ed342d1bb2bbb3b3def108fb006a64c9956482d3c97fdf235f203610204dbb6d97170f96cef9f49d9b6ee653c557d1d01534804a8b54ce7824276098804a955422c56de3c89850b7f6f66ed83504bb520ded2fb65794d59ea221f82e3556a5596f1ed5ea8d5aa37e553f6e1deeb7f6ebbb272f8e9b07cd44163cc3a4d028f9a9d2f6032698368adab6a4c9c02441b98a436891b630cc875081d654184774a4a64320675205ba451af5605825cde479804f475ccac8802672408ad02df25e51ee8853190452902b457d20efd07044e92a794bbd845bd4bf4fef0e9b0ced73b06f7fff836f9c89ebf4c5f6b5fd881b172931312c705f8055b9a01fa472335bd8185c9f69a97c5005cd66bd76828690ee7bf2b17de1889ea1ca2416664d9522274be33d0e9440d6d0ba30e2097a6709fad1a6e82f23ce02465d016a8cce2fe01d3da8d9a58279cb883c38240b25a76aeaa1aa6b93c17d5db6e53047e92e4239a586861c26f1032e28abad8af81306b19c1fdb287eb5283eb1abcb91dcfafafa518957f6e30fe88df54d9a4baa6fd6a647322b1bf825a8ad8bb9e1badf059f51a36c243f73ed779bc582a81d93583aa25127193fdf1127b5c649d65a6bce3a36dd0894863aae35d2b1126f3c843a1f5f93c4b70488ec6688870f2316e7843250f3a7f588bd165a0682d1253456baab7bd5eb2cf6c94ad59ef418e56e5b4c18987871411fe6663c0434cdd0921332652472b05cffd1bb95cf4cbb8db62edbbcfbdfe5dd13e5c3ea25709b10df47423c41e4566cb2b7a1fb52a17ba49fcbf1da3a7a85a33776d0dc71e947f7d02606969df37d58f878964b4f535f82e6c6e01b9eaf7a21247ee84adc3cd09951f9385d0543418517934bec154347b4c8e9cfe494465696507fcc34f88409b2af7c8207b500b401e588b7d433091e514c5fa31222337430a11cfb05768d81dc8c1807d25740b519001ef5f080b7c0c3972090e2820360722bdc72c43b894c3e44da04606faea787c672d782243b8710b92c3c5ee6e81df02c4320bec4875464a0e06304e894e250cbe53688fa72d7affe52d0b19f18c25ccdf5a881a1540c47b94b6c7d523f9683f4ad39f2eb4677c3b2c36a308a32e1336f41d1b53907358c8991c4e354eb3dfbedc81159d1b5eca715e1454a6124c8e9bb1e997db521910647b4b9274792a72f5da3c92fa47998cc17af389620b7964d93ab54b799c7080b42ca54960712cd3dfdabdbec1c9100d02ec9d9ad157ec9d3a24d6adc11bf5d9150492ec530310a799e9f21621cca80e2726b9d96fe18316da4421aedb1643ea17d158586dc3033f215bda1fc511f88c6a034b89740bd798f2e5ca740311915e57a11f3984f3933b18d787a9ab796c0847aa0fa995d5393f692e79ce55547a07d9afaa0313824944c18d08ec021a59102674b1d0b5fc9c0064bd07014733a612850b5f7de3006a16b6fe408b72982f4a69255f24ac56604012501e62e1b48659b11340a8866deb540b68ef8836a0f779226c123dd88075250159301eb2b2c036cfd95d3c843036c3f15430e358f4b1da9048cdde28f948a3513676a0581b5d1727bddee9ca7ed431e7b697b57311a321d20bd092675182b1a581fa28d416864a0172dedc9b7c182ebf34d194e351413371d702c03962e3bf882b5a8d4c8f69c03f5a93782acf9f696a5a6b785543061d49a95aceb55926ca6239df56b749fb0fd762cc9b17a139b2711d2f5633d88849746b813eb10426de9b4fb881a5801acff00512ea91e39e24f60c39121e8b83903d79ade67d9b5c6c43e9345ec19c682245b0d769529b93eb8b95201753e4b57834e75dca94e01f35e96af06bb2f5c64b6a436d6e057d4747b0b59ce4a6735e23dd902465e5cab11a69225efa715b88ecf33c982fefda25d8d51902ef2b0b5be0689446c8e413e3dacc7602a5dc049e781d508995c41379f38d688632e59d0cfe79a356a33972cfa209ba1d6b03f972c8d9f4d6aeb10c8450b0876965aad9c48a5bbc3ed7af815d7c3b943e47641dc2e88db0571bb206e17c46f6641fcf1e6e4f5cfd4dba4fb8f92ae3ba218470ff74ec3e25f69ce291fd4381b408b1cd48e884f63b213d2e40ec85e0f3dc76cf2c98bdd7ddba3c98ebd0519c3f4bac6c073475c642f3a6891b7d8abaac9adce69e345a29cddf0ec848a05b841428557134f41fa9fdedf155a474eeacfc84ea3b17bf48c60168e70b304fef32a39030fd7dcc6e1b3475cdc5c80c5414eae1cb86d6feecfc93de090d8c263c2c488f599d1444f5764055168e8356c3af2ddddbf413df4fc', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137230, 3433, 10.0, 10.0, 'mg', 'PO', 1, 'Pediatric', X'789c333450c84d5708f057284c01001091030a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137231, 3433, 10.0, 20.0, 'mg', 'PO', 1, 'Pediatric', X'789c3334d0353250c84d5708f057284c010017d90399', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137232, 3433, 20.0, 60.0, 'mg', 'PO', 1, 'Pediatric', X'789c3332d0353350c84d5708f057284c01001813039e', X'789ced5a5b73da3814fe2b1a663a93ce4202e45a765f686836ed342d1bb2bbb3b3def108fb006a64c9956482d3c97fdf235f203610204dbb6d97170f96cef9f49d9b6ee653c557d1d01534804a8b54ce7824276098804a955422c56de3c89850b7f6f66ed83504bb520ded2fb65794d59ea221f82e3556a5596f1ed5ea8d5aa37e553f6e1deeb7f6ebbb272f8e9b07cd44163cc3a4d028f9a9d2f6032698368adab6a4c9c02441b98a436891b630cc875081d654184774a4a64320675205ba451af5605825cde479804f475ccac8802672408ad02df25e51ee8853190452902b457d20efd07044e92a794bbd845bd4bf4fef0e9b0ced73b06f7fff836f9c89ebf4c5f6b5fd881b172931312c705f8055b9a01fa472335bd8185c9f69a97c5005cd66bd76828690ee7bf2b17de1889ea1ca2416664d9522274be33d0e9440d6d0ba30e2097a6709fad1a6e82f23ce02465d016a8cce2fe01d3da8d9a58279cb883c38240b25a76aeaa1aa6b93c17d5db6e53047e92e4239a586861c26f1032e28abad8af81306b19c1fdb287eb5283eb1abcb91dcfafafa518957f6e30fe88df54d9a4baa6fd6a647322b1bf825a8ad8bb9e1badf059f51a36c243f73ed779bc582a81d93583aa25127193fdf1127b5c649d65a6bce3a36dd0894863aae35d2b1126f3c843a1f5f93c4b70488ec6688870f2316e7843250f3a7f588bd165a0682d1253456baab7bd5eb2cf6c94ad59ef418e56e5b4c18987871411fe6663c0434cdd0921332652472b05cffd1bb95cf4cbb8db62edbbcfbdfe5dd13e5c3ea25709b10df47423c41e4566cb2b7a1fb52a17ba49fcbf1da3a7a85a33776d0dc71e947f7d02606969df37d58f878964b4f535f82e6c6e01b9eaf7a21247ee84adc3cd09951f9385d0543418517934bec154347b4c8e9cfe494465696507fcc34f88409b2af7c8207b500b401e588b7d433091e514c5fa31222337430a11cfb05768d81dc8c1807d25740b519001ef5f080b7c0c3972090e2820360722bdc72c43b894c3e44da04606faea787c672d782243b8710b92c3c5ee6e81df02c4320bec4875464a0e06304e894e250cbe53688fa72d7affe52d0b19f18c25ccdf5a881a1540c47b94b6c7d523f9683f4ad39f2eb4677c3b2c36a308a32e1336f41d1b53907358c8991c4e354eb3dfbedc81159d1b5eca715e1454a6124c8e9bb1e997db521910647b4b9274792a72f5da3c92fa47998cc17af389620b7964d93ab54b799c7080b42ca54960712cd3dfdabdbec1c9100d02ec9d9ad157ec9d3a24d6adc11bf5d9150492ec530310a799e9f21621cca80e2726b9d96fe18316da4421aedb1643ea17d158586dc3033f215bda1fc511f88c6a034b89740bd798f2e5ca740311915e57a11f3984f3933b18d787a9ab796c0847aa0fa995d5393f692e79ce55547a07d9afaa0313824944c18d08ec021a59102674b1d0b5fc9c0064bd07014733a612850b5f7de3006a16b6fe408b72982f4a69255f24ac56604012501e62e1b48659b11340a8866deb540b68ef8836a0f779226c123dd88075250159301eb2b2c036cfd95d3c843036c3f15430e358f4b1da9048cdde28f948a3513676a0581b5d1727bddee9ca7ed431e7b697b57311a321d20bd092675182b1a581fa28d416864a0172dedc9b7c182ebf34d194e351413371d702c03962e3bf882b5a8d4c8f69c03f5a93782acf9f696a5a6b785543061d49a95aceb55926ca6239df56b749fb0fd762cc9b17a139b2711d2f5633d88849746b813eb10426de9b4fb881a5801acff00512ea91e39e24f60c39121e8b83903d79ade67d9b5c6c43e9345ec19c682245b0d769529b93eb8b95201753e4b57834e75dca94e01f35e96af06bb2f5c64b6a436d6e057d4747b0b59ce4a6735e23dd902465e5cab11a69225efa715b88ecf33c982fefda25d8d51902ef2b0b5be0689446c8e413e3dacc7602a5dc049e781d508995c41379f38d688632e59d0cfe79a356a33972cfa209ba1d6b03f972c8d9f4d6aeb10c8450b0876965aad9c48a5bbc3ed7af815d7c3b943e47641dc2e88db0571bb206e17c46f6641fcf1e6e4f5cfd4dba4fb8f92ae3ba218470ff74ec3e25f69ce291fd4381b408b1cd48e884f63b213d2e40ec85e0f3dc76cf2c98bdd7ddba3c98ebd0519c3f4bac6c073475c642f3a6891b7d8abaac9adce69e345a29cddf0ec848a05b841428557134f41fa9fdedf155a474eeacfc84ea3b17bf48c60168e70b304fef32a39030fd7dcc6e1b3475cdc5c80c5414eae1cb86d6feecfc93de090d8c263c2c488f599d1444f5764055168e8356c3af2ddddbf413df4fc', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137233, 3433, 20.0, 50.0, 'mg', 'PO', 1, 'Pediatric', X'789c3332d0353550c84d5708f057284c01001808039d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137234, 3433, 20.0, 60.0, 'mg', 'PO', 1, 'Pediatric', X'789c3332d0353350c84d5708f057284c01001813039e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137235, 3433, 10.0, 20.0, 'mg', 'PO', 1, 'Pediatric', X'789c3334d0353250c84d5708f057284c010017d90399', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137236, 3433, 10.0, 20.0, 'mg', 'PO', 1, 'Pediatric', X'789c3334d0353250c84d5708f057284c010017d90399', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137237, 3433, 20.0, 20.0, 'mg', 'PO', 1, 'Pediatric', X'789c333250c84d5708f057284c0100109c030b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137238, 3433, 10.0, 40.0, 'mg', 'PO', 1, 'Pediatric', X'789c3334d0353150c84d5708f057284c010017ef039b', X'789ced5a5b73da3814fe2b1a663a93ce4202e45a765f686836ed342d1bb2bbb3b3def108fb006a64c9956482d3c97fdf235f203610204dbb6d97170f96cef9f49d9b6ee653c557d1d01534804a8b54ce7824276098804a955422c56de3c89850b7f6f66ed83504bb520ded2fb65794d59ea221f82e3556a5596f1ed5ea8d5aa37e553f6e1deeb7f6ebbb272f8e9b07cd44163cc3a4d028f9a9d2f6032698368adab6a4c9c02441b98a436891b630cc875081d654184774a4a64320675205ba451af5605825cde479804f475ccac8802672408ad02df25e51ee8853190452902b457d20efd07044e92a794bbd845bd4bf4fef0e9b0ced73b06f7fff836f9c89ebf4c5f6b5fd881b172931312c705f8055b9a01fa472335bd8185c9f69a97c5005cd66bd76828690ee7bf2b17de1889ea1ca2416664d9522274be33d0e9440d6d0ba30e2097a6709fad1a6e82f23ce02465d016a8cce2fe01d3da8d9a58279cb883c38240b25a76aeaa1aa6b93c17d5db6e53047e92e4239a586861c26f1032e28abad8af81306b19c1fdb287eb5283eb1abcb91dcfafafa518957f6e30fe88df54d9a4baa6fd6a647322b1bf825a8ad8bb9e1badf059f51a36c243f73ed779bc582a81d93583aa25127193fdf1127b5c649d65a6bce3a36dd0894863aae35d2b1126f3c843a1f5f93c4b70488ec6688870f2316e7843250f3a7f588bd165a0682d1253456baab7bd5eb2cf6c94ad59ef418e56e5b4c18987871411fe6663c0434cdd0921332652472b05cffd1bb95cf4cbb8db62edbbcfbdfe5dd13e5c3ea25709b10df47423c41e4566cb2b7a1fb52a17ba49fcbf1da3a7a85a33776d0dc71e947f7d02606969df37d58f878964b4f535f82e6c6e01b9eaf7a21247ee84adc3cd09951f9385d0543418517934bec154347b4c8e9cfe494465696507fcc34f88409b2af7c8207b500b401e588b7d433091e514c5fa31222337430a11cfb05768d81dc8c1807d25740b519001ef5f080b7c0c3972090e2820360722bdc72c43b894c3e44da04606faea787c672d782243b8710b92c3c5ee6e81df02c4320bec4875464a0e06304e894e250cbe53688fa72d7affe52d0b19f18c25ccdf5a881a1540c47b94b6c7d523f9683f4ad39f2eb4677c3b2c36a308a32e1336f41d1b53907358c8991c4e354eb3dfbedc81159d1b5eca715e1454a6124c8e9bb1e997db521910647b4b9274792a72f5da3c92fa47998cc17af389620b7964d93ab54b799c7080b42ca54960712cd3dfdabdbec1c9100d02ec9d9ad157ec9d3a24d6adc11bf5d9150492ec530310a799e9f21621cca80e2726b9d96fe18316da4421aedb1643ea17d158586dc3033f215bda1fc511f88c6a034b89740bd798f2e5ca740311915e57a11f3984f3933b18d787a9ab796c0847aa0fa995d5393f692e79ce55547a07d9afaa0313824944c18d08ec021a59102674b1d0b5fc9c0064bd07014733a612850b5f7de3006a16b6fe408b72982f4a69255f24ac56604012501e62e1b48659b11340a8866deb540b68ef8836a0f779226c123dd88075250159301eb2b2c036cfd95d3c843036c3f15430e358f4b1da9048cdde28f948a3513676a0581b5d1727bddee9ca7ed431e7b697b57311a321d20bd092675182b1a581fa28d416864a0172dedc9b7c182ebf34d194e351413371d702c03962e3bf882b5a8d4c8f69c03f5a93782acf9f696a5a6b785543061d49a95aceb55926ca6239df56b749fb0fd762cc9b17a139b2711d2f5633d88849746b813eb10426de9b4fb881a5801acff00512ea91e39e24f60c39121e8b83903d79ade67d9b5c6c43e9345ec19c682245b0d769529b93eb8b95201753e4b57834e75dca94e01f35e96af06bb2f5c64b6a436d6e057d4747b0b59ce4a6735e23dd902465e5cab11a69225efa715b88ecf33c982fefda25d8d51902ef2b0b5be0689446c8e413e3dacc7602a5dc049e781d508995c41379f38d688632e59d0cfe79a356a33972cfa209ba1d6b03f972c8d9f4d6aeb10c8450b0876965aad9c48a5bbc3ed7af815d7c3b943e47641dc2e88db0571bb206e17c46f6641fcf1e6e4f5cfd4dba4fb8f92ae3ba218470ff74ec3e25f69ce291fd4381b408b1cd48e884f63b213d2e40ec85e0f3dc76cf2c98bdd7ddba3c98ebd0519c3f4bac6c073475c642f3a6891b7d8abaac9adce69e345a29cddf0ec848a05b841428557134f41fa9fdedf155a474eeacfc84ea3b17bf48c60168e70b304fef32a39030fd7dcc6e1b3475cdc5c80c5414eae1cb86d6feecfc93de090d8c263c2c488f599d1444f5764055168e8356c3af2ddddbf413df4fc', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137239, 1269, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'789cc5566d4fdb4810fe2ba34848544a20040aa7d02f69b8bb56ba2294cb97aaaeaccd7ae28c58cf5abbeb3656c57fefac1342935a0df4e8f59bd71e3ff3cc336ffba593b92a4f5915d81942e75d5592b39ab8d3854ee54c7cb708a1f4c3e3e3cf748bc59175797ca2e32d53af9d2a314b55887f0cfa83f35effa477d29ff62f862f2f8667a747838bf33fcecf1a5bd4812c7bb1fcd2f91b199d32cd73c065f3fbb42e7198f08803cdc806d20977616a4bd2ca247c65bdca11feb2aef043181c8076a88a2e58e25020878427b60ae8c1ce619415c4e48353d1e310c23dc8d8168565983a95215c4bf002f55ae9e0ec4c89b3b1e028ae1bb6d5ec5bc277f22aa899c178faf0514e86f8b6393c04f0c07cbf8cdfd8de7d8ce8a3ac3221952889f32d595ad874de162506caed96a12a4b536ff480e9db2b58c245efe40c3255fbce7604d1e5bfb7c429f17c8ddc4d6722053adac9cb0ab7917b0d7ad26f85fc81488dbf9f64bd1bfcff4dfb39fc3dbe9c1a973798910a8ef4530b223d1c14d6a78ab3d49a0cdd8b5f5521e9e1e95e47cfa17d893a7abbb16565d443bcf78e6e1ce6ac58d73091af9c27d2edaf13fe476836d6e0c8dfc697656cf19990f26a8e6d0a4e90c54f8bdc4d630ee17a94f0262df1d822d71b2cc56b6bd21e8bf2a841b31bf5fe717315a7fdcad84b42d30d42471c3e006febb61f76639f46fb54ab80b97524e45743eda744ddcdccaf55f5bf24ee895d3db62c2b89389365f47d298f8c4197d7b2ac401be5fd71dcd0091be564edd912193edb8a339fb0565593239a838b020315a522177bba0b85cd7a1e3fa16babf27d0c4799fce8319da0d2df336c1dc6320d6cb56db790452e28ec29d0270a35b88a13a936552e6aa39624218c8f20a3f99c3419ec49b056cb5939b74095b0afe4ffcdd48143e95d6339c70c2a8f2f5afa6eb5d6b738b0125bc19a558e9bb920c899d20b4cb87495a350090b514d88f9d815eb2e7ad26cfa2da1ef26e0f7c4fe7c5e9fba1917ca154a8b2a79bde5fe8d32f39ea139cae5b0df3beb43113dbd4301b3867c31044352dc97307e7f73f6b27f09affa47a707e06b1fb0200d6ae6ad2b238f84ff5ccaea5a5d1d853823bc3a3d88587aa1e45a5934574cbdfabe5e88d6c739a8c1bafb379a3265ba90a1746e26b182a4d3575e63192f7e26d6862c4fd09635f2faa67a29fd1c1b90e2a29ac9a0f0711a90b7062b5d9b5e985c8f8431878584e5b10bc40b018b6ac605179078fdd9938743c9905dd65ab9a880442894da4ae88792dfdd7d053f6e1fa6', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137240, 307, 10.0, 10.0, 'mg', 'IV', NULL, 'Adult', X'789c3334c84d57f00c53c82f5208f00700194303b5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137241, 307, 6.0, 6.0, 'mg', NULL, NULL, 'Adult', X'789c33cb4d57084c49ac5448cb2f5230345000328b0142890673', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137242, 307, 5.0, 5.0, 'mg', 'IV', NULL, 'Adult', X'789c33cd4d57f00c0300064901c9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137243, 307, 10.0, 10.0, 'mg', 'PO', NULL, 'Adult', X'789c0bcecc4bcf49553034c84d5708f05748c92f4e5548494d2e4a4d2c4e2d5628aecc2d28c9cf2d56482c5130b150c8c82f2d2ad651482a2d51c8cb2f513032818800002763176e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137244, 307, 0.6, 0.6, 'mg/kg', NULL, NULL, 'Pediatric', X'789c33d03353c84dd7cf4e07000aea028a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137245, 307, 10.0, 18.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacc8cc2dcd5548c92f4e55c84f533034d035b450c84dd70709e828942516652626e5a42a24552a149794a654020089f9106a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137246, 307, 0.6, 0.6, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d03353c84dd7cf4e57c8cf4b4e5508f007002aa9050e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137247, 307, 10.0, 18.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacc8cc2dcd5548c92f4e55c84f533034d035b450c84dd70709e828942516652626e5a42a24552a149794a654020089f9106a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137248, 307, 0.5, 0.5, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d03355c84dd7cf4e5708f0572834cb282a56a830d435524849ac2c060071900855', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137249, 307, 10.0, 18.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacc8cc2dcd5548c92f4e55c84f533034d035b450c84dd70709e828942516652626e5a42a24552a149794a654020089f9106a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137250, 606, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137251, 7653, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789cf3cdcfcbcfa84c294a2c49d5cf4d4c2eca4f2eaa2c2e49cc2956d0f0057193325334ad140c0d0c72d31502fc150a0d8d3200f40b11ad', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137252, 7653, 50.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789cf34d4c2eca4f2eaa2c2e49cc29b6523035d0353430c84d5708f057305128c9cc4d2d564849cccca95448cb2f523005b22b8b01ba1410ce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137253, 7653, 100.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789cf3cdcfcbcfa84c294a2c49d5cf4d4c2eca4f2eaa2c2e49cc2956d0f0057193325334ad140c0d0c72d31502fc15521233732a15124b149252534a32735301e8a01673', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137254, 7653, 50.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789cf34d4c2eca4f2eaa2c2e49cc29b6523035d0353430c84d5708f0574849cccca954482c51484a4d29c9cc4d050042a50e9a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137255, 7653, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c15c8b10d80201005d0557ea99568e90e445740388504b8e48028db1bcaf73467f6dd89a9b4246385adf4524d2c98f4e015dcbc63552a3d380f70b68437541f3236786e52c0370a7dcd44845c49ec48fa018cd41fe6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137256, 7653, 50.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789cf34d4c2eca4f2eaa2c2e49cc29b6523035d0353430c84d5708f057c8cf4b4e5528cf2cc9c8cc533052c8c82f2d2a56c84f53284ead284dcc51c8cc2b492d4a0609a602002299180d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137257, 3681, 0.25, 0.25, 'mg', 'IV', NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4e55b05530d03332cd4d57f00c532834ca285228cd2bc9cc51484d4b4b4d2e51d0c84dac5028c92f49cc012a34d403aad3040076db13b5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137258, 3681, 0.5, 0.5, 'mg', 'IV', NULL, 'Adult', X'789c2bcf2cc950c8484d2c2a51484bcccc292d4a55b05530d033cd4d57f00cd35128c948cd03728d207c8542938c2285d2bc92cc1c85d4b4b4d4e41285fc2285dcc40a0543900e00b9411876', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137259, 29958, 250.0, 500.0, 'mg', 'IM', NULL, 'Adult', X'789cf3cdcc49b152303235d0353530c84d57f0f4d5f70c53b0c8000050b40652', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137260, 29958, 500.0, 1000.0, 'mg', 'IM', NULL, 'Adult', X'789cf3cd4fd10d4e2d4b2d4ab552303530d035343030c84d57f0f4d5f70c532834d3b5c80000af6b0981', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137261, 29958, 1.0, 1.5, 'g', 'IM', NULL, 'Adult', X'789cf3c94c4b5508c9284a4d2c49cdcbcc4bb75230d435d4334d57f0f4d5f70c532834cb0000c4c50a80', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137262, 29958, 12.0, 12.0, 'g', NULL, NULL, 'Adult', X'789cf34dacb05230344ad74f49ac0400173603b8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137263, 29958, 1.0, 1.0, 'g', 'IM', NULL, 'Adult', X'789c334c57f0f4d5f70c53283434020014120311', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137264, 29958, 500.0, 500.0, 'mg', 'IM', NULL, 'Adult', X'789c333530c84d57f0f4d5f70c5328343402001f1003e2', X'789ced5a6d6fdb3812fe2b44803ba458db919db8e9bac5024e9ab6d93659234e8b2ece85414bb4ccad446a492a8dbae87fbf8794ed58b61cc56a0fb7b8cb87261135f3706638af54ffda0b541a8e058dd95e8fec9db229fd2a232ef61a642f55915d9b1993e8dec1c117fe99c52da942fb173f28906a5fd18405636a2c47c7eb3c6d7aed66dbbbf68e7b5dafe779ade3f6d1a1d771b4cc375c0a0dcabff65e33c1148ddcdf86dd3af6eb2c613dd2d68684eeada51e895396cc6824752215c7e34ba969c8c82ba962dd2389fc123045a652112efec83758d20c8d62223433d0753d2f0e9f937683741aa4ede197677fe3c7a1e78523712553c3349153d20f622eb836f9f63d72fea141ce2f20868c6329c8b5a2012397301b50fbc26753a75a3a59d5ee1b960c9d44cc3efdeb139e60aecfeee14edb825e0f31fb2af9b74f768f7e9046660c6db9080b962c916961f171a74079c1a3a0473a5dafe94c04550fce3f9067b391b8904173c86e9862ce7c38d415823f9f362dcd3b3e65e47aa618354c40089c5eb3ddeade51591c7a8be54e7810d06caf6818abc3fbebf3c6f8bdf0659c44dc074e5090afbdc46a774ab80782a5b1f4a5ef43b3fc41705a4058d5ab1ce44c04d2a72ae086ebf140c9649645f496ebc6f8251366cd499702ddb6c9fea1d77cea11380c9930f8202389923e0b52c59eacef738f4f3821fe2ec7b3ee368fe753cb4fd7cdf8bf63887a9aacdbe36fa1ca7f4c8887d783dca42ce0d428eeef9acbf75f1c8f5fd24c3f29701cc1fa079f5d44cf450ef80d0f58600f0321ff8a2bd4586c85d4d1c96917aa91b6cb08e4e9b674bddcf9977ce77173dc1e5f48616645195e743c57587f982c23f1cb1cf2e976c8673f4cbb52a53a5d9b66b7ee9e27dde2fecdc3c3dd44b07d462ab8c9c67dffcf942b3457cb20835c87b95c6b27deeede6713bbab47f04a17a5eb96592723fa0b37fe8c184906bf11c5421e3341beccf0c34aba6b8c0d13e6739b29649246f4ce8517a20fb083a0c2cf7ae404158bfa66de780de994a13163824623e13a1d3461ea342287dd66f7a847427ec3a0dd7cb1dd6e1e2e16539dd28804d011b1da20c68a1e301f65102b6eb9ebfd835011cc319c233a94176daf2ec6b366e708306f582c11cc51a6b99e43792db84d48749a2411832da1c780296ea460768b25719e3573699619612ed891d73c2e138d6cca467994e56f8fb66869bdf2e75dc18ebbe560d0ed1e2c0b85882a42fd5c90cb992db77eb7478434e09972c1825263565a51c802cd1b96c09f7cb2ef3c88fc932c2dfb64242eef36ab91b54f11888a7211d87660c3affb51c45498d930f223aaf5819db76aecd20fd0e36936be62d4dfdca5ac380c61169916e92e596a50dfd005d291404728e389f433b358e90bbaa87d233134682b856efe2a674263e4196622000382f11233889246de721f090a948c7f45c903cf2926131835e0698cb3984e41b0992ae6d94d8a82682f39556ac620c515d570854b9a6a469d837c90314ab340ceef4f02fc8d544006d44e817d81a27beb945154686a673663857faf70da54ada899cc2236b12f77c85c2b33e99aadaa07b50d0eecb3e2167796ae865a252ea06c3ba26ac835cef192b3883f3fd807e02d280bfc5bdda162c6bd631bdfb1159017de520db6a42cf05b1fabe6755405be12afac86c999c6601a2f998ade5070eb0738c4827eece8f35b80bf55bcaf27a3c7807f0cf8c780ffb101ffdf8ea93ab79d8fc7b8718c83195531f56524c3ac70986f68346d467c6a2fc35b18dff60f5bc7e46c78f5122deb0583a965c475dcb3d70f3ca611daea78befa15031f172442a7ac9e93d3df07475d6f24ce6ed1cee743d57b8566d7a2f8332a00e26ebcfdfcdd091a4c94129f07347a0e9819c7896be2b328225fb00d89531f192e31982b89ce308532bdab43e42dad308096f0b1f110a909f6bdc13f56ddd9be6545430d4742a7dab72261b7033d076364df8d225106839d8f0417d02b767d3f5edd58c79ec068abaccaaa62a830e0b81a89e523d997cacd246c3ab59200db8732888e1c7df81344c8043a7dd063ccc0e83c5bb1185d6a6aa30aa44b09ed178bf7d7e7440a48b22f90d275a60d8b81c1c534571af81f319363a209a8412c7eec8c04cd85c021c3664a36c824354e40786cb0221ba80fefa1be235cd1cccaf45ac934217d82b4cc1292c0453311dac027ee13cb5c324d8294d9d1e6ac45a69401c8a68d8f4775769cefb4bc48bcb76823a33809ede9bf56342603991bd4b2fda642e7d479c1046a6ba14e839c34c86983bcde73fdd2c2e732479987f612760bd2f21286d5c0f8c051e490627365eb0b41711642c271495886f2b15d01736623c1dddd02627170254057bbe2a080d791e76238ecd7b0c6c555295b95d4a7fd664dcea1415fd6226709529f8ad1af9419edbc6afb16f983a12e94dbaa4a84772d02f7735da6fd3afa9053730172c9426a0344af035eb6480840d45ac96a39350062f759093ce516a9d2e9422a7a8b6449898f040749b6b8639565dfb46c6a8a5226bed6d204590c6598d7e07c8bb64873ab82ae13d6f38d0fee6050e74fdefd5427243790de0e4e6b01b9d89eb86640270dd28f93532258f8a3a01259c75530e4da2ff2e5667e283389a9f219aabe2813a1325b0d698410dc7ad8d5fc331ed6e71e60126748b7315774c2cb03a5cadf1618376914a20daa731080b01f16840f73eaa4552feaf1e05cb41ec0a9ed2c72af2253c55211f0b2d8dd0526b01d33eaea77c2d4d3a78f20816351b40775bcbbefa3a737df27c240b334980b41994a5d9b416b009da4eaf34c462893f00fb4d7d4e775608686a169b45f64e74261ce317882dfd781fb1d878bf69312366f5c226e27dc1a48af3029fb5c3bef3569449565af954d4e54eadf130495fcef58c8e5f784d18062e0489543885398d74e7e7524794359ecce26b5730166cdac2c1c2b613ef089e2d2e626c1a7dc2f0dc60d900baefd8d889c4534ce0227122d8fa9eace34c3ac8b541ddf4d26659d4525ce15f73f336334ff1e41f2d0b6776bf4e6819d765f505b7a37db3e3bed0b19677e690b59edb54e14890a80c65fd1704b21aaae22ec06a5c8b91e8bb02c6c575b1e9295326dbd7cfc1ea07df7257281f6a40edcab54af1c9d60becb67aadea8346089916e7c348bc16b7be2f8b479e9f27877f2ff7177b2e35ddc90b1713fd2b2e01b7717749aec5f502e76fc4f4d5548551f41963ce3394f7e617ac5a60cf5d65fbb293c4ba48ff69eed7c15f9eddbbf01b68cd48d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137265, 29958, 1.0, 1.0, 'g', 'IM', NULL, 'Adult', X'789c334c57f0f4d5f70c53a83054d03036d0353350c8cdcc53484a4dcb2f4a552828ca4f4e4d292d4ad50400df340c2d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137266, 29958, 40.0, 40.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3331c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d51283434ca000091320980', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137267, 29958, 20.0, 20.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523032c84dd7cf4e57f0f4d5f70c53a8503004008c8008b2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137268, 29958, 6.0, 6.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dac50304bd74f49ac0400117f0351', X'789ced5a6d6fdb3812fe2b44803ba458db919db8e9bac5024e9ab6d93659234e8b2ece85414bb4ccad446a492a8dbae87fbf8794ed58b61cc56a0fb7b8cb87261135f3706638af54ffda0b541a8e058dd95e8fec9db229fd2a232ef61a642f55915d9b1993e8dec1c117fe99c52da942fb173f28906a5fd18405636a2c47c7eb3c6d7aed66dbbbf68e7b5dafe779ade3f6d1a1d771b4cc375c0a0dcabff65e33c1148ddcdf86dd3af6eb2c613dd2d68684eeada51e895396cc6824752215c7e34ba969c8c82ba962dd2389fc123045a652112efec83758d20c8d62223433d0753d2f0e9f937683741aa4ede197677fe3c7a1e78523712553c3349153d20f622eb836f9f63d72fea141ce2f20868c6329c8b5a2012397301b50fbc26753a75a3a59d5ee1b960c9d44cc3efdeb139e60aecfeee14edb825e0f31fb2af9b74f768f7e9046660c6db9080b962c916961f171a74079c1a3a0473a5dafe94c04550fce3f9067b391b8904173c86e9862ce7c38d415823f9f362dcd3b3e65e47aa618354c40089c5eb3ddeade51591c7a8be54e7810d06caf6818abc3fbebf3c6f8bdf0659c44dc074e5090afbdc46a774ab80782a5b1f4a5ef43b3fc41705a4058d5ab1ce44c04d2a72ae086ebf140c9649645f496ebc6f8251366cd499702ddb6c9fea1d77cea11380c9930f8202389923e0b52c59eacef738f4f3821fe2ec7b3ee368fe753cb4fd7cdf8bf63887a9aacdbe36fa1ca7f4c8887d783dca42ce0d428eeef9acbf75f1c8f5fd24c3f29701cc1fa079f5d44cf450ef80d0f58600f0321ff8a2bd4586c85d4d1c96917aa91b6cb08e4e9b674bddcf9977ce77173dc1e5f48616645195e743c57587f982c23f1cb1cf2e976c8673f4cbb52a53a5d9b66b7ee9e27dde2fecdc3c3dd44b07d462ab8c9c67dffcf942b3457cb20835c87b95c6b27deeede6713bbab47f04a17a5eb96592723fa0b37fe8c184906bf11c5421e3341beccf0c34aba6b8c0d13e6739b29649246f4ce8517a20fb083a0c2cf7ae404158bfa66de780de994a13163824623e13a1d3461ea342287dd66f7a847427ec3a0dd7cb1dd6e1e2e16539dd28804d011b1da20c68a1e301f65102b6eb9ebfd835011cc319c233a94176daf2ec6b366e708306f582c11cc51a6b99e43792db84d48749a2411832da1c780296ea460768b25719e3573699619612ed891d73c2e138d6cca467994e56f8fb66869bdf2e75dc18ebbe560d0ed1e2c0b85882a42fd5c90cb992db77eb7478434e09972c1825263565a51c802cd1b96c09f7cb2ef3c88fc932c2dfb64242eef36ab91b54f11888a7211d87660c3affb51c45498d930f223aaf5819db76aecd20fd0e36936be62d4dfdca5ac380c61169916e92e596a50dfd005d291404728e389f433b358e90bbaa87d233134682b856efe2a674263e4196622000382f11233889246de721f090a948c7f45c903cf2926131835e0698cb3984e41b0992ae6d94d8a82682f39556ac620c515d570854b9a6a469d837c90314ab340ceef4f02fc8d544006d44e817d81a27beb945154686a673663857faf70da54ada899cc2236b12f77c85c2b33e99aadaa07b50d0eecb3e2167796ae865a252ea06c3ba26ac835cef192b3883f3fd807e02d280bfc5bdda162c6bd631bdfb1159017de520db6a42cf05b1fabe6755405be12afac86c999c6601a2f998ade5070eb0738c4827eece8f35b80bf55bcaf27a3c7807f0cf8c780ffb101ffdf8ea93ab79d8fc7b8718c83195531f56524c3ac70986f68346d467c6a2fc35b18dff60f5bc7e46c78f5122deb0583a965c475dcb3d70f3ca611daea78befa15031f172442a7ac9e93d3df07475d6f24ce6ed1cee743d57b8566d7a2f8332a00e26ebcfdfcdd091a4c94129f07347a0e9819c7896be2b328225fb00d89531f192e31982b89ce308532bdab43e42dad308096f0b1f110a909f6bdc13f56ddd9be6545430d4742a7dab72261b7033d076364df8d225106839d8f0417d02b767d3f5edd58c79ec068abaccaaa62a830e0b81a89e523d997cacd246c3ab59200db8732888e1c7df81344c8043a7dd063ccc0e83c5bb1185d6a6aa30aa44b09ed178bf7d7e7440a48b22f90d275a60d8b81c1c534571af81f319363a209a8412c7eec8c04cd85c021c3664a36c824354e40786cb0221ba80fefa1be235cd1cccaf45ac934217d82b4cc1292c0453311dac027ee13cb5c324d8294d9d1e6ac45a69401c8a68d8f4775769cefb4bc48bcb76823a33809ede9bf56342603991bd4b2fda642e7d479c1046a6ba14e839c34c86983bcde73fdd2c2e732479987f612760bd2f21286d5c0f8c051e490627365eb0b41711642c271495886f2b15d01736623c1dddd02627170254057bbe2a080d791e76238ecd7b0c6c555295b95d4a7fd664dcea1415fd6226709529f8ad1af9419edbc6afb16f983a12e94dbaa4a84772d02f7735da6fd3afa9053730172c9426a0344af035eb6480840d45ac96a39350062f759093ce516a9d2e9422a7a8b6449898f040749b6b8639565dfb46c6a8a5226bed6d204590c6598d7e07c8bb64873ab82ae13d6f38d0fee6050e74fdefd5427243790de0e4e6b01b9d89eb86640270dd28f93532258f8a3a01259c75530e4da2ff2e5667e283389a9f219aabe2813a1325b0d698410dc7ad8d5fc331ed6e71e60126748b7315774c2cb03a5cadf1618376914a20daa731080b01f16840f73eaa4552feaf1e05cb41ec0a9ed2c72af2253c55211f0b2d8dd0526b01d33eaea77c2d4d3a78f20816351b40775bcbbefa3a737df27c240b334980b41994a5d9b416b009da4eaf34c462893f00fb4d7d4e775608686a169b45f64e74261ce317882dfd781fb1d878bf69312366f5c226e27dc1a48af3029fb5c3bef3569449565af954d4e54eadf130495fcef58c8e5f784d18062e0489543885398d74e7e7524794359ecce26b5730166cdac2c1c2b613ef089e2d2e626c1a7dc2f0dc60d900baefd8d889c4534ce0227122d8fa9eace34c3ac8b541ddf4d26659d4525ce15f73f336334ff1e41f2d0b6776bf4e6819d765f505b7a37db3e3bed0b19677e690b59edb54e14890a80c65fd1704b21aaae22ec06a5c8b91e8bb02c6c575b1e9295326dbd7cfc1ea07df7257281f6a40edcab54af1c9d60becb67aadea8346089916e7c348bc16b7be2f8b479e9f27877f2ff7177b2e35ddc90b1713fd2b2e01b7717749aec5f502e76fc4f4d5548551f41963ce3394f7e617ac5a60cf5d65fbb293c4ba48ff69eed7c15f9eddbbf01b68cd48d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137269, 29958, 2000.0, 2000.0, 'g', NULL, NULL, 'Pediatric', X'789cb331323030480700047f0166', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137270, 29958, 40.0, 40.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3331c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d51283434ca000091320980', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137271, 29958, 20.0, 20.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523032c84dd7cf4e57f0f4d5f70c53a8503004008c8008b2', X'789ced5a6d6fdb3812fe2b44803ba458db919db8e9bac5024e9ab6d93659234e8b2ece85414bb4ccad446a492a8dbae87fbf8794ed58b61cc56a0fb7b8cb87261135f3706638af54ffda0b541a8e058dd95e8fec9db229fd2a232ef61a642f55915d9b1993e8dec1c117fe99c52da942fb173f28906a5fd18405636a2c47c7eb3c6d7aed66dbbbf68e7b5dafe779ade3f6d1a1d771b4cc375c0a0dcabff65e33c1148ddcdf86dd3af6eb2c613dd2d68684eeada51e895396cc6824752215c7e34ba969c8c82ba962dd2389fc123045a652112efec83758d20c8d62223433d0753d2f0e9f937683741aa4ede197677fe3c7a1e78523712553c3349153d20f622eb836f9f63d72fea141ce2f20868c6329c8b5a2012397301b50fbc26753a75a3a59d5ee1b960c9d44cc3efdeb139e60aecfeee14edb825e0f31fb2af9b74f768f7e9046660c6db9080b962c916961f171a74079c1a3a0473a5dafe94c04550fce3f9067b391b8904173c86e9862ce7c38d415823f9f362dcd3b3e65e47aa618354c40089c5eb3ddeade51591c7a8be54e7810d06caf6818abc3fbebf3c6f8bdf0659c44dc074e5090afbdc46a774ab80782a5b1f4a5ef43b3fc41705a4058d5ab1ce44c04d2a72ae086ebf140c9649645f496ebc6f8251366cd499702ddb6c9fea1d77cea11380c9930f8202389923e0b52c59eacef738f4f3821fe2ec7b3ee368fe753cb4fd7cdf8bf63887a9aacdbe36fa1ca7f4c8887d783dca42ce0d428eeef9acbf75f1c8f5fd24c3f29701cc1fa079f5d44cf450ef80d0f58600f0321ff8a2bd4586c85d4d1c96917aa91b6cb08e4e9b674bddcf9977ce77173dc1e5f48616645195e743c57587f982c23f1cb1cf2e976c8673f4cbb52a53a5d9b66b7ee9e27dde2fecdc3c3dd44b07d462ab8c9c67dffcf942b3457cb20835c87b95c6b27deeede6713bbab47f04a17a5eb96592723fa0b37fe8c184906bf11c5421e3341beccf0c34aba6b8c0d13e6739b29649246f4ce8517a20fb083a0c2cf7ae404158bfa66de780de994a13163824623e13a1d3461ea342287dd66f7a847427ec3a0dd7cb1dd6e1e2e16539dd28804d011b1da20c68a1e301f65102b6eb9ebfd835011cc319c233a94176daf2ec6b366e708306f582c11cc51a6b99e43792db84d48749a2411832da1c780296ea460768b25719e3573699619612ed891d73c2e138d6cca467994e56f8fb66869bdf2e75dc18ebbe560d0ed1e2c0b85882a42fd5c90cb992db77eb7478434e09972c1825263565a51c802cd1b96c09f7cb2ef3c88fc932c2dfb64242eef36ab91b54f11888a7211d87660c3affb51c45498d930f223aaf5819db76aecd20fd0e36936be62d4dfdca5ac380c61169916e92e596a50dfd005d291404728e389f433b358e90bbaa87d233134682b856efe2a674263e4196622000382f11233889246de721f090a948c7f45c903cf2926131835e0698cb3984e41b0992ae6d94d8a82682f39556ac620c515d570854b9a6a469d837c90314ab340ceef4f02fc8d544006d44e817d81a27beb945154686a673663857faf70da54ada899cc2236b12f77c85c2b33e99aadaa07b50d0eecb3e2167796ae865a252ea06c3ba26ac835cef192b3883f3fd807e02d280bfc5bdda162c6bd631bdfb1159017de520db6a42cf05b1fabe6755405be12afac86c999c6601a2f998ade5070eb0738c4827eece8f35b80bf55bcaf27a3c7807f0cf8c780ffb101ffdf8ea93ab79d8fc7b8718c83195531f56524c3ac70986f68346d467c6a2fc35b18dff60f5bc7e46c78f5122deb0583a965c475dcb3d70f3ca611daea78befa15031f172442a7ac9e93d3df07475d6f24ce6ed1cee743d57b8566d7a2f8332a00e26ebcfdfcdd091a4c94129f07347a0e9819c7896be2b328225fb00d89531f192e31982b89ce308532bdab43e42dad308096f0b1f110a909f6bdc13f56ddd9be6545430d4742a7dab72261b7033d076364df8d225106839d8f0417d02b767d3f5edd58c79ec068abaccaaa62a830e0b81a89e523d997cacd246c3ab59200db8732888e1c7df81344c8043a7dd063ccc0e83c5bb1185d6a6aa30aa44b09ed178bf7d7e7440a48b22f90d275a60d8b81c1c534571af81f319363a209a8412c7eec8c04cd85c021c3664a36c824354e40786cb0221ba80fefa1be235cd1cccaf45ac934217d82b4cc1292c0453311dac027ee13cb5c324d8294d9d1e6ac45a69401c8a68d8f4775769cefb4bc48bcb76823a33809ede9bf56342603991bd4b2fda642e7d479c1046a6ba14e839c34c86983bcde73fdd2c2e732479987f612760bd2f21286d5c0f8c051e490627365eb0b41711642c271495886f2b15d01736623c1dddd02627170254057bbe2a080d791e76238ecd7b0c6c555295b95d4a7fd664dcea1415fd6226709529f8ad1af9419edbc6afb16f983a12e94dbaa4a84772d02f7735da6fd3afa9053730172c9426a0344af035eb6480840d45ac96a39350062f759093ce516a9d2e9422a7a8b6449898f040749b6b8639565dfb46c6a8a5226bed6d204590c6598d7e07c8bb64873ab82ae13d6f38d0fee6050e74fdefd5427243790de0e4e6b01b9d89eb86640270dd28f93532258f8a3a01259c75530e4da2ff2e5667e283389a9f219aabe2813a1325b0d698410dc7ad8d5fc331ed6e71e60126748b7315774c2cb03a5cadf1618376914a20daa731080b01f16840f73eaa4552feaf1e05cb41ec0a9ed2c72af2253c55211f0b2d8dd0526b01d33eaea77c2d4d3a78f20816351b40775bcbbefa3a737df27c240b334980b41994a5d9b416b009da4eaf34c462893f00fb4d7d4e775608686a169b45f64e74261ce317882dfd781fb1d878bf69312366f5c226e27dc1a48af3029fb5c3bef3569449565af954d4e54eadf130495fcef58c8e5f784d18062e0489543885398d74e7e7524794359ecce26b5730166cdac2c1c2b613ef089e2d2e626c1a7dc2f0dc60d900baefd8d889c4534ce0227122d8fa9eace34c3ac8b541ddf4d26659d4525ce15f73f336334ff1e41f2d0b6776bf4e6819d765f505b7a37db3e3bed0b19677e690b59edb54e14890a80c65fd1704b21aaae22ec06a5c8b91e8bb02c6c575b1e9295326dbd7cfc1ea07df7257281f6a40edcab54af1c9d60becb67aadea8346089916e7c348bc16b7be2f8b479e9f27877f2ff7177b2e35ddc90b1713fd2b2e01b7717749aec5f502e76fc4f4d5548551f41963ce3394f7e617ac5a60cf5d65fbb293c4ba48ff69eed7c15f9eddbbf01b68cd48d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137272, 29958, 6.0, 6.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dac50304bd74f49ac0400117f0351', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137273, 29958, 2000.0, 2000.0, 'g', NULL, NULL, 'Pediatric', X'789cb333323030480700048b0168', X'789ced5a6d6fdb3812fe2b44803ba458db919db8e9bac5024e9ab6d93659234e8b2ece85414bb4ccad446a492a8dbae87fbf8794ed58b61cc56a0fb7b8cb87261135f3706638af54ffda0b541a8e058dd95e8fec9db229fd2a232ef61a642f55915d9b1993e8dec1c117fe99c52da942fb173f28906a5fd18405636a2c47c7eb3c6d7aed66dbbbf68e7b5dafe779ade3f6d1a1d771b4cc375c0a0dcabff65e33c1148ddcdf86dd3af6eb2c613dd2d68684eeada51e895396cc6824752215c7e34ba969c8c82ba962dd2389fc123045a652112efec83758d20c8d62223433d0753d2f0e9f937683741aa4ede197677fe3c7a1e78523712553c3349153d20f622eb836f9f63d72fea141ce2f20868c6329c8b5a2012397301b50fbc26753a75a3a59d5ee1b960c9d44cc3efdeb139e60aecfeee14edb825e0f31fb2af9b74f768f7e9046660c6db9080b962c916961f171a74079c1a3a0473a5dafe94c04550fce3f9067b391b8904173c86e9862ce7c38d415823f9f362dcd3b3e65e47aa618354c40089c5eb3ddeade51591c7a8be54e7810d06caf6818abc3fbebf3c6f8bdf0659c44dc074e5090afbdc46a774ab80782a5b1f4a5ef43b3fc41705a4058d5ab1ce44c04d2a72ae086ebf140c9649645f496ebc6f8251366cd499702ddb6c9fea1d77cea11380c9930f8202389923e0b52c59eacef738f4f3821fe2ec7b3ee368fe753cb4fd7cdf8bf63887a9aacdbe36fa1ca7f4c8887d783dca42ce0d428eeef9acbf75f1c8f5fd24c3f29701cc1fa079f5d44cf450ef80d0f58600f0321ff8a2bd4586c85d4d1c96917aa91b6cb08e4e9b674bddcf9977ce77173dc1e5f48616645195e743c57587f982c23f1cb1cf2e976c8673f4cbb52a53a5d9b66b7ee9e27dde2fecdc3c3dd44b07d462ab8c9c67dffcf942b3457cb20835c87b95c6b27deeede6713bbab47f04a17a5eb96592723fa0b37fe8c184906bf11c5421e3341beccf0c34aba6b8c0d13e6739b29649246f4ce8517a20fb083a0c2cf7ae404158bfa66de780de994a13163824623e13a1d3461ea342287dd66f7a847427ec3a0dd7cb1dd6e1e2e16539dd28804d011b1da20c68a1e301f65102b6eb9ebfd835011cc319c233a94176daf2ec6b366e708306f582c11cc51a6b99e43792db84d48749a2411832da1c780296ea460768b25719e3573699619612ed891d73c2e138d6cca467994e56f8fb66869bdf2e75dc18ebbe560d0ed1e2c0b85882a42fd5c90cb992db77eb7478434e09972c1825263565a51c802cd1b96c09f7cb2ef3c88fc932c2dfb64242eef36ab91b54f11888a7211d87660c3affb51c45498d930f223aaf5819db76aecd20fd0e36936be62d4dfdca5ac380c61169916e92e596a50dfd005d291404728e389f433b358e90bbaa87d233134682b856efe2a674263e4196622000382f11233889246de721f090a948c7f45c903cf2926131835e0698cb3984e41b0992ae6d94d8a82682f39556ac620c515d570854b9a6a469d837c90314ab340ceef4f02fc8d544006d44e817d81a27beb945154686a673663857faf70da54ada899cc2236b12f77c85c2b33e99aadaa07b50d0eecb3e2167796ae865a252ea06c3ba26ac835cef192b3883f3fd807e02d280bfc5bdda162c6bd631bdfb1159017de520db6a42cf05b1fabe6755405be12afac86c999c6601a2f998ade5070eb0738c4827eece8f35b80bf55bcaf27a3c7807f0cf8c780ffb101ffdf8ea93ab79d8fc7b8718c83195531f56524c3ac70986f68346d467c6a2fc35b18dff60f5bc7e46c78f5122deb0583a965c475dcb3d70f3ca611daea78befa15031f172442a7ac9e93d3df07475d6f24ce6ed1cee743d57b8566d7a2f8332a00e26ebcfdfcdd091a4c94129f07347a0e9819c7896be2b328225fb00d89531f192e31982b89ce308532bdab43e42dad308096f0b1f110a909f6bdc13f56ddd9be6545430d4742a7dab72261b7033d076364df8d225106839d8f0417d02b767d3f5edd58c79ec068abaccaaa62a830e0b81a89e523d997cacd246c3ab59200db8732888e1c7df81344c8043a7dd063ccc0e83c5bb1185d6a6aa30aa44b09ed178bf7d7e7440a48b22f90d275a60d8b81c1c534571af81f319363a209a8412c7eec8c04cd85c021c3664a36c824354e40786cb0221ba80fefa1be235cd1cccaf45ac934217d82b4cc1292c0453311dac027ee13cb5c324d8294d9d1e6ac45a69401c8a68d8f4775769cefb4bc48bcb76823a33809ede9bf56342603991bd4b2fda642e7d479c1046a6ba14e839c34c86983bcde73fdd2c2e732479987f612760bd2f21286d5c0f8c051e490627365eb0b41711642c271495886f2b15d01736623c1dddd02627170254057bbe2a080d791e76238ecd7b0c6c555295b95d4a7fd664dcea1415fd6226709529f8ad1af9419edbc6afb16f983a12e94dbaa4a84772d02f7735da6fd3afa9053730172c9426a0344af035eb6480840d45ac96a39350062f759093ce516a9d2e9422a7a8b6449898f040749b6b8639565dfb46c6a8a5226bed6d204590c6598d7e07c8bb64873ab82ae13d6f38d0fee6050e74fdefd5427243790de0e4e6b01b9d89eb86640270dd28f93532258f8a3a01259c75530e4da2ff2e5667e283389a9f219aabe2813a1325b0d698410dc7ad8d5fc331ed6e71e60126748b7315774c2cb03a5cadf1618376914a20daa731080b01f16840f73eaa4552feaf1e05cb41ec0a9ed2c72af2253c55211f0b2d8dd0526b01d33eaea77c2d4d3a78f20816351b40775bcbbefa3a737df27c240b334980b41994a5d9b416b009da4eaf34c462893f00fb4d7d4e775608686a169b45f64e74261ce317882dfd781fb1d878bf69312366f5c226e27dc1a48af3029fb5c3bef3569449565af954d4e54eadf130495fcef58c8e5f784d18062e0489543885398d74e7e7524794359ecce26b5730166cdac2c1c2b613ef089e2d2e626c1a7dc2f0dc60d900baefd8d889c4534ce0227122d8fa9eace34c3ac8b541ddf4d26659d4525ce15f73f336334ff1e41f2d0b6776bf4e6819d765f505b7a37db3e3bed0b19677e690b59edb54e14890a80c65fd1704b21aaae22ec06a5c8b91e8bb02c6c575b1e9295326dbd7cfc1ea07df7257281f6a40edcab54af1c9d60becb67aadea8346089916e7c348bc16b7be2f8b479e9f27877f2ff7177b2e35ddc90b1713fd2b2e01b7717749aec5f502e76fc4f4d5548551f41963ce3394f7e617ac5a60cf5d65fbb293c4ba48ff69eed7c15f9eddbbf01b68cd48d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137274, 29958, 60.0, 60.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3333c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d5128b4c8000088300957', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137275, 29958, 20.0, 20.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523032c84dd7cf4e57f0f4d5f70c53a8503004008c8008b2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137276, 29958, 6.0, 6.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dac50304bd74f49ac0400117f0351', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137277, 29958, 25.0, 100.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3332d5353430c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d512834d3b5c80000b4140a79', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137278, 29958, 20.0, 33.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523032d03536ce4dd7cf4e57f0f4d5f70c53a850300400a38d0945', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137279, 29958, 6.0, 6.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dac50304bd74f49ac0400117f0351', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137280, 29958, 150.0, 150.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c333435c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d5128b4c850a850303450004a150300fabf0c71', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137281, 29958, 50.0, 50.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523035c84dd7cf4e57f0f4d5f70c53a8503004008cb308b5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137282, 8509, 180.0, 180.0, 'mg', NULL, NULL, 'Adult', X'789c73740eb65230b430c84d57d02829cf57b004b14a129372524b8a351572f2135332f3d21552f28b53010cb90d9f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137283, 8509, 90.0, 90.0, 'mg', NULL, 1, 'Adult', X'789cf34dcccc2b49cd4bcc4b4eb552b034c84d572829cf4c4e554849cccca904009c2d0a6a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137284, 4802, 1.0, 2.0, 'mcg/kg', 'IV', NULL, 'Adult', X'789c73cc4bcc494f2dce4cb45230d43552c84d4ed7cf4e57f00cd3f7f4d551283436d0353350c8cdcc530808f20300200f0c73', X'789ccd55db6e1b3710fd154240df24ef4a8e62605114109c3a3190a88664e4a51b2c46e468c59a3bdcf052470dfcef1deeca17c537444081be91bb6738e7cc700ebf0f948b7545d0e0a0108333a400b43583a1184467d2a74d08ad2fb2ec5a5f6173645d9d563a7b88f4d2418baa82900226f9e4ed281f8fc6f9657e524c8f8b497e94bfc94ff249874519b425cfc8ef83f748e8c074eb80dfbaf0cb6d8b45497fb4da6ae54b7a673dd428ceac6b7c21ce3f0f85a6e080c083198ab4f20a5d03a6a453db3496c4a5038562ce92386019574637f00f76c9e3ea61fe1bfe14606530edfefcc23ba3e9aadbdcf3d91179bd22b7c09b2fe9dc998a26544c5e53bda76f46606af41a0a311e4d4423ebecaa665dd9f9a7a1f87a9c8fdee6a2d1242e16f39296a820d14dd8e31d36db38212d054dd146cfd55847cf90ae529c4cacc0a31276bd16c106306265d5565ca3ae37e1e76ad0e9b840a521382d9fd2921f4df725ccc5d7246ae30ec8b46c516a30d5856da381fb4b729becc2614d40722b16fc97ea92ab725ad247906157a3dfbf498781c573f9560ec107aea4b91a0ab24138947c3d9014aa9216c85d10bda292ba5e95346794c2b5a684b8d3bdf75dace283937a92626d1d8be73bfbfe6c217e1353eedfc78c5b180366e3a313ee5b19f37c3529988700f557f481a3438f1fe7dca697624ea6bf703345f491192bebb18ffb35453e1733cd1fc57cc0c6b222b3f5da3f0368598f3ca028874ed68f0d7d7dc4de25afeac1bed254dd9db01bba539bac4193d2f2890b3433065dbd4df59606bccf92f51d705167ea6f741eab05827c9ce58903074b749a67759f4d4b0883fd54bd8664627b5096753be3bcf441b79d3a6e02448f907db68dee2762691bb20649724397d7b89b93990f1b24fd28dbab13f912ed1f35fe8f78ffc7547ed64137c0cf93b4c6d6db3d4e1fc0ac4746afb11093d11bb1b1d1f17bf709f9306bb46f0ab19bc9927a67eb4caeb3ae04931b2046a5399ec9fedf1c9cb469886dcb738ac9a9b00d6c4f505bc61ee2ff4bc46a66bcdd637e7ef7020bbf7ba10e3581678e7ad907ee83aabb2076809b9b7f01ae2df9ba', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137285, 4802, 1.0, 3.0, 'mcg/kg', NULL, NULL, 'Adult', X'789c0b4e4d492cc9cccfb35230d43556c84d4ed7cf4ed7cf285248cecf2bc9cc2bcd2f2d56c8cc4b2b2d062a0100439c0f86', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137286, 4802, 0.5, 2.0, 'mcg/kg', 'IV', NULL, 'Pediatric', X'789c33d033d53552c84d4ed7cf4e57f00cd3f7f4532834048a6414010059fc06eb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137287, 1316, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c0b4b4ccfcc4bccb152303430c84d57282e2d28d0513082b3ad150c5515928b52137381a25016009d8f0fa8', X'789ced585b6fdb3614fe2b070606b4801d3b973583f3e4e5b276485623490b0c7361d0d4b14d84225592b2ad16f9effb28c517396ebb6428fad2274987e7c6733ffadc485c3e191a9172a34b8d536d8353a9f86435379ad4c89d8ee0690899efb6db7375c7e99e7593f8a6dadbd85e3a9171321421121d740e5eb53afbadfdce6de7b8fb6ba77b74b077d4f9edf0f05589cb32286b3c303f377a49aa8cf2c189082b4181172597db22e3eec0f44c50e3dc4c841e9826951207e6cc7a3161bab02ef503736b332585eeeeff42d2b14807e6bd98280308ed773ae9847c9e654d3a58bd9fd01215d015d15b67b3a970859970450aece0ac9c42e0b5cd037bb263aa6bdca550096f92dd246fd2ac5261604e6d9a5a43b74e244c7fc1dc1b1a53bc5deba2bc1e5daa8fb94a9a74c69e0d2fa877417dc730adcaa228ba098ecd244c9b1409d4e9bbeb73eae7694637991345932e4b9f2813094fabcb6d82602c7acdae0efcd3ca3b7a13e4b40ebeb13a8f3237a02b4ceadb7912f95cf5af36f56feed616aae4bc804b723db3b3a55f3603a875d8ac7f1fe3869c4ae1b8497f14865b4b25b63ee990cee2c5eb40d87b64a92fe4dd23975e1592352c7b5b7ab50cc67cb4198ff7000531d21cbffef9802fadcc5df9b10ecc75447e3b513670ef3f44eebd24d76188f85566520ff72a24102fc2242a51c22bdf24990761d8e688995e96e982462a41f828c3a20639681dd19cf9ced3186e1eb10f04674094a7b98213a4759975254797974fa46b7cccd87925adb6aeeea281919b7acc6a475526f5dfd3c7a9a7c52125a2880aeab04cb8e5d171ed880414c6258375e35cc7ccdbcd620b6f7f8d77dcda3f7a40adb9b6a62d92964548d984ada41c9832a7fb6fe9d7451b5c68b1e2e6b59dc3963089b77ac684384a91f2d3134a2c191b08f1320737f273a1814bf369598836c5665156a1c5221aec0b82437496b4880a9373e9ab24af2a49ac2d1092da2865aa26d356623d930fecac4a4ee8791a3e2dc6cb08ed2330047249ee8ad21bd42f129e440ce36730bfc9582aa1877d9be55aacfbc0923f4ac8c408230bbac6a9990c50617fa717ab22bb19872f5136e845cdd02f07e652c8501914617e17e9fbce8ea052415e8cf9cbbc6e701a0acacd9db173b3cd78c75d1bd70cca5d562a931cbd6b65ca6ea36e97688ad79c41cf9d56aee8633d95a2acc3551257cdc8efd195350ac9419717b77eef6b62fe533ddbb6f9b7abda599c1c2a643f5466b8e2d080c035e3ba2bbecd76853f8cf84314009ea06841f9aa763ed1dedbeefac106ffae4e7f621a9ea20239a150bbe48e24ec69cd6e5260b421a985f7ed38293e434a2f89dd8587d72ce46329bb5c74c34ea1d9d5f052146a2b658eb69607543ac3686d686681931d59554d5bbb3bab724e55013630a3dc1978a0ed63109785268b8d31c44ecbae08a8c4e8b0da82507de284382901b983f7845378cd98754938d22a56e9f2bdde42372b0c3d48dc82aea5d6c0de627a62ff083c675d09cd58cf94a40c4e5c7d60084f3390885162d38a7b79bcd52a6738ac6aab11b98f83c49a60cdc260b68e4329a2eda941fe0c2f6e07c24f37fe7837fef4c1f7f1c153e731c84b451cd12745cd19af851eb7b41a7397de5543cbc05c3158595831ed925628bf2774fa77ff083bf872b039a137666cbb14b7d8a8952f60f114571623582aab5c7abec04e5cedb723a5b93d66c971c00585531a2b172c6d9e335c5eb19c0aaccfe9d08e873df968e93f5fa05550bac48a4371d53b96ea6347883b22898ddf026fcc548d14569dfda396d0f00f21c238c459dc6385749ce4124ea20a9fb0036a8848470eab15a1d3d972c88ea63008d638ca63aac7801dff0bc4365d52605c75589a5cca022651a178cef4cb3cec696febdd76751304cbc3af0065c64bb6ff7b49f54fd9527d7d82dba9ced7795524c30d92e5f0366624a2e47a5f38cf2c1225b0ef62d6d8f807b0b53fadd16a5861598fbec4e621db9feaabfbfb7f01d661d242', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137288, 1316, 10.0, 10.0, 'mg', NULL, NULL, 'Adult', X'789cf32fca2fc8482caacc4b4f4dccb1523034c84d572829ca4fce48050084620990', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137289, 1316, 200.0, 200.0, 'mg', NULL, NULL, 'Adult', X'789c333230c84d5708085328cc2856a830564849ac2c06003bdf0635', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137290, 1316, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c73cc29b152303430c84d5708085328cc2856a830574849ac2c06005e6907b3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137291, 1316, 10.0, 10.0, 'mg', 'PO', NULL, 'Adult', X'789c3334c84d5708f05730add04f49ac54a830345100d2c5004ea406fd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137292, 1316, 10.0, 10.0, 'mg', 'PO', 3, 'Adult', X'789c3334c84d5708f05728c94c010012700356', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137293, 4614, 320.0, 320.0, 'mg', 'PO', NULL, 'Adult', X'789c33363250c84d5708f057283432c95048cb2f52482c51c8494d2c2e5130554849ac2c0600a7a20a63', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137294, 4614, 320.0, 320.0, 'mg', 'PO', NULL, 'Adult', X'789c33363250c84d5708f057283432c950a830554849ac2c060041350646', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137295, 4614, 320.0, 320.0, 'mg', 'PO', NULL, 'Adult', X'789c333632c84d5708f057a8305428cf2cc9000024e704ce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137296, 277, 500.0, 875.0, 'mg', 'PO', NULL, 'Adult', X'789c333530d0b53037cd4d5708f05728343402001fe703ee', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137297, 277, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c33343030c84d5708f057283432c950a8503034504849ac2c06004ce0069e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137298, 277, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c33343030c84d5708f05728b4c850a8503034504849ac2c060047a00670', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137299, 277, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c33343030c84d5708f05728b4c850a8503034504849ac2c060047a00670', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137300, 277, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c33343030c84d5708f057a85030d45128c948cd53308509155a6400858d1552122b8b01e3a70b6e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137301, 277, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f05728b4c850a85030574849ac2c06003e67061a', X'789ced5c6b6fdb3816fd2b44805da418bf6327ad3b18c079b4c9346983381d74b12e0c5aba96b9914895a4dc6807f9ef7b49cb762ccb91a3b43b4d471f1ad81279781fe73e4859fd73c7959137e434809d2ed9e905e29639ccf719dfa9909d48fae6ea44eb5075ebf5afec06829a909ef9c4eaa9c1ca9134047748b599d36ab4f6ab8d66b5d9b86e1c74f79addf641ed55bbf1aad3b663c1d14c708523ffdc790b1c24f5ed670db776fa751c4297f402c64575c02f81270b0df8b150d403f246c8407589c08944093f327015e2d050453e5488a6231f345e98c057f3717101f181bbe012093e5035bfb1c0ed6b09dcd393347697345b9d0a69351af8a7837fda8d46e0d53b24387f3d5fb63bbbd331775e27c05df3b5425e1e74ccb5943873d08e9db041b42e39309307fc4a441a141163d273d1304c694967a25d7e18f023110482936b495d20efd19fcad80f3de4bf2617e2966aea55f02ec34bd603d1e8be13eef0925dce7cfbf767fc86c6beb15f964e59ba219f1cf7c6de7d36e83d37f2f510adccb8b7e2ea0c69e69418b65646a225abd690a830f9d26cedac0a6d5631ee0b8797132a63ee31cdd40a40b3615c6367b7da13724b9a0de2d25865007dd066f6f0025c463761bc7c18a2cf78a41e922167fe31708d36e88d94036a13080220db27c067b45be2ee59d8013f1be3bf7f1e67e01f4d7c1ac4a89f3f3c02394577a1acf58f12f444ae899d423f48d0310c4928c1e3946b12221d51e62c5dcee30086c74c195e3f84db6c575bcd8d06a53e521c7c7fd523ef85264da509720d634602d5014a31e03d07e305950f82880b470421687b3d6da8ea5c99e548290294d51df0b4b7f6aacd7632fa682205721c835f4a0632632c41693193646882e96d22983b7c0353905b29d369602a3519e7c6abe3fa6615974d9949175ff6ab89ede64e61121130d4c024981a064c756fafb66727279c49cbb455fc27347a38f0cffed1da3f4e627efb304e2780328ecb382ee3f84789e3e2d1988eeb321ccb702cc3f189e1582488d60a6c19456514fdada3e8d111900ea13204ca1078de21f0cd199c0e9192c22585bf2f85bf2bc3d2742e29f66c29f68414b1d63a970efcab1cf88c4d9f66d1b3b3fd0f21f0f68fadaccc97668bac25731efbe0696f65e4af7b81e80e78ab51dddba04eb33549e980ba77ee4b3fe017f4b64bee010cf86f096ea7daee6c8b8bb6a9b6ac81d6b0eda17addc5713907e1a903f95f5b094f07fc01fd969ba194442951e660a44a3a24062a71fccb46f5d5e391db8db95d56f59c85995574c0f7abcdd6d6cb74aa390bcde7652e96b547132663301d0f7bce9788497087971c22b440ea68a6985cebdaa38b96f66dcf14efce3af3c420bf75e657db89e834dee649e9da539a646d913ad64dd9251b7cbeb74e816eb2c2cb6a8a065b98feb4360c635f489625767a85c3b363d3f02d73b75da0f5900e2754faf1f0819661832aab0d442a56f66bfb4b97ce29d67948cd65c91bee9a7cf12225c5e6146b8d9a14c1ee4a99b397c85ab19b65ad5475eb6edd4064c9f7f4d2f0d832f51365f0871e9e9429bc4ce1650a2f53f8cf98c2cb3cf74df2dcda616c99e8ca445726ba1f28d13da388ccfd815e19926548fe0421f96d79bdf1573725b14b62ff9f89fd3da897e677c9bd927b19dcfbe6b448f3aee4c5b3e4c55fe5b6cd4ff44bbf6d554b4270cc2f6e2e4518f97469c7c58b82b31fd33831b9c2bbdc1bf02e391cf073eae8e48dc58f0a8843ed9b95037e059cfa64f684160d675e1434ef7c268f6e07fc14cc8f729c8d230abfcf981233ff9747c7e665d9d96035647cb84098ff1a099d2829e32e7332ccd2f37d905e4cb4208e4f95aa9b776f0b3cd5eeb9c80405c32ba0cefa2a990407c944949286d37012fbf49621114fe3d04072d3214c71434aa65439916ffa8501efffdeaf5f9fbc478b2b885c1140309294231e71841db2e1545df095058f19957202b442388d30daeb530c89193daea89a183f53973a13dc85f6fad7f5def935011fa67446928bc811185294835d98a28dd1fdcaca07320a8862ce0d07a5aa3efa8cc8b96d108c43c070551fa21b1102379f35065e30124eace757c0904b8413e6339ad8c32018635408e5b70ccc07c69508ec7847f03136548293114ce894d9b7859d09e51ee09ad742e809869b420b89d96bba8f0eb2efefb3ac13c2d2694f715a69c12c0b3ef6573bb8fb0ea881f0e215539e527f8c7a8eb1d4eed50ec844925db40ba71ad48b0a69565bf612e363cab542e95d948cf9ae048eb71b38a34a9ab5b61d444d0d512fd0c080a26048a8a04b924233e027b78e84a452492cab6698511247d9f7ef9dd9bd333e6123864b8dd06618aec614d84590af14ffa8180b3aa8cc48cbcdf05c23b0405986fd458033c84ff4ef60d562fd0157917220443c1feaf36c01643752114a19a305ce069c71143fb0f5146f4d29aa32f263727faa34aa200f35ceb81af0c557b22b24e1d882c0786c24416c0795c1023843efff8222c41c0b1f8ec722fe9521439656a20b4d913e1f71e842c231e27ebc3e2382a324bb1c19a762a591d30ed2713c531af13f618bc705b6311af9fba935e0742604e3046d2645858c226d05c4e073efc986a3f71e18bd1c784f3323d35b29a290f488322745245c9e1411bcb9904c11370253e94f6a644c01814cc87e6a17593159697132fc604ec2fec64a68bcff56d2805c8a9941cdb40fd2b324b6d430a8b5b93a157258214715f276c7969e4551b1237770897bb01b901647d75000e30f26994bd16c56d90c80b3ed84c04484f90c894bbc2c943c314e4c2060bfee388830f7dbb7c061515040a98b7ebf9731ed2a6fda55a16947bd6ac1997d8d7d498d9c84b8bb900156a82c9be52e5f23ff012c62d9a6ca9b7d5e335b285bda3cc082b885d36c78bc078f9af05069c0f735e22120d66e019994ce9308017023c66c72c8b6481e8b2eb086de9a6d29167e6dba880d6ccc93e4b46612931f01ff6fa6267934c41c66bac60233dff93052cca8a0b2c2314ff064e1fa12869cf40fcf7f2902b586f4eef2a810900ded59c5576185f482f08870f0be1554288ab8189b41d36f1533f37c3209a874006b3ecf12e153330f66718c9229456e069f30aff0e44b293460ae0d98a423562c69cf31a691ef610b54c40d08614e58b883c65461ad48ee16e68b2568318023d355cc3845c61222dc316445ee63605c660e1ca24249fd1e4c317d7a1822482b8aad41116ef71cecdff5d34448f6d056088abb2edb62d002408791bc9908df357b056c8243eab022307d0dd8304adcb6254205d4d7c926ae00dcbfd0b9d87a520249d7620e089c22486f2445ea2bcb5e1df9549ae98572c9a18c9c07822077fe39784c3c258c2e296e3622691102dc2b0a07fbd30249e59442605d13992d016e2be322d1f8071b49264c66e26ccc9ccc505cb3c905eec3d7e271f6bea49588168ba88bd81121a6e960b92529d21e5d31e706b4566c8318b92e3672241bef2820749add37aec1f438354577bde133bb7a2e82d8d9aa795c23ac954460f2c7865f526f430dca2f2030c52a6459073e5ee6a69dcd8ec63c918e7c81bb29ec3dd13c2e1b8fcd7fc897e5a95c4bdf07da355bd505da8b0262bd89d43dbf71706c229399decb2dd9106a61b78c7abedbca0e7704fabc7ece521e97fc3d8e4b1e79fcd60718f67c257656cfde17a627bb1794f117459f3b6523e5fc67abcb39c364cedde7bbbbbbff0118599f68', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137302, 277, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f05728b4c850a8503034d13532544849ac2c0600550f06d8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137303, 277, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f05728b4c850a85030d635574849ac2c0600495e067a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137304, 277, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c33343030c84d5708f05728b4c850a85030d63534514849ac2c0600536706d4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137305, 277, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c33343030c84d5708f05728b4c850a8503056c8cdcf2bc92806005037072a', X'789ced5c6b6fdb3816fd2b44805da418bf6327ad3b18c079b4c9346983381d74b12e0c5aba96b9914895a4dc6807f9ef7b49cb762ccb91a3b43b4d471f1ad81279781fe73e4859fd73c7959137e434809d2ed9e905e29639ccf719dfa9909d48fae6ea44eb5075ebf5afec06829a909ef9c4eaa9c1ca9134047748b599d36ab4f6ab8d66b5d9b86e1c74f79addf641ed55bbf1aad3b663c1d14c708523ffdc790b1c24f5ed670db776fa751c4297f402c64575c02f81270b0df8b150d403f246c8407589c08944093f327015e2d050453e5488a6231f345e98c057f3717101f181bbe012093e5035bfb1c0ed6b09dcd393347697345b9d0a69351af8a7837fda8d46e0d53b24387f3d5fb63bbbd331775e27c05df3b5425e1e74ccb5943873d08e9db041b42e39309307fc4a441a141163d273d1304c694967a25d7e18f023110482936b495d20efd19fcad80f3de4bf2617e2966aea55f02ec34bd603d1e8be13eef0925dce7cfbf767fc86c6beb15f964e59ba219f1cf7c6de7d36e83d37f2f510adccb8b7e2ea0c69e69418b65646a225abd690a830f9d26cedac0a6d5631ee0b8797132a63ee31cdd40a40b3615c6367b7da13724b9a0de2d25865007dd066f6f0025c463761bc7c18a2cf78a41e922167fe31708d36e88d94036a13080220db27c067b45be2ee59d8013f1be3bf7f1e67e01f4d7c1ac4a89f3f3c02394577a1acf58f12f444ae899d423f48d0310c4928c1e3946b12221d51e62c5dcee30086c74c195e3f84db6c575bcd8d06a53e521c7c7fd523ef85264da509720d634602d5014a31e03d07e305950f82880b470421687b3d6da8ea5c99e548290294d51df0b4b7f6aacd7632fa682205721c835f4a0632632c41693193646882e96d22983b7c0353905b29d369602a3519e7c6abe3fa6615974d9949175ff6ab89ede64e61121130d4c024981a064c756fafb66727279c49cbb455fc27347a38f0cffed1da3f4e627efb304e2780328ecb382ee3f84789e3e2d1988eeb321ccb702cc3f189e1582488d60a6c19456514fdada3e8d111900ea13204ca1078de21f0cd199c0e9192c22585bf2f85bf2bc3d2742e29f66c29f68414b1d63a970efcab1cf88c4d9f66d1b3b3fd0f21f0f68fadaccc97668bac25731efbe0696f65e4af7b81e80e78ab51dddba04eb33549e980ba77ee4b3fe017f4b64bee010cf86f096ea7daee6c8b8bb6a9b6ac81d6b0eda17addc5713907e1a903f95f5b094f07fc01fd969ba194442951e660a44a3a24062a71fccb46f5d5e391db8db95d56f59c85995574c0f7abcdd6d6cb74aa390bcde7652e96b547132663301d0f7bce9788497087971c22b440ea68a6985cebdaa38b96f66dcf14efce3af3c420bf75e657db89e834dee649e9da539a646d913ad64dd9251b7cbeb74e816eb2c2cb6a8a065b98feb4360c635f489625767a85c3b363d3f02d73b75da0f5900e2754faf1f0819661832aab0d442a56f66bfb4b97ce29d67948cd65c91bee9a7cf12225c5e6146b8d9a14c1ee4a99b397c85ab19b65ad5475eb6edd4064c9f7f4d2f0d832f51365f0871e9e9429bc4ce1650a2f53f8cf98c2cb3cf74df2dcda616c99e8ca445726ba1f28d13da388ccfd815e19926548fe0421f96d79bdf1573725b14b62ff9f89fd3da897e677c9bd927b19dcfbe6b448f3aee4c5b3e4c55fe5b6cd4ff44bbf6d554b4270cc2f6e2e4518f97469c7c58b82b31fd33831b9c2bbdc1bf02e391cf073eae8e48dc58f0a8843ed9b95037e059cfa64f684160d675e1434ef7c268f6e07fc14cc8f729c8d230abfcf981233ff9747c7e665d9d96035647cb84098ff1a099d2829e32e7332ccd2f37d905e4cb4208e4f95aa9b776f0b3cd5eeb9c80405c32ba0cefa2a990407c944949286d37012fbf49621114fe3d04072d3214c71434aa65439916ffa8501efffdeaf5f9fbc478b2b885c1140309294231e71841db2e1545df095058f19957202b442388d30daeb530c89193daea89a183f53973a13dc85f6fad7f5def935011fa67446928bc811185294835d98a28dd1fdcaca07320a8862ce0d07a5aa3efa8cc8b96d108c43c070551fa21b1102379f35065e30124eace757c0904b8413e6339ad8c32018635408e5b70ccc07c69508ec7847f03136548293114ce894d9b7859d09e51ee09ad742e809869b420b89d96bba8f0eb2efefb3ac13c2d2694f715a69c12c0b3ef6573bb8fb0ea881f0e215539e527f8c7a8eb1d4eed50ec844925db40ba71ad48b0a69565bf612e363cab542e95d948cf9ae048eb71b38a34a9ab5b61d444d0d512fd0c080a26048a8a04b924233e027b78e84a452492cab6698511247d9f7ef9dd9bd333e6123864b8dd06618aec614d84590af14ffa8180b3aa8cc48cbcdf05c23b0405986fd458033c84ff4ef60d562fd0157917220443c1feaf36c01643752114a19a305ce069c71143fb0f5146f4d29aa32f263727faa34aa200f35ceb81af0c557b22b24e1d882c0786c24416c0795c1023843efff8222c41c0b1f8ec722fe9521439656a20b4d913e1f71e842c231e27ebc3e2382a324bb1c19a762a591d30ed2713c531af13f618bc705b6311af9fba935e0742604e3046d2645858c226d05c4e073efc986a3f71e18bd1c784f3323d35b29a290f488322745245c9e1411bcb9904c11370253e94f6a644c01814cc87e6a17593159697132fc604ec2fec64a68bcff56d2805c8a9941cdb40fd2b324b6d430a8b5b93a157258214715f276c7969e4551b1237770897bb01b901647d75000e30f26994bd16c56d90c80b3ed84c04484f90c894bbc2c943c314e4c2060bfee388830f7dbb7c061515040a98b7ebf9731ed2a6fda55a16947bd6ac1997d8d7d498d9c84b8bb900156a82c9be52e5f23ff012c62d9a6ca9b7d5e335b285bda3cc082b885d36c78bc078f9af05069c0f735e22120d66e019994ce9308017023c66c72c8b6481e8b2eb086de9a6d29167e6dba880d6ccc93e4b46612931f01ff6fa6267934c41c66bac60233dff93052cca8a0b2c2314ff064e1fa12869cf40fcf7f2902b586f4eef2a810900ded59c5576185f482f08870f0be1554288ab8189b41d36f1533f37c3209a874006b3ecf12e153330f66718c9229456e069f30aff0e44b293460ae0d98a423562c69cf31a691ef610b54c40d08614e58b883c65461ad48ee16e68b2568318023d355cc3845c61222dc316445ee63605c660e1ca24249fd1e4c317d7a1822482b8aad41116ef71cecdff5d34448f6d056088abb2edb62d002408791bc9908df357b056c8243eab022307d0dd8304adcb6254205d4d7c926ae00dcbfd0b9d87a520249d7620e089c22486f2445ea2bcb5e1df9549ae98572c9a18c9c07822077fe39784c3c258c2e296e3622691102dc2b0a07fbd30249e59442605d13992d016e2be322d1f8071b49264c66e26ccc9ccc505cb3c905eec3d7e271f6bea49588168ba88bd81121a6e960b92529d21e5d31e706b4566c8318b92e3672241bef2820749add37aec1f438354577bde133bb7a2e82d8d9aa795c23ac954460f2c7865f526f430dca2f2030c52a6459073e5ee6a69dcd8ec63c918e7c81bb29ec3dd13c2e1b8fcd7fc897e5a95c4bdf07da355bd505da8b0262bd89d43dbf71706c229399decb2dd9106a61b78c7abedbca0e7704fabc7ece521e97fc3d8e4b1e79fcd60718f67c257656cfde17a627bb1794f117459f3b6523e5fc67abcb39c364cedde7bbbbbbff0118599f68', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137306, 277, 50.0, 100.0, 'mg/kg', 'PO', NULL, 'Adult', X'789c3335d0353430c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d3b5c850a85030345100ca14030007160ca0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137307, 277, 12.5, 12.5, 'mg', 'PO', NULL, 'Adult', X'789c73cb2c2a2e5170c92f4eb5523034d233cd4dd73536d633ce4dd7cf4e5708f057a850300400c09f0a19', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137308, 277, 20.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3332d03536c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca000088d50949', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137309, 277, 10.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d03534cd4dd7cf4e5708f057a8503004008857087f', X'789ced5c6b6fdb3816fd2b44805da418bf6327ad3b18c079b4c9346983381d74b12e0c5aba96b9914895a4dc6807f9ef7b49cb762ccb91a3b43b4d471f1ad81279781fe73e4859fd73c7959137e434809d2ed9e905e29639ccf719dfa9909d48fae6ea44eb5075ebf5afec06829a909ef9c4eaa9c1ca9134047748b599d36ab4f6ab8d66b5d9b86e1c74f79addf641ed55bbf1aad3b663c1d14c708523ffdc790b1c24f5ed670db776fa751c4297f402c64575c02f81270b0df8b150d403f246c8407589c08944093f327015e2d050453e5488a6231f345e98c057f3717101f181bbe012093e5035bfb1c0ed6b09dcd393347697345b9d0a69351af8a7837fda8d46e0d53b24387f3d5fb63bbbd331775e27c05df3b5425e1e74ccb5943873d08e9db041b42e39309307fc4a441a141163d273d1304c694967a25d7e18f023110482936b495d20efd19fcad80f3de4bf2617e2966aea55f02ec34bd603d1e8be13eef0925dce7cfbf767fc86c6beb15f964e59ba219f1cf7c6de7d36e83d37f2f510adccb8b7e2ea0c69e69418b65646a225abd690a830f9d26cedac0a6d5631ee0b8797132a63ee31cdd40a40b3615c6367b7da13724b9a0de2d25865007dd066f6f0025c463761bc7c18a2cf78a41e922167fe31708d36e88d94036a13080220db27c067b45be2ee59d8013f1be3bf7f1e67e01f4d7c1ac4a89f3f3c02394577a1acf58f12f444ae899d423f48d0310c4928c1e3946b12221d51e62c5dcee30086c74c195e3f84db6c575bcd8d06a53e521c7c7fd523ef85264da509720d634602d5014a31e03d07e305950f82880b470421687b3d6da8ea5c99e548290294d51df0b4b7f6aacd7632fa682205721c835f4a0632632c41693193646882e96d22983b7c0353905b29d369602a3519e7c6abe3fa6615974d9949175ff6ab89ede64e61121130d4c024981a064c756fafb66727279c49cbb455fc27347a38f0cffed1da3f4e627efb304e2780328ecb382ee3f84789e3e2d1988eeb321ccb702cc3f189e1582488d60a6c19456514fdada3e8d111900ea13204ca1078de21f0cd199c0e9192c22585bf2f85bf2bc3d2742e29f66c29f68414b1d63a970efcab1cf88c4d9f66d1b3b3fd0f21f0f68fadaccc97668bac25731efbe0696f65e4af7b81e80e78ab51dddba04eb33549e980ba77ee4b3fe017f4b64bee010cf86f096ea7daee6c8b8bb6a9b6ac81d6b0eda17addc5713907e1a903f95f5b094f07fc01fd969ba194442951e660a44a3a24062a71fccb46f5d5e391db8db95d56f59c85995574c0f7abcdd6d6cb74aa390bcde7652e96b547132663301d0f7bce9788497087971c22b440ea68a6985cebdaa38b96f66dcf14efce3af3c420bf75e657db89e834dee649e9da539a646d913ad64dd9251b7cbeb74e816eb2c2cb6a8a065b98feb4360c635f489625767a85c3b363d3f02d73b75da0f5900e2754faf1f0819661832aab0d442a56f66bfb4b97ce29d67948cd65c91bee9a7cf12225c5e6146b8d9a14c1ee4a99b397c85ab19b65ad5475eb6edd4064c9f7f4d2f0d832f51365f0871e9e9429bc4ce1650a2f53f8cf98c2cb3cf74df2dcda616c99e8ca445726ba1f28d13da388ccfd815e19926548fe0421f96d79bdf1573725b14b62ff9f89fd3da897e677c9bd927b19dcfbe6b448f3aee4c5b3e4c55fe5b6cd4ff44bbf6d554b4270cc2f6e2e4518f97469c7c58b82b31fd33831b9c2bbdc1bf02e391cf073eae8e48dc58f0a8843ed9b95037e059cfa64f684160d675e1434ef7c268f6e07fc14cc8f729c8d230abfcf981233ff9747c7e665d9d96035647cb84098ff1a099d2829e32e7332ccd2f37d905e4cb4208e4f95aa9b776f0b3cd5eeb9c80405c32ba0cefa2a990407c944949286d37012fbf49621114fe3d04072d3214c71434aa65439916ffa8501efffdeaf5f9fbc478b2b885c1140309294231e71841db2e1545df095058f19957202b442388d30daeb530c89193daea89a183f53973a13dc85f6fad7f5def935011fa67446928bc811185294835d98a28dd1fdcaca07320a8862ce0d07a5aa3efa8cc8b96d108c43c070551fa21b1102379f35065e30124eace757c0904b8413e6339ad8c32018635408e5b70ccc07c69508ec7847f03136548293114ce894d9b7859d09e51ee09ad742e809869b420b89d96bba8f0eb2efefb3ac13c2d2694f715a69c12c0b3ef6573bb8fb0ea881f0e215539e527f8c7a8eb1d4eed50ec844925db40ba71ad48b0a69565bf612e363cab542e95d948cf9ae048eb71b38a34a9ab5b61d444d0d512fd0c080a26048a8a04b924233e027b78e84a452492cab6698511247d9f7ef9dd9bd333e6123864b8dd06618aec614d84590af14ffa8180b3aa8cc48cbcdf05c23b0405986fd458033c84ff4ef60d562fd0157917220443c1feaf36c01643752114a19a305ce069c71143fb0f5146f4d29aa32f263727faa34aa200f35ceb81af0c557b22b24e1d882c0786c24416c0795c1023843efff8222c41c0b1f8ec722fe9521439656a20b4d913e1f71e842c231e27ebc3e2382a324bb1c19a762a591d30ed2713c531af13f618bc705b6311af9fba935e0742604e3046d2645858c226d05c4e073efc986a3f71e18bd1c784f3323d35b29a290f488322745245c9e1411bcb9904c11370253e94f6a644c01814cc87e6a17593159697132fc604ec2fec64a68bcff56d2805c8a9941cdb40fd2b324b6d430a8b5b93a157258214715f276c7969e4551b1237770897bb01b901647d75000e30f26994bd16c56d90c80b3ed84c04484f90c894bbc2c943c314e4c2060bfee388830f7dbb7c061515040a98b7ebf9731ed2a6fda55a16947bd6ac1997d8d7d498d9c84b8bb900156a82c9be52e5f23ff012c62d9a6ca9b7d5e335b285bda3cc082b885d36c78bc078f9af05069c0f735e22120d66e019994ce9308017023c66c72c8b6481e8b2eb086de9a6d29167e6dba880d6ccc93e4b46612931f01ff6fa6267934c41c66bac60233dff93052cca8a0b2c2314ff064e1fa12869cf40fcf7f2902b586f4eef2a810900ded59c5576185f482f08870f0be1554288ab8189b41d36f1533f37c3209a874006b3ecf12e153330f66718c9229456e069f30aff0e44b293460ae0d98a423562c69cf31a691ef610b54c40d08614e58b883c65461ad48ee16e68b2568318023d355cc3845c61222dc316445ee63605c660e1ca24249fd1e4c317d7a1822482b8aad41116ef71cecdff5d34448f6d056088abb2edb62d002408791bc9908df357b056c8243eab022307d0dd8304adcb6254205d4d7c926ae00dcbfd0b9d87a520249d7620e089c22486f2445ea2bcb5e1df9549ae98572c9a18c9c07822077fe39784c3c258c2e296e3622691102dc2b0a07fbd30249e59442605d13992d016e2be322d1f8071b49264c66e26ccc9ccc505cb3c905eec3d7e271f6bea49588168ba88bd81121a6e960b92529d21e5d31e706b4566c8318b92e3672241bef2820749add37aec1f438354577bde133bb7a2e82d8d9aa795c23ac954460f2c7865f526f430dca2f2030c52a6459073e5ee6a69dcd8ec63c918e7c81bb29ec3dd13c2e1b8fcd7fc897e5a95c4bdf07da355bd505da8b0262bd89d43dbf71706c229399decb2dd9106a61b78c7abedbca0e7704fabc7ece521e97fc3d8e4b1e79fcd60718f67c257656cfde17a627bb1794f117459f3b6523e5fc67abcb39c364cedde7bbbbbbff0118599f68', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137310, 277, 30.0, 30.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dacb0523036c84dd7cf4ed74f49ac040029a00526', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137311, 277, 25.0, 45.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3332d53531cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca00008a030954', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137312, 277, 12.5, 22.5, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d233d5350212b9e9fad9e90a01fe0a150a8600a79d0945', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137313, 277, 875.0, 875.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052b03037cd4dd74fc92f4e0500244f04d3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137314, 277, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3336c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca50a850303450004a140300dd850ba4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137315, 277, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034cd4dd7cf4e5708f057a850300400734907f1', X'789ced5c6b6fdb3816fd2b44805da418bf6327ad3b18c079b4c9346983381d74b12e0c5aba96b9914895a4dc6807f9ef7b49cb762ccb91a3b43b4d471f1ad81279781fe73e4859fd73c7959137e434809d2ed9e905e29639ccf719dfa9909d48fae6ea44eb5075ebf5afec06829a909ef9c4eaa9c1ca9134047748b599d36ab4f6ab8d66b5d9b86e1c74f79addf641ed55bbf1aad3b663c1d14c708523ffdc790b1c24f5ed670db776fa751c4297f402c64575c02f81270b0df8b150d403f246c8407589c08944093f327015e2d050453e5488a6231f345e98c057f3717101f181bbe012093e5035bfb1c0ed6b09dcd393347697345b9d0a69351af8a7837fda8d46e0d53b24387f3d5fb63bbbd331775e27c05df3b5425e1e74ccb5943873d08e9db041b42e39309307fc4a441a141163d273d1304c694967a25d7e18f023110482936b495d20efd19fcad80f3de4bf2617e2966aea55f02ec34bd603d1e8be13eef0925dce7cfbf767fc86c6beb15f964e59ba219f1cf7c6de7d36e83d37f2f510adccb8b7e2ea0c69e69418b65646a225abd690a830f9d26cedac0a6d5631ee0b8797132a63ee31cdd40a40b3615c6367b7da13724b9a0de2d25865007dd066f6f0025c463761bc7c18a2cf78a41e922167fe31708d36e88d94036a13080220db27c067b45be2ee59d8013f1be3bf7f1e67e01f4d7c1ac4a89f3f3c02394577a1acf58f12f444ae899d423f48d0310c4928c1e3946b12221d51e62c5dcee30086c74c195e3f84db6c575bcd8d06a53e521c7c7fd523ef85264da509720d634602d5014a31e03d07e305950f82880b470421687b3d6da8ea5c99e548290294d51df0b4b7f6aacd7632fa682205721c835f4a0632632c41693193646882e96d22983b7c0353905b29d369602a3519e7c6abe3fa6615974d9949175ff6ab89ede64e61121130d4c024981a064c756fafb66727279c49cbb455fc27347a38f0cffed1da3f4e627efb304e2780328ecb382ee3f84789e3e2d1988eeb321ccb702cc3f189e1582488d60a6c19456514fdada3e8d111900ea13204ca1078de21f0cd199c0e9192c22585bf2f85bf2bc3d2742e29f66c29f68414b1d63a970efcab1cf88c4d9f66d1b3b3fd0f21f0f68fadaccc97668bac25731efbe0696f65e4af7b81e80e78ab51dddba04eb33549e980ba77ee4b3fe017f4b64bee010cf86f096ea7daee6c8b8bb6a9b6ac81d6b0eda17addc5713907e1a903f95f5b094f07fc01fd969ba194442951e660a44a3a24062a71fccb46f5d5e391db8db95d56f59c85995574c0f7abcdd6d6cb74aa390bcde7652e96b547132663301d0f7bce9788497087971c22b440ea68a6985cebdaa38b96f66dcf14efce3af3c420bf75e657db89e834dee649e9da539a646d913ad64dd9251b7cbeb74e816eb2c2cb6a8a065b98feb4360c635f489625767a85c3b363d3f02d73b75da0f5900e2754faf1f0819661832aab0d442a56f66bfb4b97ce29d67948cd65c91bee9a7cf12225c5e6146b8d9a14c1ee4a99b397c85ab19b65ad5475eb6edd4064c9f7f4d2f0d832f51365f0871e9e9429bc4ce1650a2f53f8cf98c2cb3cf74df2dcda616c99e8ca445726ba1f28d13da388ccfd815e19926548fe0421f96d79bdf1573725b14b62ff9f89fd3da897e677c9bd927b19dcfbe6b448f3aee4c5b3e4c55fe5b6cd4ff44bbf6d554b4270cc2f6e2e4518f97469c7c58b82b31fd33831b9c2bbdc1bf02e391cf073eae8e48dc58f0a8843ed9b95037e059cfa64f684160d675e1434ef7c268f6e07fc14cc8f729c8d230abfcf981233ff9747c7e665d9d96035647cb84098ff1a099d2829e32e7332ccd2f37d905e4cb4208e4f95aa9b776f0b3cd5eeb9c80405c32ba0cefa2a990407c944949286d37012fbf49621114fe3d04072d3214c71434aa65439916ffa8501efffdeaf5f9fbc478b2b885c1140309294231e71841db2e1545df095058f19957202b442388d30daeb530c89193daea89a183f53973a13dc85f6fad7f5def935011fa67446928bc811185294835d98a28dd1fdcaca07320a8862ce0d07a5aa3efa8cc8b96d108c43c070551fa21b1102379f35065e30124eace757c0904b8413e6339ad8c32018635408e5b70ccc07c69508ec7847f03136548293114ce894d9b7859d09e51ee09ad742e809869b420b89d96bba8f0eb2efefb3ac13c2d2694f715a69c12c0b3ef6573bb8fb0ea881f0e215539e527f8c7a8eb1d4eed50ec844925db40ba71ad48b0a69565bf612e363cab542e95d948cf9ae048eb71b38a34a9ab5b61d444d0d512fd0c080a26048a8a04b924233e027b78e84a452492cab6698511247d9f7ef9dd9bd333e6123864b8dd06618aec614d84590af14ffa8180b3aa8cc48cbcdf05c23b0405986fd458033c84ff4ef60d562fd0157917220443c1feaf36c01643752114a19a305ce069c71143fb0f5146f4d29aa32f263727faa34aa200f35ceb81af0c557b22b24e1d882c0786c24416c0795c1023843efff8222c41c0b1f8ec722fe9521439656a20b4d913e1f71e842c231e27ebc3e2382a324bb1c19a762a591d30ed2713c531af13f618bc705b6311af9fba935e0742604e3046d2645858c226d05c4e073efc986a3f71e18bd1c784f3323d35b29a290f488322745245c9e1411bcb9904c11370253e94f6a644c01814cc87e6a17593159697132fc604ec2fec64a68bcff56d2805c8a9941cdb40fd2b324b6d430a8b5b93a157258214715f276c7969e4551b1237770897bb01b901647d75000e30f26994bd16c56d90c80b3ed84c04484f90c894bbc2c943c314e4c2060bfee388830f7dbb7c061515040a98b7ebf9731ed2a6fda55a16947bd6ac1997d8d7d498d9c84b8bb900156a82c9be52e5f23ff012c62d9a6ca9b7d5e335b285bda3cc082b885d36c78bc078f9af05069c0f735e22120d66e019994ce9308017023c66c72c8b6481e8b2eb086de9a6d29167e6dba880d6ccc93e4b46612931f01ff6fa6267934c41c66bac60233dff93052cca8a0b2c2314ff064e1fa12869cf40fcf7f2902b586f4eef2a810900ded59c5576185f482f08870f0be1554288ab8189b41d36f1533f37c3209a874006b3ecf12e153330f66718c9229456e069f30aff0e44b293460ae0d98a423562c69cf31a691ef610b54c40d08614e58b883c65461ad48ee16e68b2568318023d355cc3845c61222dc316445ee63605c660e1ca24249fd1e4c317d7a1822482b8aad41116ef71cecdff5d34448f6d056088abb2edb62d002408791bc9908df357b056c8243eab022307d0dd8304adcb6254205d4d7c926ae00dcbfd0b9d87a520249d7620e089c22486f2445ea2bcb5e1df9549ae98572c9a18c9c07822077fe39784c3c258c2e296e3622691102dc2b0a07fbd30249e59442605d13992d016e2be322d1f8071b49264c66e26ccc9ccc505cb3c905eec3d7e271f6bea49588168ba88bd81121a6e960b92529d21e5d31e706b4566c8318b92e3672241bef2820749add37aec1f438354577bde133bb7a2e82d8d9aa795c23ac954460f2c7865f526f430dca2f2030c52a6459073e5ee6a69dcd8ec63c918e7c81bb29ec3dd13c2e1b8fcd7fc897e5a95c4bdf07da355bd505da8b0262bd89d43dbf71706c229399decb2dd9106a61b78c7abedbca0e7704fabc7ece521e97fc3d8e4b1e79fcd60718f67c257656cfde17a627bb1794f117459f3b6523e5fc67abcb39c364cedde7bbbbbbff0118599f68', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137316, 277, 80.0, 90.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb330d0b534c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca50a850303450004a140300f5240c3f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137317, 277, 40.0, 45.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523031d03531cd4dd7cf4e5708f057a85030040088b40885', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137318, 277, 1000.0, 1000.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230343030c84dd74fc92f4e0500273404f0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137319, 277, 80.0, 90.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb330d0b534c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca50a85030d5353450004a1503000c920ca1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137320, 277, 40.0, 45.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523031d03531cd4dd7cf4ed74f49ac5408f057a850300400b14609f2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137321, 277, 1000.0, 1000.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230343030c84dd74fc92f4e0500273404f0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137322, 277, 90.0, 90.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb334c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca50a85030d5353450004a150300f4980c0c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137323, 277, 45.0, 45.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523031cd4dd7cf4e5708f057a850300400737307f4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137324, 277, 500.0, 500.0, 'mg', NULL, NULL, 'Pediatric', X'789c3356c8cdcf2bc92856d0553051a84c4d2c2ab652303530c84dd74fc92f4e05008ee8096f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137325, 277, 4000.0, 4000.0, 'mg', NULL, NULL, 'Pediatric', X'789cb33355a84c4d2c2ab65230313030c84dd74f49ac04003d8a0617', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137326, 277, 50.0, 50.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3335c84dd7cf4e5708c857283432c950a8503034504849ac2c06005dee0763', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137327, 277, 1000.0, 1000.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230343030c84dd74f49ac0400222e0483', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137328, 277, 90.0, 90.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb334c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4d03534ca50a850303450004a150300f40b0c0f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137329, 277, 1000.0, 1000.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230343030c84dd74fc92f4e0500273404f0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137330, 277, 50.0, 50.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c3335c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5170f27451a85030d735345100ca140300e6030ba1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137331, 277, 2000.0, 2000.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230323030c84dd74f49ac040022380484', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137332, 277, 50.0, 50.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3335c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4c850a8503034d1353254004a150300f4b70c0f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137333, 277, 16.6, 16.6, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d333cb4dd7cf4e5708f057a8300400793d0836', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137334, 277, 500.0, 500.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052303530c84dd74fc92f4e050023ca04c4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137335, 277, 50.0, 100.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3335d0353430c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4d03534ca0000a1f709df', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137336, 277, 50.0, 100.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3335d0353430c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d3b5c850a85030345100ca14030007160ca0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137337, 3788, 17.0, 17.0, 'g', 'IN', NULL, 'Adult', X'789cf32f4accb152303457485748c92c2ececf294b4d51c8cc53303432d035323150c8f551c8c92c2ccd4c010009520cb3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137338, 3788, 0.2, 0.8, 'g/kg', NULL, NULL, 'Pediatric', X'789c33d0335228c95730d0b35048d7cf4ed74f49ac5428c9c82f4dcf50c805329352158a4b128b4a525314124b143232d333528b1452f28b5315f2d3140cc15a00b57e1578', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137339, 3788, 17.0, 17.0, 'g', NULL, 1, 'Pediatric', X'789cf34dacc8cc2dcd554849cccca95448c92f4e55c84f5330345748d74f49ac0400a7ce0a4e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137340, 3788, 1.0, 1.5, 'g/kg', NULL, 1, 'Pediatric', X'789cf32f4accb152305428c95730d4335548d7cf4e574849cccca95448cb2f5230d63503f22a8b01d94e0b7a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137341, 3788, 100.0, 100.0, 'g', NULL, 1, 'Pediatric', X'789cf34dacc8cc2dcd554849cccca95448c92f4e55c84f533034305048d74f49ac0400b1400a77', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137342, 449, 25.0, 25.0, 'mg', 'IV', NULL, 'Adult', X'789cf30cb352303255c84dd707123e0a8979290aa60620aea101889f945f5292935a0c00c24e0ae4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137343, 449, 30.0, 30.0, 'mg', NULL, NULL, 'Adult', X'789cf32f4accb152303650c84dd75130835096200a005842068f', X'789ced58596fdb4610fe2b033dd980645d50da08cd838fb876e10b96ab3c5401b12287e242cb5d7677299b09fcdf3b43cab6282b916b343dd0bc5826b9737fb3fbcd7e6e44369f055aa4d81842e3482a2fc5274c1b4d68e456f1bbc4fbcc0ddbed5b39c774cfd819ff27dbb5a52eb422c328109e257a9dde9b56a7dbea766e3a3f0c07dde1e0c7bdb76f7b8337fd722d865e1aed68e5e7c67e944a2d9db782df95af3cde955a6e8a0c87137d285428f314c244688d0aa6ca8473b4137d649c98211c1b9bba893e1d0fa1378074d6a63f67207404830e3f763bfc3c35de2ba4759756a821f4f95313de543f6ff967a2af4deed18189a1eed5104ec74db8ba245f4c9a1a0d375644081794333784436123f990867cba1add3dbdf2624a76e9e9b78ff4a4a49e970f4f617e21beed05580a064bc1e041f0fe23dbdd8f72e503ca91d4b35a5a37f8d9d8f7560a15c4726aa55265d0c1adf44940559551b0404d0bc25c091b5874198961b023e320c1d4440581478642a9227065b4bb357b674644e40344c621bc83ce5e55a5f90c765271f7aec7b9dfa50c5389544ed95fa0851e50feb9185c7e0d21199411bd9f5a14f34ad9ad06a9bd012eefac92a5da490d46f1ca8c8220af1dd09208439223eb56ba3997574464849f51544920f8c4248b71cc59592088d89392eee0c18f21f9dd1facba3d60afd79d252d8f3a8630f2c27a521be78e8c80f0306875cbe013cb585a06d5ef5000a7d704303016129362952bf25c2c8c8c40234610d33701919559a38e2a2ef628cfac58ad92176152848c4cf1e2428d08cf205c65a90404ac02021810500202564cc1032060c721c94f2927bbeb2e7ea5114affaf901c658d9b004b89a246943a22df3d46134d45ce1e049e0afd53b730133d429ce8d04acf81026500e1f75c86737233468b3aa4cf1c20ef7a659a1d4c0bb845394bfc6b3bf8abe65ed0c74bf180c583523c7812afba799461c81d7a65b2bc2a87dbdad45716675ae8b008ae49622da98f1fa1fa48fbd8065c9d517f54bb01b74ebdad1f3e0de1c85016459621a181db4dc68478acda933bd679ea10356fc234f7cb9c73a27c915568046d3c24c2a671ae5801758ca08a6ef0e71a3525610346cadd6e0817a4c8f93c921835817d0845ce3e4ef423c2bebc6883bd1364786d44e5b7b0b8b54d5e51d175547c2fe9bfaaa4ff7839d6f1f13fafc7370f7f3ddfffb2f8ff06775e7ec4961ed58eff6707dfbe526867c5843b81cff476a884632656217cc90a3e10d16a8526cd14dec10a379ae8282f89d6b4c8480cc850e86107f7667bf0e1eac32ef18922cdbc493927e090e81e425264c6a37665cc233eec2955c45c5da1234bec6da2db3d9a3e8864f46d44e47366891725c85cb0a4e82063ea47222e21a6a29c64ae2e872042a290137d7e3ad13cbbd0314f9386b00593df19ba2ac3e315de550be3b04a2fa9a689e9840627ebadc91272ba5c61d2c2505d13cad3d918a2c2c5b90e2b95945e4a8cf4942d98a217add2479a6f484f8585b6e59e00996642da943ce02f1c4d2ca4ca2dbe96367da928db19d3aae42ad56d90dd153efbbc34db55b350500a058f4235ade7a7db95d09a9acc17cab65dd17833a57f1cf1ca3126b87e1863b652c2115a69f2faba031a66977a9bb03fae30da8483838312494f503f3c3926bcff326adfbcbfd8b09157b3719d9290b92c419ab8012302fb44bf57b860120f67c737aec451446111d68ee4a74f348071eb5e08da30447bc1a8a43da849c79db0961aa8c9bde065262ae41ed3c897940b16c29948aae5fb9fe99d5c90cd84fb205362c61d725e0855fe736009f109a976cd253a9e3a8c6c1599d328d8b5d4a882db5e684c39373e21344c4d587893a16655efef68c3c80a4b635544f65cb5573c63392fbb0638397ec1a8408bea187f2ac7165c2f172ec789bf1207eb20fb0e84ff0e10bed76ab5567f92995c31a316a1516656d45278a91dfaf2a2a95406efa0d7eaa752c3cee99838c5515edd2bd656745bfdc42e179c08158392310ea1df1a2494073a98a74649970e61792a7320a1c56a3ef8d55219da3186f89a38ce91af10497960e2603f7c76117bc8948a6fe85a70aa133995c4ab0e050f112abfa3ad40995bc73b86369c502a4c9487af247b23c4605f3953e778841f0653e1935486eee94af87079657a50dd7cc28db993a1f4c472aa0b4d387e767f753dbe7e2d5f5973637babad0bd41a765b0c2fbfff5d6a08961a82470d357bdb32b22594ea82f8f8d905314bd356727fff0779856ea9', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137344, 449, 0.25, 0.25, 'mg/kg', 'IV', NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4e55b05530d0333255c84dd7cf4e57d0c84dacb0353200f234153cc31492f2734a8b15f2cb528b148c147233f34a4b528b0147c81362', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137345, 449, 10.0, 10.0, 'mg', 'IN', NULL, 'Adult', X'789c158cc11180200c045bb912b4062b092432193071086afbc2736ff6f62043760b65e9485da8aa15b07f06b5e1d8375c05c9db13127382b765de34546c04a6c292e72f045da3c24f10bfd2170be5a133fe03448d2505', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137346, 449, 0.35, 0.35, 'mg/kg', NULL, NULL, 'Adult', X'789cf34c53c8cc4b4d4b4b4d2ec92c4b55484c2b492d52303455c8cdcc2b2d492db65230d03336cd4dd7cf4e57d0c84dacb03502723415f2cb80aa8c608a00165f16ac', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137347, 449, 5.0, 15.0, 'mg', NULL, NULL, 'Adult', X'789cf34c53484d4b4b4d2ec92c4bb552082e492c2a51c8cc4b2b2dcecccf53482c5130d5353455c84dd7cf2802003e7e0e4e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137348, 449, 30.0, 30.0, 'mg', 'PO', NULL, 'Adult', X'789c73cecf2bce4c492d523036c84d57f00c5208f057c82f52c8c8cf4d5548c92f4e5528c957482ccbcf4c51c84b4d4d514803ca252aa41465160000266a1347', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137349, 1008, 10.0, 10.0, 'mg', 'PO', 1, 'Adult', X'789c732c2ec9c84d54d02828ca2fc8a8cc49acc82cd6d45148ccc9492d4acf4c5628cac8cccb2cc92cb6523034c84d5708f0574849cccca904001bd1132d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137350, 1008, 10.0, 10.0, 'mg', NULL, 1, 'Adult', X'789c73ad482d4ace2c4ed5cdcc4b294d4e4d51482c2ec9c84db4523034c84d5730ca502828cacc2f5228c9574885aa54c84dac80c8a62466e6540200fced16de', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137351, 1008, 4.0, 4.0, 'mg', 'PO', 1, 'Pediatric', X'789c3334d23532c9cdb7523051c84d57d0482f4acc2bcd492dd65408f0574849cccca904009c9b0a19', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137352, 1008, 4.0, 4.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d235abb4523051c84d5708f0574849cccca9040030a50583', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137353, 1008, 5.0, 5.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d33534adb4523055c84d5708f0574849cccca9040034c305b8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137354, 1008, 10.0, 10.0, 'mg', 'PO', 1, 'Pediatric', X'789cb33334adb4523034c84d5708f0574849cccca904003259059f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137355, 1008, 10.0, 10.0, 'mg', 'PO', 1, 'Pediatric', X'789cb3333455a84c4d2c2ab652303450c84d5708f0574849cccca904005c4d078a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137356, 21794, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137357, 910, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137358, 15374, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137359, 690, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f0572834d3b5c850a85030d73534504849ac2c06005a98070b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137360, 690, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c73cb2c2a2e5170c92f4eb552303530c84d5708f057a85030040060ed071f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137361, 690, 15.0, 15.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c3334cd4dd7cf4e57f00c53a830d45128c948cd5330d74308169a650000b6b40a3c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137362, 690, 15.0, 15.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c73cb2c2a2e5170c92f4eb5523034cd4dd7cf4e57f00c53a83004006b6207d1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137363, 690, 1.0, 1.0, 'g', NULL, NULL, 'Adult', X'789cf34dacb0523054482f4accd54fc92f4e05002a630553', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137364, 690, 500.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789c333530d0353735c84d5708f05728b4c850a85030d53534504849ac2c060063d7076f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137365, 690, 15.0, 15.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c3334cd4dd7cf4e57f00c53a8503004001e6403e4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137366, 690, 7.5, 7.5, 'mg/kg', 'IV', NULL, 'Adult', X'789c73cecf2dc8492d4955c8cc4b2b2dcecccf5330cc502828cacc2f5228c957282e2d4a4f2daad45128c948cd5330d733cd4dd7cf4e57f00c532834cb50a850300200d9681560', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137367, 690, 1.0, 1.0, 'g', NULL, NULL, 'Adult', X'789cf34dacb052305448d74fc92f4e05001af30413', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137368, 690, 750.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789c333735c84d5708f05728b4c850a85030d53534504849ac2c06004fb206ad', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137369, 690, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f05728343452a8503034514849ac2c06004118060b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137370, 690, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f05728343452a85030574849ac2c06003bfe05dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137371, 690, 250.0, 250.0, 'mg', 'PO', NULL, 'Adult', X'789c73cc29b152f04dac54282d4e55303235c84d5708f05728b4c850a85030574849ac2c56c8cc5328284a4dcf4bcc2b5128482cc94ccd2b290600df071249', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137372, 690, 2.0, 2.0, 'g', 'PO', NULL, 'Adult', X'789c3352485708f057a8503004000cfa0262', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137373, 690, 2.0, 2.0, 'g', 'PO', NULL, 'Adult', X'789cf3cccd2dcdcb4fcecf2d482d49cd2bb1523052485708f057a8503004008d7b0900', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137374, 690, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789cf3cccd2dcdcb4fcecf2d28cacfcd2c4e4db152303530c84d5708f057283434ca50a85030574849ac2c060034f10db6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137375, 690, 2.0, 2.0, 'g', 'PO', NULL, 'Adult', X'789c3352485708f057a8503004000cfa0262', X'789ced5c6d73db3612fe2b3bbee99d3cb56449f14b4fc97446b613dbd7f8652cc797ce29c3814888440d022c403a563afeefb700a91752b4a5d0699bb4fc128724f06077b1fbec0204f5db86a712df1124a41b3dd838a3b1928279e493e474630b3612c5cdfd208e23dddbdefec86e69d892ca37ff63db4bcdb5ab48443d87c4a657b7dddd6bb63bcd4efbbabddf7bd1e9edecb43a3b7b7bdd3ddb96ba31934263cbdf368ea9a08a70fbff98dedbeed79388f6e0220ea81a0a226236623266ae1e8a23a9894fe18d54a1ee0dc5e9cd505c5ef4a0bbdb0efd97f0627fd7fcd96de3d5501cca309402ae15f1289ca39eba076f38f127dc0a918c16e578c05b3119716aaefef701af3813b7f6622ed78228ab4dd45f68fcf0c1e0f7bd84c70eaac0849fd3b7449ea95d9c6eaee5e5c55058f5e0f2027edd6bfe10c03deca39dc12313b4cf1ba6740c3804da6fd6ee1e3aa9a93a689eed5b1f4e6fe0beb305685f01fbadf9cd5ff7823c44aec3509c917bbc07be22e1b6870d36f246b33a8674c45c87b33baa1c32d22ed53aa7014ad5dcdf9d6a60e5df9dca5f827728b9546817b4c420513e5513e7548c534339974a46c184937b961f63516ca33b7a42c4694c818971a2b12774028814930a62093ac52db7070274e78a3fa6f5a988a98e994029ad01882e48f4191a5f9e1e150d9675ed748d3a3bd9540f2845e73f3d1a8a31ea314e3807457d165251027a40dc982a86f2dd109f095994af30c87e36469fc73d38231348344d836cae43da064d8a96a4be09538848cca888b1e3c2cc40c3c87a9f100e7dad0986c0506c0e4517a6be5922eeb5626e20317a972d79ad2889514944390dc34448172717e756a0a473ccc5874a864c536f212050c96041cb670a7bcc88f29605ed16a73c67d40cf157e8ee98a72f1ef5ff9673c4c663e6324e73f0678c7bcd507a8b7c6007eab49b0b3e826148a74d8c476393868fc1091f598cc17e47049a68e232618874b344809396134d30065951b9a665db9487f2e342039d0261471810264ecb60df291a078ac54c6f3918df89523883db1155684633994ee35c8ae6b13453e8ba846fe6879fcd07348c22403ee1bf2ad5a46cb86b1a13912cf93ca002c62cc64c13d88340266a6916d64a0d266a57a604d308d1e6bdf2aeb61a206def4cdbff6e5873b7588d73336f9ba6b96f257315336e9dbaead455a7ae3a75d5a9eb6f9bba9e9d028a39a5ce01750ea873409d03ea1cf0cde480af94b28b99a5e6ec9ab36bceae39bbe6ece716b04566add9b066c39a0d6b36fc66d9f0cb105891166b06ab19ac66b09ac1fe0806fbdab9a6c88d35d9d464f36d91cd5f9236beee305c3ae157c7611d875f4dec7c596f5c7a0f5abbe337e18ecf7b73f2874f72d1cdea59fefd67f94bd9b838777f0d2357c25eff5b84747f872251c758ebacfb2d41e355a7db6efb798bedb776217def7879b16dc26de787c219ca628bf2e544e3470beef4cf8f9c571de74c8a38702eb8971fed55b6fe921c5900819b9d0c7b1b6f4f25e8749b9848968498b59dcb31143f2e0276769b2fda65786b81952bf598266503154f9f96582e7ba5bb03b6e37a6f080a47685fedecdefa46d99c00e0b13be651af589ee6e49949b3204a2715054d99e2ceb87906f8c36378f903ba16adfba8620b75b2d3d0b9fa657359bf7f3da1e0a3f214f5cb347a7a83300dd2828d0724a4404c3ac2a71e9644308b36e8fb74fbbf94f9811dd6045ea58a6f4de0cff800eb1f4b8cf0e836ca37ea524befe86a9ffa937cea0ba958e5f3bb3f50cb41445d133797324a3899fbdd6caf36dd437427bda138188ab71868b6550f06644ce309563bc263e60ee1437145f14f2620ae9c3cbb3f702e8178bf24daee4a807903a36c332674628b688af0437142b17046512618bc3d3836e5b0391204648ca10dd327581163a0c7525033d0acf9b9396b14459ca63b1f336587e2501d7278d569f7e088ba8a129dc1eeb6bffbb2639e50b3cdea66da43c36a0fff9ccfe1e6b4f407164684a9d0eec9788b526d01096582561232c6276326a857d5890e567bc891f930f60aa516be769839f4954df6ec849888156138c16e896b1c70e2dec28144027389c2ea53fa54a001b0040e998b46141e2812eb9740ee24f32011829a73c644d97deb97e8069aaa3be426e313248a9434173387b26b6f4e953f3147c95c4eb4de369ff29a0da94c4e68185b738a0c6ae70d2b6bf3566fd3f4746520b9dd203765320af522e3be23a6133e668a848b4fb30abe4295daf770523575ae287197ad5446ea03742759289b07947d4ad02228baa6516c5c173541edcc4221f5c0711498ef8d40d004b30289038c9a0bd33477e7b5706914103ebd3e9998a505151a81ee1846ec544ec361e88f4237ff2303a1a580c14478b892c0b5e9b5bc47d8d711a60e15e290e7e8a5320b86b734b99511ca4630ba1626de609bf50f110cbbe8b2b548faa5724eef85d9a06373fa70281a1a170cdc0332d2317a1f8c5126787d7d710224068ec11243fc51a655711aa9dcdc331e80337f4e705689f5be1b19b2d852116ae2631bc3a41ed3b84243978b8d2b10a5028a8a205912cef1718ccdd00057440726a68947dc809a969f3e61346ae33f44dda2a779081434474a7e1490287c66ac81ae9bee2da109cda26c84d99bd391994368607d8ca22dd965cdedb3d43dd6d938cb5ae6b6cce6beb44ee298b5cd613cea49ab218b5d67c152d8607fc421d7d03adfd399f5cce13feed6ab47b07d9d595f67a16f6e8c25875e8387675d9cac4b0eb1c4a35763a69d1cece4cc3a15e44c7d7f1df1b296b9fe264256f7b5adf25e94c5d41a4e336d59903b8bc475049f36cd8a9dbf0def2e7f9e53136f4dbc35f1d6c4fba7106f4d3f19fd5459c8d57efdd5faf5654090925cc9a53fc979f709e1e3266763da03f3b2c178d94872a6c31ebc35dfdcbe84c39f2f7776db3de81efe1b57cc01435f910a1df6de358b58b3c1f2ce381734f6dbdf6dbe84b1593a43a3b3fbdda6817303ccf63a043986be9b36cff6405de691cffcdda774153bfb152767304b178cae5eccfe44f3aa0f864227da35b5148eb63dcd3da849a2138cb5092a703ac44487d286766f041fdd11c550b8092c76c55cca9009448c3dae866276090da9ec0e49eadb06db4565989ba10fbe471126822a1fdb6368dbd7642ee51c3e620bc8fdced63b6c3a93d0ec43bcbb3e0529509286c03ca827c80aa1ddd4c8be8c43fcf79da1108687622490f7dda120a9104859683325b76094a45b381831de826cd8fac513ade70d173433321d2b9944d00724321a0116996a929609800f679269f0126ab64a5eb7604c2802193a7abf5365c46c24ac6fed21a3a72b27e42a2ba199fd634353973235a8e976a17cebaa699581a8ada93a5b70b005875b70bc614bf3598962b9200dd119ec234897530169058c1ba63056d06c56d91280f79df5a420c2be734834f895605e9b50b02f7b11623a7315145ac261495801e66c30e857e97655a9db61bf59b1e7202651d09a1695987fabd8ecb005bf5024f96aa67adb82d0bca79fc4662946d711c006c839f58909105d043c6f818f80981d25ade4d408305b7154b3c89954e41ec992808b04879254f4c69396a1269e50f1a99226c862985859859e3f61e5a599514197c5e39a036fcf61e0f5e0e0edf755a096907eba3cac0464437b6453bc8eb6a01f468720a8ffa5a02259658a075429f4e37233af66cfac3784446171e362f72a32108e215879b20701f32b77be5432a6c8b52156da23561e262bcd3005b94bb88f5550151b208479c92b5c34a68e5a55a4c0a8c70beba215110e4d6991ba15aedc68824ba2b2e0fd2c1ccfd4ca98589f8b5351a53e060a3a17c112a19287f75dace0e3a7855839b79a265e2605a12ab1a506a9007490a8db4072cf9c93c06a38222eab02338829568ee65442265448788c57e8fe55e07e36c7deb080039a152f1c3bbb5590de288201a0ad0bc70927ca74af124d072a719f0884953501f5997c2a9256ceb8d989489445081334ae59d25571bf1342433b3389591ae0ba7252259bdeb09162d2d0936063e696066311e38c6977291e034ec289670522e501b5b23499b83242ae0ee72b932a95c515736f691c6bf60c31d298c6aa11c8dd7ab5635f109377976b3eb38017e6fce65af5e392b75a4124d23fd6fc8af88fa4a1c1ca1442ef300f599fa31c6f672f17ca1c6f15d6219766cbcd33d6f166e7a49f87d3b02722a6609b6568dfff6b1543247a61de84d946461653a5b3b7d25e348aa55d38c6d3155779b49f6e3c7c58de6da9374dfe1e9b269fb90937a0d4e9732d73beb1f0fbead03823acf454f95a3bc9e5486bffbabb93f579f8f0f0f0f07f2af44f80', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137376, 690, 250.0, 250.0, 'mg', 'PO', NULL, 'Adult', X'789c333235c84d5708f05728b4c850a85030d535574849ac2c06004997067e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137377, 690, 2.0, 2.0, 'g', 'PO', NULL, 'Adult', X'789c73cc29b1523052485708f05728543032c950a85030564849ac2c06005cd1072f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137378, 690, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f05728b4c850a8503034d03534514849ac2c060054f606d6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137379, 690, 500.0, 500.0, 'mg', 'IV', NULL, 'Adult', X'789c333530c84d57f00c5328b4c850d048cf2c4b5528cf2cc900004dc80729', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137380, 690, 250.0, 375.0, 'mg', 'PO', NULL, 'Adult', X'789c333235d0353637cd4d5708f0572834cb50a8503034d03534514849ac2c56d0c8cc5348cecf4dcacc4b2cc9cccfd304001f000d9d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137381, 690, 2.0, 2.0, 'g', 'PO', NULL, 'Adult', X'789c3352485708f057a8503054d028cf2cc95048ac029245f9b995c999799a00873109d0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137382, 690, 500.0, 500.0, 'mg', 'IV', NULL, 'Adult', X'789c33353050c84d57f00c53482d4b2daa543053c8c82f2d2a06004da2073b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137383, 690, 7.5, 7.5, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d73355c84dd7cf4e5708f0d7f70c532834b1c8000037ec0582', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137384, 690, 7.5, 7.5, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230d73355c84dd7cf4e5708f0d7f70c53a8503004009b6f0913', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137385, 690, 7.5, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d733d5353455c84dd7cf4ed74f49ac5408f0d7f70c53283434d23532c900007acc080c', X'789ced5c6d73db3612fe2b3bbee99d3cb56449f14b4fc97446b613dbd7f8652cc797ce29c3814888440d022c403a563afeefb700a91752b4a5d0699bb4fc128724f06077b1fbec0204f5db86a712df1124a41b3dd838a3b1928279e493e474630b3612c5cdfd208e23dddbdefec86e69d892ca37ff63db4bcdb5ab48443d87c4a657b7dddd6bb63bcd4efbbabddf7bd1e9edecb43a3b7b7bdd3ddb96ba31934263cbdf368ea9a08a70fbff98dedbeed79388f6e0220ea81a0a226236623266ae1e8a23a9894fe18d54a1ee0dc5e9cd505c5ef4a0bbdb0efd97f0627fd7fcd96de3d5501cca309402ae15f1289ca39eba076f38f127dc0a918c16e578c05b3119716aaefef701af3813b7f6622ed78228ab4dd45f68fcf0c1e0f7bd84c70eaac0849fd3b7449ea95d9c6eaee5e5c55058f5e0f2027edd6bfe10c03deca39dc12313b4cf1ba6740c3804da6fd6ee1e3aa9a93a689eed5b1f4e6fe0beb305685f01fbadf9cd5ff7823c44aec3509c917bbc07be22e1b6870d36f246b33a8674c45c87b33baa1c32d22ed53aa7014ad5dcdf9d6a60e5df9dca5f827728b9546817b4c420513e5513e7548c534339974a46c184937b961f63516ca33b7a42c4694c818971a2b12774028814930a62093ac52db7070274e78a3fa6f5a988a98e994029ad01882e48f4191a5f9e1e150d9675ed748d3a3bd9540f2845e73f3d1a8a31ea314e3807457d165251027a40dc982a86f2dd109f095994af30c87e36469fc73d38231348344d836cae43da064d8a96a4be09538848cca888b1e3c2cc40c3c87a9f100e7dad0986c0506c0e4517a6be5922eeb5626e20317a972d79ad2889514944390dc34448172717e756a0a473ccc5874a864c536f212050c96041cb670a7bcc88f29605ed16a73c67d40cf157e8ee98a72f1ef5ff9673c4c663e6324e73f0678c7bcd507a8b7c6007eab49b0b3e826148a74d8c476393868fc1091f598cc17e47049a68e232618874b344809396134d30065951b9a665db9487f2e342039d0261471810264ecb60df291a078ac54c6f3918df89523883db1155684633994ee35c8ae6b13453e8ba846fe6879fcd07348c22403ee1bf2ad5a46cb86b1a13912cf93ca002c62cc64c13d88340266a6916d64a0d266a57a604d308d1e6bdf2aeb61a206def4cdbff6e5873b7588d73336f9ba6b96f257315336e9dbaead455a7ae3a75d5a9eb6f9bba9e9d028a39a5ce01750ea873409d03ea1cf0cde480af94b28b99a5e6ec9ab36bceae39bbe6ece716b04566add9b066c39a0d6b36fc66d9f0cb105891166b06ab19ac66b09ac1fe0806fbdab9a6c88d35d9d464f36d91cd5f9236beee305c3ae157c7611d875f4dec7c596f5c7a0f5abbe337e18ecf7b73f2874f72d1cdea59fefd67f94bd9b838777f0d2357c25eff5b84747f872251c758ebacfb2d41e355a7db6efb798bedb776217def7879b16dc26de787c219ca628bf2e544e3470beef4cf8f9c571de74c8a38702eb8971fed55b6fe921c5900819b9d0c7b1b6f4f25e8749b9848968498b59dcb31143f2e0276769b2fda65786b81952bf598266503154f9f96582e7ba5bb03b6e37a6f080a47685fedecdefa46d99c00e0b13be651af589ee6e49949b3204a2715054d99e2ceb87906f8c36378f903ba16adfba8620b75b2d3d0b9fa657359bf7f3da1e0a3f214f5cb347a7a83300dd2828d0724a4404c3ac2a71e9644308b36e8fb74fbbf94f9811dd6045ea58a6f4de0cff800eb1f4b8cf0e836ca37ea524befe86a9ffa937cea0ba958e5f3bb3f50cb41445d133797324a3899fbdd6caf36dd437427bda138188ab71868b6550f06644ce309563bc263e60ee1437145f14f2620ae9c3cbb3f702e8178bf24daee4a807903a36c332674628b688af0437142b17046512618bc3d3836e5b0391204648ca10dd327581163a0c7525033d0acf9b9396b14459ca63b1f336587e2501d7278d569f7e088ba8a129dc1eeb6bffbb2639e50b3cdea66da43c36a0fff9ccfe1e6b4f407164684a9d0eec9788b526d01096582561232c6276326a857d5890e567bc891f930f60aa516be769839f4954df6ec849888156138c16e896b1c70e2dec28144027389c2ea53fa54a001b0040e998b46141e2812eb9740ee24f32011829a73c644d97deb97e8069aaa3be426e313248a9434173387b26b6f4e953f3147c95c4eb4de369ff29a0da94c4e68185b738a0c6ae70d2b6bf3566fd3f4746520b9dd203765320af522e3be23a6133e668a848b4fb30abe4295daf770523575ae287197ad5446ea03742759289b07947d4ad02228baa6516c5c173541edcc4221f5c0711498ef8d40d004b30289038c9a0bd33477e7b5706914103ebd3e9998a505151a81ee1846ec544ec361e88f4237ff2303a1a580c14478b892c0b5e9b5bc47d8d711a60e15e290e7e8a5320b86b734b99511ca4630ba1626de609bf50f110cbbe8b2b548faa5724eef85d9a06373fa70281a1a170cdc0332d2317a1f8c5126787d7d710224068ec11243fc51a655711aa9dcdc331e80337f4e705689f5be1b19b2d852116ae2631bc3a41ed3b84243978b8d2b10a5028a8a205912cef1718ccdd00057440726a68947dc809a969f3e61346ae33f44dda2a779081434474a7e1490287c66ac81ae9bee2da109cda26c84d99bd391994368607d8ca22dd965cdedb3d43dd6d938cb5ae6b6cce6beb44ee298b5cd613cea49ab218b5d67c152d8607fc421d7d03adfd399f5cce13feed6ab47b07d9d595f67a16f6e8c25875e8387675d9cac4b0eb1c4a35763a69d1cece4cc3a15e44c7d7f1df1b296b9fe264256f7b5adf25e94c5d41a4e336d59903b8bc475049f36cd8a9dbf0def2e7f9e53136f4dbc35f1d6c4fba7106f4d3f19fd5459c8d57efdd5faf5654090925cc9a53fc979f709e1e3266763da03f3b2c178d94872a6c31ebc35dfdcbe84c39f2f7776db3de81efe1b57cc01435f910a1df6de358b58b3c1f2ce381734f6dbdf6dbe84b1593a43a3b3fbdda6817303ccf63a043986be9b36cff6405de691cffcdda774153bfb152767304b178cae5eccfe44f3aa0f864227da35b5148eb63dcd3da849a2138cb5092a703ac44487d286766f041fdd11c550b8092c76c55cca9009448c3dae866276090da9ec0e49eadb06db4565989ba10fbe471126822a1fdb6368dbd7642ee51c3e620bc8fdced63b6c3a93d0ec43bcbb3e0529509286c03ca827c80aa1ddd4c8be8c43fcf79da1108687622490f7dda120a9104859683325b76094a45b381831de826cd8fac513ade70d173433321d2b9944d00724321a0116996a929609800f679269f0126ab64a5eb7604c2802193a7abf5365c46c24ac6fed21a3a72b27e42a2ba199fd634353973235a8e976a17cebaa699581a8ada93a5b70b005875b70bc614bf3598962b9200dd119ec234897530169058c1ba63056d06c56d91280f79df5a420c2be734834f895605e9b50b02f7b11623a7315145ac261495801e66c30e857e97655a9db61bf59b1e7202651d09a1695987fabd8ecb005bf5024f96aa67adb82d0bca79fc4662946d711c006c839f58909105d043c6f818f80981d25ade4d408305b7154b3c89954e41ec992808b04879254f4c69396a1269e50f1a99226c862985859859e3f61e5a599514197c5e39a036fcf61e0f5e0e0edf755a096907eba3cac0464437b6453bc8eb6a01f468720a8ffa5a02259658a075429f4e37233af66cfac3784446171e362f72a32108e215879b20701f32b77be5432a6c8b52156da23561e262bcd3005b94bb88f5550151b208479c92b5c34a68e5a55a4c0a8c70beba215110e4d6991ba15aedc68824ba2b2e0fd2c1ccfd4ca98589f8b5351a53e060a3a17c112a19287f75dace0e3a7855839b79a265e2605a12ab1a506a9007490a8db4072cf9c93c06a38222eab02338829568ee65442265448788c57e8fe55e07e36c7deb080039a152f1c3bbb5590de288201a0ad0bc70927ca74af124d072a719f0884953501f5997c2a9256ceb8d989489445081334ae59d25571bf1342433b3389591ae0ba7252259bdeb09162d2d0936063e696066311e38c6977291e034ec289670522e501b5b23499b83242ae0ee72b932a95c515736f691c6bf60c31d298c6aa11c8dd7ab5635f109377976b3eb38017e6fce65af5e392b75a4124d23fd6fc8af88fa4a1c1ca1442ef300f599fa31c6f672f17ca1c6f15d6219766cbcd33d6f166e7a49f87d3b02722a6609b6568dfff6b1543247a61de84d946461653a5b3b7d25e348aa55d38c6d3155779b49f6e3c7c58de6da9374dfe1e9b269fb90937a0d4e9732d73beb1f0fbead03823acf454f95a3bc9e5486bffbabb93f579f8f0f0f0f07f2af44f80', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137386, 690, 7.5, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230d733d5353455c84dd7cf4e5708f0d7f70c53a850300400b3b509a6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137387, 690, 15.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3334d5353650c84dd7cf4ed74f49ac5408f0d7f70c53283434ca00005e270742', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137388, 690, 7.5, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230d733d5353455c84dd7cf4e5708f0d7f70c53a850300400b3b509a6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137389, 690, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c333650c84dd7cf4ed74f49ac5408f0d7f70c532834cb000049560682', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137390, 690, 7.5, 7.5, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230d73355c84dd7cf4e5708f0d7f70c53a8503004009b6f0913', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137391, 690, 4.0, 4.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb052305148d74f49ac040016df03a9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137392, 690, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c333455c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca50a8503057008a170300d8140b9d', X'789ced5c6d73db3612fe2b3bbee99d3cb56449f14b4fc97446b613dbd7f8652cc797ce29c3814888440d022c403a563afeefb700a91752b4a5d0699bb4fc128724f06077b1fbec0204f5db86a712df1124a41b3dd838a3b1928279e493e474630b3612c5cdfd208e23dddbdefec86e69d892ca37ff63db4bcdb5ab48443d87c4a657b7dddd6bb63bcd4efbbabddf7bd1e9edecb43a3b7b7bdd3ddb96ba31934263cbdf368ea9a08a70fbff98dedbeed79388f6e0220ea81a0a226236623266ae1e8a23a9894fe18d54a1ee0dc5e9cd505c5ef4a0bbdb0efd97f0627fd7fcd96de3d5501cca309402ae15f1289ca39eba076f38f127dc0a918c16e578c05b3119716aaefef701af3813b7f6622ed78228ab4dd45f68fcf0c1e0f7bd84c70eaac0849fd3b7449ea95d9c6eaee5e5c55058f5e0f2027edd6bfe10c03deca39dc12313b4cf1ba6740c3804da6fd6ee1e3aa9a93a689eed5b1f4e6fe0beb305685f01fbadf9cd5ff7823c44aec3509c917bbc07be22e1b6870d36f246b33a8674c45c87b33baa1c32d22ed53aa7014ad5dcdf9d6a60e5df9dca5f827728b9546817b4c420513e5513e7548c534339974a46c184937b961f63516ca33b7a42c4694c818971a2b12774028814930a62093ac52db7070274e78a3fa6f5a988a98e994029ad01882e48f4191a5f9e1e150d9675ed748d3a3bd9540f2845e73f3d1a8a31ea314e3807457d165251027a40dc982a86f2dd109f095994af30c87e36469fc73d38231348344d836cae43da064d8a96a4be09538848cca888b1e3c2cc40c3c87a9f100e7dad0986c0506c0e4517a6be5922eeb5626e20317a972d79ad2889514944390dc34448172717e756a0a473ccc5874a864c536f212050c96041cb670a7bcc88f29605ed16a73c67d40cf157e8ee98a72f1ef5ff9673c4c663e6324e73f0678c7bcd507a8b7c6007eab49b0b3e826148a74d8c476393868fc1091f598cc17e47049a68e232618874b344809396134d30065951b9a665db9487f2e342039d0261471810264ecb60df291a078ac54c6f3918df89523883db1155684633994ee35c8ae6b13453e8ba846fe6879fcd07348c22403ee1bf2ad5a46cb86b1a13912cf93ca002c62cc64c13d88340266a6916d64a0d266a57a604d308d1e6bdf2aeb61a206def4cdbff6e5873b7588d73336f9ba6b96f257315336e9dbaead455a7ae3a75d5a9eb6f9bba9e9d028a39a5ce01750ea873409d03ea1cf0cde480af94b28b99a5e6ec9ab36bceae39bbe6ece716b04566add9b066c39a0d6b36fc66d9f0cb105891166b06ab19ac66b09ac1fe0806fbdab9a6c88d35d9d464f36d91cd5f9236beee305c3ae157c7611d875f4dec7c596f5c7a0f5abbe337e18ecf7b73f2874f72d1cdea59fefd67f94bd9b838777f0d2357c25eff5b84747f872251c758ebacfb2d41e355a7db6efb798bedb776217def7879b16dc26de787c219ca628bf2e544e3470beef4cf8f9c571de74c8a38702eb8971fed55b6fe921c5900819b9d0c7b1b6f4f25e8749b9848968498b59dcb31143f2e0276769b2fda65786b81952bf598266503154f9f96582e7ba5bb03b6e37a6f080a47685fedecdefa46d99c00e0b13be651af589ee6e49949b3204a2715054d99e2ceb87906f8c36378f903ba16adfba8620b75b2d3d0b9fa657359bf7f3da1e0a3f214f5cb347a7a83300dd2828d0724a4404c3ac2a71e9644308b36e8fb74fbbf94f9811dd6045ea58a6f4de0cff800eb1f4b8cf0e836ca37ea524befe86a9ffa937cea0ba958e5f3bb3f50cb41445d133797324a3899fbdd6caf36dd437427bda138188ab71868b6550f06644ce309563bc263e60ee1437145f14f2620ae9c3cbb3f702e8178bf24daee4a807903a36c332674628b688af0437142b17046512618bc3d3836e5b0391204648ca10dd327581163a0c7525033d0acf9b9396b14459ca63b1f336587e2501d7278d569f7e088ba8a129dc1eeb6bffbb2639e50b3cdea66da43c36a0fff9ccfe1e6b4f407164684a9d0eec9788b526d01096582561232c6276326a857d5890e567bc891f930f60aa516be769839f4954df6ec849888156138c16e896b1c70e2dec28144027389c2ea53fa54a001b0040e998b46141e2812eb9740ee24f32011829a73c644d97deb97e8069aaa3be426e313248a9434173387b26b6f4e953f3147c95c4eb4de369ff29a0da94c4e68185b738a0c6ae70d2b6bf3566fd3f4746520b9dd203765320af522e3be23a6133e668a848b4fb30abe4295daf770523575ae287197ad5446ea03742759289b07947d4ad02228baa6516c5c173541edcc4221f5c0711498ef8d40d004b30289038c9a0bd33477e7b5706914103ebd3e9998a505151a81ee1846ec544ec361e88f4237ff2303a1a580c14478b892c0b5e9b5bc47d8d711a60e15e290e7e8a5320b86b734b99511ca4630ba1626de609bf50f110cbbe8b2b548faa5724eef85d9a06373fa70281a1a170cdc0332d2317a1f8c5126787d7d710224068ec11243fc51a655711aa9dcdc331e80337f4e705689f5be1b19b2d852116ae2631bc3a41ed3b84243978b8d2b10a5028a8a205912cef1718ccdd00057440726a68947dc809a969f3e61346ae33f44dda2a779081434474a7e1490287c66ac81ae9bee2da109cda26c84d99bd391994368607d8ca22dd965cdedb3d43dd6d938cb5ae6b6cce6beb44ee298b5cd613cea49ab218b5d67c152d8607fc421d7d03adfd399f5cce13feed6ab47b07d9d595f67a16f6e8c25875e8387675d9cac4b0eb1c4a35763a69d1cece4cc3a15e44c7d7f1df1b296b9fe264256f7b5adf25e94c5d41a4e336d59903b8bc475049f36cd8a9dbf0def2e7f9e53136f4dbc35f1d6c4fba7106f4d3f19fd5459c8d57efdd5faf5654090925cc9a53fc979f709e1e3266763da03f3b2c178d94872a6c31ebc35dfdcbe84c39f2f7776db3de81efe1b57cc01435f910a1df6de358b58b3c1f2ce381734f6dbdf6dbe84b1593a43a3b3fbdda6817303ccf63a043986be9b36cff6405de691cffcdda774153bfb152767304b178cae5eccfe44f3aa0f864227da35b5148eb63dcd3da849a2138cb5092a703ac44487d286766f041fdd11c550b8092c76c55cca9009448c3dae866276090da9ec0e49eadb06db4565989ba10fbe471126822a1fdb6368dbd7642ee51c3e620bc8fdced63b6c3a93d0ec43bcbb3e0529509286c03ca827c80aa1ddd4c8be8c43fcf79da1108687622490f7dda120a9104859683325b76094a45b381831de826cd8fac513ade70d173433321d2b9944d00724321a0116996a929609800f679269f0126ab64a5eb7604c2802193a7abf5365c46c24ac6fed21a3a72b27e42a2ba199fd634353973235a8e976a17cebaa699581a8ada93a5b70b005875b70bc614bf3598962b9200dd119ec234897530169058c1ba63056d06c56d91280f79df5a420c2be734834f895605e9b50b02f7b11623a7315145ac261495801e66c30e857e97655a9db61bf59b1e7202651d09a1695987fabd8ecb005bf5024f96aa67adb82d0bca79fc4662946d711c006c839f58909105d043c6f818f80981d25ade4d408305b7154b3c89954e41ec992808b04879254f4c69396a1269e50f1a99226c862985859859e3f61e5a599514197c5e39a036fcf61e0f5e0e0edf755a096907eba3cac0464437b6453bc8eb6a01f468720a8ffa5a02259658a075429f4e37233af66cfac3784446171e362f72a32108e215879b20701f32b77be5432a6c8b52156da23561e262bcd3005b94bb88f5550151b208479c92b5c34a68e5a55a4c0a8c70beba215110e4d6991ba15aedc68824ba2b2e0fd2c1ccfd4ca98589f8b5351a53e060a3a17c112a19287f75dace0e3a7855839b79a265e2605a12ab1a506a9007490a8db4072cf9c93c06a38222eab02338829568ee65442265448788c57e8fe55e07e36c7deb080039a152f1c3bbb5590de288201a0ad0bc70927ca74af124d072a719f0884953501f5997c2a9256ceb8d989489445081334ae59d25571bf1342433b3389591ae0ba7252259bdeb09162d2d0936063e696066311e38c6977291e034ec289670522e501b5b23499b83242ae0ee72b932a95c515736f691c6bf60c31d298c6aa11c8dd7ab5635f109377976b3eb38017e6fce65af5e392b75a4124d23fd6fc8af88fa4a1c1ca1442ef300f599fa31c6f672f17ca1c6f15d6219766cbcd33d6f166e7a49f87d3b02722a6609b6568dfff6b1543247a61de84d946461653a5b3b7d25e348aa55d38c6d3155779b49f6e3c7c58de6da9374dfe1e9b269fb90937a0d4e9732d73beb1f0fbead03823acf454f95a3bc9e5486bffbabb93f579f8f0f0f0f07f2af44f80', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137393, 690, 7.0, 7.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523057c84dd7cf4e5708f057a850300400728c07e2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137394, 690, 1.0, 1.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb052305448d74f49ac040016ca03a6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137395, 690, 500.0, 500.0, 'mg', 'PO', NULL, 'Pediatric', X'789c333530c84d5708f05748c92ccb4c494d5128b4c850a85030574849ac2c060082d20913', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137396, 690, 500.0, 500.0, 'mg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb552303530c84d5708f057a85030040060ed071f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137397, 690, 2.0, 2.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb052305248d74f49ac040016d103a7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137398, 690, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c333455c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4c850a8503057000a170300cdf80b72', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137399, 690, 7.0, 7.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523057c84dd7cf4e5708f057a850300400728c07e2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137400, 690, 2.0, 2.0, 'g', 'PO', NULL, 'Pediatric', X'789c3352485708f057a8503004000cfa0262', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137401, 1004, 25.0, 25.0, 'mg', 'PO', 4, 'Adult', X'789c3332cd4d5708f05708f474010011e402f9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137402, 1004, 25.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c3332d5353430c84d5708f0573054c8c82f2d52484a4dcb2f4a55484c2ec92ccb2ca9d453f04dac54284a2d484d2c51283432c900009322107d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137403, 14155, 0.2, 0.2, 'mg', 'IV', NULL, 'Adult', X'789c6d8c310e83400c04bfb20f40e802a24a953245da88d6d2f990a57006ece4fdf8449b6ab5d2cca47ec0bae0f9be430aa452e6fd4bce38d836adc6a0e27c604cd661915ffc9cc5452b7d90faf1afdc85bd3139b21a1bb404395d24f61b56a970c5eb31c778741ad6a8563b0194ae2f45', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137404, 14155, 3.0, 3.0, 'mg', NULL, NULL, 'Adult', X'789cf34c53c8cfcba95428482c2ac94ccc51284a2d2ec8cf2b4e5528c95730ce4dd751c84dac5428cec92f07aa29c92c294a2c014b99e6a603006e3e14fe', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137405, 14155, 0.01, 0.01, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c5dcdb10e82500c85e15739232406c1c0a289bb03ab7be32dd0085cb8b788bebd4536c7fec9777a2df0610af0bd3b23cff202437b7cb6489609eaad9c2ca4b8dd2f90063292e379216550a31c5056f180c01393fef43fdeec6c9b32626f2554068e196a7adbadd4c3f9c81bae76ec036c06c9dac9a3e3973d9188deaf1cd22fc9fa3601', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137406, 7430, 10.0, 40.0, 'mg', 'PO', NULL, 'Adult', X'789cf3a82c482d2a49cd2bcecccfb352303450d0553031c84d5708f057084c49acd451c84dac50b0008ae80379004ff90e32', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137407, 7430, 0.07, 0.07, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d3353453a84c4d2c52c8cf49b15230d03330cf4dd7cf4e5708f057284c49acd451c84dac503031000a027900370f0dd4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137408, 3029, 250.0, 250.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303235c84dd70151faa60ab93e008a720860', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137409, 3029, 30.0, 60.0, 'mg/kg', 'PO', 2, 'Adult', X'789c73cecf2dc849ad5028482c2ac94ccc51284ecdac2a2d4a2db6523036d03533c84dd7cf4ed74f49ac5408f057d048c92ccb4c494d5148ca4cd12dc94cd104009be414d8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137410, 3029, 10.0, 15.0, 'mg/kg', 'PO', 1, 'Adult', X'789c0b2e492c2ab1523034d03534cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d510874d12dc94c0100f41f0c7a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137411, 3029, 5.0, 10.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf3cc4b2e4a4d2c4e5548aa5430d53534c84dd7cf4ed74f49ac542834570052c500ba090ae4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137412, 3029, 60.0, 60.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf34dacb0523033c84dd7cf4ed74f49ac040029c10529', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137413, 3029, 250.0, 250.0, 'mg', NULL, NULL, 'Adult', X'789c73c92ccb4c495548c92f4e2d56b0333235c84dd74f49ac04005f8b07ca', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137414, 3029, 20.0, 20.0, 'mg', 'IV', NULL, 'Adult', X'789c734cc9cdcccb2c2e492d52f00c5348c92f4e55482c5648543033d0054a9496a42a64e6a5951667e6e729683cea5c6264909bae0f91d0040072ec1557', X'789ced586d6fdb4612fe2b037f720029921ddb2de44301254e9b1c6ac7673bc11d4e05b12247d29e97bbecee523153f8bfdf33a46489b252bfdcf580e2f2c526a999d97979e699ddfd6d27f3e534b12ae79d01ed7c52a6f04ea7894a75b6d3a19dd21bf93e8bb108835eefb3bee6fca5f35379d2bd7be221f5aae02c5151b4f6fbfb47ddfe5e77af7fd5ff7ed03f181c7cfff2f0d5617fffbb5a96d3a89d0d90fc6d6798e5daea10bd926ff5a7c837b595abaae0c1c80e6dd4a9b3f3d20465e3c89eb8a0a64c3f3a9f8701ed1ff6f36947fef50e29ff79642f5c1939909b50dbf4803e78653af4fed3c8be7179ee2c5d7995319d21053044275c28ac735c3f5cb3e5c5938b6b4ff4f662ede5b2f0da5e1b0ec77419d5fc8bf3757ce5783dc45b7c8a6a0c29bcfdf317bc1928d52fab58db413e5c800df9db5f649561569a98203fda4e5b9944bc85e11b2a948f5a190aacbf945ea27ed5ef1e2181bdeb692f53159d7fa0dd4ccf75c6198d75d68d3a7b31b288cdc701edf5bb7b872dd9a5e8df4e447264dfdbd4b30a4ce38a0e51fd95f0afdf11fe85913d5537035a5b12f5e4855290652873785436a3a8a572f86cdc675391b6c426638fc70205651b616d98fdab0c0b9d316c6484b246988b3904082116a842632fb02f73323c6703cd93daf55a33d00f358a16ee38b22e525ac65eeacb30eba533fe4c9f759c119055b0a55415307005bcfb66e52970542a03cfa2434e020a13b52d19422e22dd99d2f8edfda7463acc5c6932e25fa102051170fe4e4a4424ae06ba5861a9a6022924ae8b1f0070a4635206408c7647e5fefed1c1be04d0fc868a0d81409bf25da13b14b440a04e44daa001907f52f57faff41df8f3b5d223e1bea2afd7ffb52e9c515e12e73c0adc21954a84b9b25ad50dde3dec434156ad51b670a8aed9e26307d2d5ca873a6120249d353501821830e1c944fa72ce8b2cff77b178aa81036d9966ac3205d41028b2985546dde8b011c7785b1ccb8fb10cc485365ca0c7f1bceb2693ae51633654067e31104818a7327479ed214cf425ca832692167a149a401c071dbe1299a32658fc2ee15734956c284b2acbb43096e0508286fc7e630e6d4f0dae00c089d88c086db9fe12864fe3bd9aadce39d32a7a0c912d8c75bec1549d156aef837603b38f26acce2318eb98365172fc9fd0ce99939f110b04c591127f5125ccb3bdfe63dbf60909f803e8faf72278060a2e0b4e51e8e4dc15a551ab7dc11d103c4fadb26945173a5cd38f2a8dce83bafe4ebbf9b2e1d6faec45ef847641c5e480520f78663a6dacbed8e2dcce0503f1dbf077e6d01252e4baa096530e4181c622c87b3aabd92655e8c64561a5b5c6a02c1d0cd78db1d30e5b227dc7c2155bd17eaa3110602277c8a5b42baaaeb497b507b499f089f3c2034242b3c6a450a7d4f198522cef95404807ca16649635d3cba0d5fd9a65a044a8b9bdd8c750abca0493dcd6d9e3ece566380f55f50fcdeb6611ff9f12fb678ff589ecf066ddc43d6e788703820763068caeb98ef5a89f2f4e26242793917dd70e6ef561e5af90ecd4ea099690783e225c4a2b24e16e47520ff7e8d299b39997a9b4daaa9c7ff8f9a7ae6723018eec8aac56e4b46d3750cff167a46398cd25e0e482557a3f1ddb7ae392bd76e546da24052eba1b9d2269f05ad573007b1c8d482fdf0f4fde214f154618c633e75a35225574d8fdcadbd5ccbb7cecd6be9ce02c097c355e354861412822d646ab661056d891e4487da8f222ba3cd48b00aa72166b96914585b7eb97d38a8d0b65516010ca1603e3b1302a48f1d442feb561165618d9b7be8262ae28c7114803dd396addbbfceb65efeaedd916326e4e801b69690a8511270ca47a73972325627d1860bc0ef4d2e5d61919d25bd35085828b503fea2f5f50fe109ed0e1ebdb9f55491e3e0cb6a461bfd52177557cd84e4bba656733d4876dddd368d97b165e1e5e54cc264bb389984dd6cd26309b2ccd2677665b9e6d60ec1127f18542b2506859db02cb872d2e959235a5e680ffad9b17ddbc4973dfdaf95b3bfff9daf97f8bdaa71ecf67cae72a75c64dabb68bca4cba464f18e7cb239ad5bb2386256774c807f4e61fe7078738cbbebd01889b8bd78f1e4e3cc385534e67cac26ae226c930bd7741bc3cbf06fa69f87ab8b8de09cbbba0991eeb4853534695637bd63b3b3d19ca1e980113dfcdebdb076c6b2d97bebef7e01b1068730bfd8c632c73a24c702dff9a5b72ac32b29fd6b7a5b464ebe7de16df197eec4dbd88b690fc757f9e70f19fdce9dd2e4e7d131c0500cbf684facb4764fc042e74880b97cad924fcf0d41cdfdefe1b3f59ade9', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137415, 3029, 30.0, 60.0, 'mg/kg', 'PO', 2, 'Adult', X'789c734c2a4ecd4b4e55284ecdac2a2d4a2dd65128cecc2dc8495548cc4b5148ce07312bac148c0d74cd0c72d3f5b3d3f553122b1502fc15345232cb3253525314923253744b32533401b65d18e5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137416, 3029, 15.0, 15.0, 'mg/kg', 'PO', 1, 'Adult', X'789c0b2e492c2ab1523034cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d510874d12dc94cd151c8cc4b2e4a4d2c4e5548aa5430d5353440284e2d4b2daa54305700b28b01c0881915', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137417, 3029, 60.0, 60.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf34dacb0523033c84dd7cf4ed74f49ac040029c10529', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137418, 3029, 250.0, 500.0, 'mg', 'PO', 3, 'Adult', X'789c73ca2cc8cf492c5248c92cce2f4a492dd251484c2e2d4955c84dcccb4cb452303235d0353530c84d5708f05728c94c01008b1b0f71', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137419, 3029, 250.0, 250.0, 'mg', 'PO', 3, 'Adult', X'789c0b2e492c2ab152303235c84d5708f05728c94cd151c84dac54c8cc4b2e4a4d2c4e5548c90712458905992939950a25f90a39f9e5a9c5250aa96969a9c925996510050061d7192e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137420, 3029, 60.0, 60.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf34dacb0523033c84dd7cf4ed74f49ac040029c10529', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137421, 3029, 250.0, 500.0, 'mg', 'PO', 2, 'Adult', X'789cf3cd4c2f4acccc4b55c8484d4c494cce48552828ca2fc8a8cc49acc82cb652303235d0353530c84d5708f05748ca4c0100970a0fe8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137422, 3029, 250.0, 250.0, 'mg', 'PO', 2, 'Adult', X'789c0b2e492c2ab152303235c84d5708f05748ca4c01003c4005e2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137423, 3029, 20.0, 40.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c0b2e492c292d56482dc8cc492d28c94c06b235f2d3d2747312935273144a8b5335ad143cc31472f2135332f3d21552f28b53ad148c0c144af2154c0c72d3f5b3d301184a166c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137424, 3029, 3.0, 6.0, 'mg/kg', NULL, NULL, 'Adult', X'789c734cc9cdcccb2c2e492d52482c51284a2c4955c84f53305628c95730cb4dd7cf4ed707ca0300f91c0cbb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137425, 3029, 20.0, 20.0, 'mg/kg', NULL, NULL, 'Adult', X'789c0dcbd10d80300805c055de0656f770081228125b485a6ae2f67aff77d20bb547400e62b6b4706ae09882a8384ad7ed56ec05dd7ca54c504d19c84bd082d85c615ed7fcdf07f75f1af4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137426, 3029, 30.0, 60.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c0b482c2ac94ccc51284ecdac2a2d4a2dd65148cecf2dc849adb0523036d03533c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5148ca4cd12dc94c0100843314b3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137427, 3029, 10.0, 15.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c0b2e492c2ab1523034d03534cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d510874d12dc94cd1010000d40ca6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137428, 3029, 5.0, 10.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf3cc4b2e4a4d2c4e5548aa5430d53534c84dd7cf4ed74f49ac542834570052c5d60abe8915560a6608196b00beb910a2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137429, 3029, 30.0, 60.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c734c2a4ecd4b4e55284ecdac2a2d4a2dd65128cecc2dc8495548cc4b5148ce07312bac148c0d74cd0c72d3f5b3d3f553122b1502fc155232cb3253525314923253744b32530087fa1894', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137430, 3029, 15.0, 15.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c0b2e492c2ab1523034cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d510874d12dc94c0100dbae0bec', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137431, 3029, 5.0, 10.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf3cc4b2e4a4d2c4e5548aa5430d53534c84dd7cf4ed74f49ac542834570052c500ba090ae4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137432, 3029, 60.0, 60.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dacb0523033c84dd7cf4ed74f49ac040029c10529', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137433, 3765, 40.0, 40.0, 'mg', NULL, NULL, 'Adult', X'789c333150c84d0700036a0159', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137434, 3765, 20.0, 20.0, 'mg', NULL, NULL, 'Adult', X'789cb355303250c84d070005cd01b4', X'789ce5576d4fdb4810fe2bab48f78d10135eda46ba93289403a977c701423ad5281aaf27f136eb5ddfbe044cc57fbf193b38182a05faad3aa1a07d79667667e699d9f1b741eee27c6aa0c4c1440c4ea2b31e4b95e3604b0ca2d3bc588450f9c96874ab16586e5b37e7911af5b15e3aa8309f42609171323e18263bc39de42a7937d9df9deced6dbf1f7f483e240d166550d678427e1bfc8e061de8661cf0ae11bfaa2b9ca4e658458741491a590f731427d6957e324eb6c41efdde27a939b265698db87290a3f893acf013f119bcba4bcd6155397ba74a08a86bb19ffc22326561094a43a6b40af596f056486b96e88232733173b61496ee22821567d72227f3e85fcc34fa769d5752f365e726356beb0564deba8a2d1225d42243e1308f1273a18cc851dab242e3e91a39ddf7f484148c6f1a37c4eca9271e6829001f46b32f3734d3ca2c9ac9da338f2ed91c9e0e497ad7f274fe6651063ddcf07d0ef3a8c394bc4ffee945682f11e53c35b3ce0ba9f9558cdbc560dd7a6da759ca628901cc6a6dbfc5612840bada2829402a72ce898e2a1796e2a12dd07c2288084a82a6f835077254ac13c2100f281ce77f7144981867d7a92988342e90a7c9a12cbb930c5b2182fd7d7cf8cff0e3d9f11645e84e1c24bc3ecaa14ecd294bd111926e0c8dd8f871b3d1af9674e9bc512086e2eaec983967882fd1464f019e45ff187865a44360ceb0ebbdf20267330ab000938b521955aa7b1495f56198af82430ca4614984a18b370c626c3ae8f633070bf27d3a20d6ec12ed2e03b820926d76eb68311f156e6b7d6e6129ae35b397adb433c2bddbef80a4618f345c819b6310bf71643e3feefc618da2b08919fd6ca0bf3b2529437e94a51d033673edaa83f678ba26cc66151fd7d89e8e67fcdaace85327306d047adafae47c457964fcb4c3f7743da5ea664da74fd13d3d3df2be5251076f33fc1c7305c191c9dfc9f26babc9b79dd1c4a7fde1b8e553531ccfaedfc690e6c4cb0aa5023d3db755d4b07e081e0f3d77383760642d2e80eb3225e5516a3e830c0d78223ccc30d4229a85b1b794ea1768a818b4d7a7b2cf256b42254240fe35fa5052626d71990f0e94c9a99c84b63283898e53bef3c05b844eb102cecf17a706aaf83365b8d6f71477eb3f9a53cfddf28a17805ff616eca7ca4c3b0dabd01f3d35ef45180eb546376faa89d4e0fd881b85d43c3a003519e0acae030a5566a04931ddffed7438cc895d1ea71708f2e52dbea37070894e51f1ede128a3ec02745bc4b91c645673de6b5aa410f9e679b04bbb423ca971b48325dbc170d36e2fc1cb482d02cbf9804b34c3afb6309eeab3af4d4e7d02bd6315347537b4306422d8aaa0cea2c9c42726b7bee63ea57765f2a3015753db81ff46a4b0a41489fb7be288277d06a247182d6da9da24b84558b45b65f452a3a086abac9aad9ef13c29614ed0769ee9e8a81f114bd53e8cc449e70a84d58339d7b5ec04d1d1a556533a95de84e89f1bb331bd7f86e83ca7d4ff273c3fb7a56fac2de70550a328adb6f3ba67f229e8d950ab194ec46e323c48b83da32e68c54c5f4e84565496daae8dfbcfd47cba93dc92f103c40e4386cb82da0e5f72ab7528db3d650a95a9e085b6b6e28d020df988dbbad5e7886e26b9f28186fcf9418f2cbf2e21669190ab8e9031b2d0d6f117067593ab2f8cb73ae1e1e13f93f1f019', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137435, 3765, 1.0, 1.0, 'mg', NULL, NULL, 'Adult', X'789cb3553054c84d070004790183', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137436, 3765, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789cb355303550c84d070005dc01b7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137437, 3765, 40.0, 40.0, 'mg', 'IV', NULL, 'Adult', X'789cb35208a92cc84c4eccc9a954303150c84d57f00c53c82f52c8cb2fca4dcc5108f05748c92f4e4c4f050a030033280e08', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137438, 3765, 10.0, 40.0, 'mg', 'PO', 2, 'Adult', X'789cb3523034d0353150c84d5708f0570874718cd475f274d151c84dac5030330089eba724560200b1f509f4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137439, 3765, 120.0, 120.0, 'mg', 'PO', 3, 'Adult', X'789cb35230343250c84dd74f49ac5408f05748c92ccb4c494d510874718c54d05508f1740100a6b309a4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137440, 3765, 0.1, 0.1, 'mg/kg', NULL, NULL, 'Adult', X'789c0b2e492c2a5130d03354c84dd7cf4ed7cf28d251c8cc4b2e4a4d2c4e55c8c82f2dcaa95428c957c84dac50c84f03aa3337852b04004840135b', X'789ce5576d4fdb4810fe2bab48f78d10135eda46ba93289403a977c701423ad5281aaf27f136eb5ddfbe044cc57fbf193b38182a05faad3aa1a07d79667667e699d9f1b741eee27c6aa0c4c1440c4ea2b31e4b95e3604b0ca2d3bc588450f9c96874ab16586e5b37e7911af5b15e3aa8309f42609171323e18263bc39de42a7937d9df9deced6dbf1f7f483e240d166550d678427e1bfc8e061de8661cf0ae11bfaa2b9ca4e658458741491a590f731427d6957e324eb6c41efdde27a939b265698db87290a3f893acf013f119bcba4bcd6155397ba74a08a86bb19ffc22326561094a43a6b40af596f056486b96e88232733173b61496ee22821567d72227f3e85fcc34fa769d5752f365e726356beb0564deba8a2d1225d42243e1308f1273a18cc851dab242e3e91a39ddf7f484148c6f1a37c4eca9271e6829001f46b32f3734d3ca2c9ac9da338f2ed91c9e0e497ad7f274fe6651063ddcf07d0ef3a8c394bc4ffee945682f11e53c35b3ce0ba9f9558cdbc560dd7a6da759ca628901cc6a6dbfc5612840bada2829402a72ce898e2a1796e2a12dd07c2288084a82a6f835077254ac13c2100f281ce77f7144981867d7a92988342e90a7c9a12cbb930c5b2182fd7d7cf8cff0e3d9f11645e84e1c24bc3ecaa14ecd294bd111926e0c8dd8f871b3d1af9674e9bc512086e2eaec983967882fd1464f019e45ff187865a44360ceb0ebbdf20267330ab000938b521955aa7b1495f56198af82430ca4614984a18b370c626c3ae8f633070bf27d3a20d6ec12ed2e03b820926d76eb68311f156e6b7d6e6129ae35b397adb433c2bddbef80a4618f345c819b6310bf71643e3feefc618da2b08919fd6ca0bf3b2529437e94a51d033673edaa83f678ba26cc66151fd7d89e8e67fcdaace85327306d047adafae47c457964fcb4c3f7743da5ea664da74fd13d3d3df2be5251076f33fc1c7305c191c9dfc9f26babc9b79dd1c4a7fde1b8e553531ccfaedfc690e6c4cb0aa5023d3db755d4b07e081e0f3d77383760642d2e80eb3225e5516a3e830c0d78223ccc30d4229a85b1b794ea1768a818b4d7a7b2cf256b42254240fe35fa5052626d71990f0e94c9a99c84b63283898e53bef3c05b844eb102cecf17a706aaf83365b8d6f71477eb3f9a53cfddf28a17805ff616eca7ca4c3b0dabd01f3d35ef45180eb546376faa89d4e0fd881b85d43c3a003519e0acae030a5566a04931ddffed7438cc895d1ea71708f2e52dbea37070894e51f1ede128a3ec02745bc4b91c645673de6b5aa410f9e679b04bbb423ca971b48325dbc170d36e2fc1cb482d02cbf9804b34c3afb6309eeab3af4d4e7d02bd6315347537b4306422d8aaa0cea2c9c42726b7bee63ea57765f2a3015753db81ff46a4b0a41489fb7be288277d06a247182d6da9da24b84558b45b65f452a3a086abac9aad9ef13c29614ed0769ee9e8a81f114bd53e8cc449e70a84d58339d7b5ec04d1d1a556533a95de84e89f1bb331bd7f86e83ca7d4ff273c3fb7a56fac2de70550a328adb6f3ba67f229e8d950ab194ec46e323c48b83da32e68c54c5f4e84565496daae8dfbcfd47cba93dc92f103c40e4386cb82da0e5f72ab7528db3d650a95a9e085b6b6e28d020df988dbbad5e7886e26b9f28186fcf9418f2cbf2e21669190ab8e9031b2d0d6f117067593ab2f8cb73ae1e1e13f93f1f019', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137441, 3765, 0.5, 2.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c0bcbcf29cd4d55c82f4b2dcac94f4c5130d033d535ca4dd7cf4ed74fc92f4e55f00c0300d2150b75', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137442, 16931, 250.0, 250.0, 'mg', 'PO', 4, 'Adult', X'789cb352303235c84d5708f05708f47451a85030d4352acf2e060043d20620', X'789ced586d6fdb3610fe2b0703c55a40ae5f5227abb12f5ed2a11d9ad66b8cedc35c08b47496b848a446524e8ca2ffbd7794fc22c781dd2c1b56a0df44ea9ed3bddfe93eb5625326a11239b686d01aa39291cc32914b85ad005aa5c9f83e75aeb0c34ee7465e63fe5c9b849f64e70eb98d8c28300e856354bfdb3f6d777bed5e77d23d1b0e5e0efb2f9f77cffadd93aea7c5c849ad2c517e6a8d626221ad3382effc95c35bcf65b22c70385523e564ac1d4e5500829edb26c53227f268aa2eb41509c22fdae496483fe8d2a1053d8726db21bc37229baa739de75ac1c48818e11da96e87705e1646b21a015c6081ca4b58ceb685fc4c574ecc32e4d39f1fe9944975ed0f1b6957621e36de9af2f347e63c8acbcc85a489544943ff4b34516996e0f42d19db2da7a4477fd0cd1318bf87dfde5cc02df4dafd9b6b4b3632963dd220ed75bb90279deba4138b254362b99031c6f0f7696a083b00ba27ec5b147113d8ee3d1f4042af65e681daacb13fbfb9684fea4f9f0219d3a5c4e27c699d54a59182d12f565f0c20d12203ba5782f488880ac9d080b79141b6ae97d169e857a2324a2a28c867a89c851be952501aacd3844ac99dda2c03f889502beaf9ea9a9deee96ca71052512c5451a2650cc2b8d44827add7ae3f68f7066b0ee3f753f587ccac563f58d2d2a2b0c8646783ee16590033ba8f81445e6ba38b02cd469787c6cdae970fc74f8d08d708face561cee84c211f15821eee1d7088fc3cc98fc1e4efb3c7298e106156e500dbebbee3bccb3423ce99fd97085a972718cb114ce9031f6e4e34ea23c3d31319043f119a565b7fde2be6cfb3135fb43ac7f1fa2d767c876529ddc434ae9d8a14a10402e2823fdeb87c6e1e3f9f911fd7155602445168e75516662d335569f1a1b4c9450d1123ed05b95b0592fa8a489c8796a30d25ef3e51b35a7dee18f1009a5b483198229334eead251b94045a52af65e1f82587094522dca758cd44390ab94c5051a02794a9953993139d5a9a97a8d5cb2a2359a4a9688ff2aade3d70ff5c7ae6a87ad78c10dbd22b6a154e19ac34e42378c7384a757f421d387115923d14692f0958fcea909182ab9b18cf67868946568122e6f1065c2da0e8f1d53b5968dacb729e0c5f658d136482e27ff8882806c5fa1309782db91488c5065a6a3a5239bdbfdd5beea1fb5bb942de773628e6c8faf7249dda4c9f716c30f28a2bb4aee61d8ba422375d9a4bbfaf5aa3379f52e2045f3229549c9ad7b579560aa7634e6c98774d2f9cc53b195440093c93880d1dbb714ee92848339b5ebd2d018e3b312521f94648600a2549362cec7e8e67aaa0a7280c1eab8ca803597ca6e0b61a332abd8282c48086662972a2671a88a5d2e49d0940502d263e1e5075d3091c2b26ebaaf6ea9a42acbfaf868f00f0bd4355fa91cd996a5a00f1604a3b18215d43322e0ec23f56066b48a52596168f0a32882392764abe9b92a2279cc6b58fe9d28a9ae4c5567aa163a9755ad0820463680f54156501b77a4b8363cb36411c94436a27e6068e0f43ec04226a42eb507a8670c61538e65cd730d576a360866da964561d0da7a2cd816efb859b2191347b4f01d4023e177a2e9086e3520ac010d6edb4173c48fc2367583cf9dc83962f05943c21ad2e058f9f8309b9aae815d05c561f4ef2bca067e15264754e91565dde1be9789ffac4cec96e8ef75e27b9df856eac4ff2d561f32d27e93861fa7c2e422d2994e960df3bf16d9bc9dc9390ee145fbb45ea65c225981aa8fcd8750ff167061ab770443a8aae7d341f7c9334ab3986a53c4e7133a3f602abdc428158a3e16ea79388aee6cd046968a3a4fd1da0c614623bae5399c745b2c212749337f9e6b9383f5df09c0eaaca40788745e64788b44910a474335fff888983742d5ca03fdff11a599df8860b5a7dbece686b0160e4a75adf4cd57864ddd1d311cd1bf6153ab7a7f76777715ecdb8405ec95bb3b967fb2e33ba6d2ae49ffa56dca63ef791e630f456debf317d27bc730', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137443, 16931, 100.0, 100.0, 'mg/kg', 'PO', NULL, 'Adult', X'789cb35230343050c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834cb2852a8503055008a170300ef5a0c65', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137444, 16931, 1.0, 1.5, 'g', 'PO', 1, 'Adult', X'789cb35230d435d4335548574849cccca95408f057c82f5248c92ccb4c494d5170f274d10df17451a800aa3253c8cdcf2bc928060064080ec2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137445, 16931, 1.0, 4.0, 'g', 'PO', NULL, 'Adult', X'789c358b410a83500c05aff20e60514b57c55d0fa057081a356013f93fa5fedb1b105703c3cca76417fd25a137dac76ba9272a18fa0a8bd186f04aa9608c8a45197c8c895d4cd1360ddcf00c7caf4b143bb9b07ac65f7c851ab25b5cab0453a9d0c575d7f3ad61f3d5e57a27d1136e0132d6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137446, 16931, 125.0, 1500.0, 'mg', 'PO', NULL, 'Adult', X'789cb352303432d535343530c84dd74f49ac5408f007002b4204e6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137447, 16931, 750.0, 1500.0, 'mg', NULL, NULL, 'Adult', X'789cb352303735d035343530c84dd74f49acd451484a2c4e4d51c8cf53282dcacc4b2caa5448ce2f28482d5248ad482e4a2dc9cccf03008d9a1137', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137448, 16931, 20.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cd3302e4a51c8c9cc4bd5b4523032d0353150c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4c8280200110a0d2d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137449, 16931, 20.0, 20.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb352303250c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca280200903509a5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137450, 16931, 30.0, 30.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c73ae2c2ec9cc2b2dca4cb452303650c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5170f274d10ff474d151c84dac5030044b0300011811b6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137451, 32707, 4.0, 4.0, 'mg/kg', NULL, NULL, 'Adult', X'789c33c94dd7cf4e57283432c950a830d73534514849ac2c06004af2069b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137452, 32707, 6.0, 6.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c33cb4dd7cf4e57f00c53283432c950a830d2355328cf2e0600510006cc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137453, 1191, 25.0, 400.0, 'mg', 'PO', 1, 'Adult', X'789c3332d535313050c84d5708f05730d4355228c9cc4d2d564849cccca9040063f80801', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137454, 1191, 25.0, 400.0, 'mg', 'PO', 1, 'Pediatric', X'789c3332d535313050c84d5708f05730d4355228c9cc4d2d564849cccca9040063f80801', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137455, 3236, 5.0, 5.0, 'mg/kg', 'IV', NULL, 'Adult', X'789cf30c5328ca2f2d49b55230cd4dd7cf4e57f00c53283434ca50a830d73534514849ac2cd65128c948cd43963732c950c82f5230838b9856e897670300608316ac', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137456, 3236, 1000.0, 1000.0, 'mg', 'PO', 3, 'Adult', X'789c0bf05728ca2f2d49b55230343030c84d5708f05728c94cd15148cf2c4b5528cf2cc95048cbcf4f0100f0c10c99', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137457, 3236, 5.0, 5.0, 'mg/kg', 'IV', NULL, 'Adult', X'789cf30c5328ca2f2d49b55230cd4dd7cf4e57f00c5330d535afd02fcfb656f0cc4bcbb752c8cb2f51302c2ed1cdc9cc4b55484c4fcd2b0100bf551122', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137458, 3236, 1000.0, 1000.0, 'mg', 'PO', 3, 'Adult', X'789c05c1d10980300c05c055de0242fbdb4ee057bb82d0340634017deafadef5862b1e4a414e299d8ade401b15abcf28f020f2cde530176c2ace0ab557f01977cc88f103a4151576', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137459, 3236, 5.0, 5.0, 'mg/kg', 'IV', NULL, 'Adult', X'789cf3cc4b294d2ec9cccf5328294a4d2cc94dcd2bb15230cd4dd7cf4e57f00c53283434ca50a83034d13532544849ac2cb656f0cc4bcbb752c8cb2f51302c2ed1cdc9cc4b55484c07ea020091b8184d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137460, 3236, 5.0, 5.0, 'mg/kg', 'IV', NULL, 'Adult', X'789cf34dcccc2b49cd4bcc4b4e5528294a4d2cc94dcd2bd151f00c5328ca2f2d49b55230cd4dd7cf4e070998ea9a57e897675b2b38e69458299821c421a29e7969f9560a79f9250a86c525ba399979a90a89e940c3005a122043', X'789ced58516fe23810fe2b239e7625288402dda5fb8260ef5ae9dab26db7d2e95821930c898563676da7855bf5bfdf3810209442cb9e4ea7bbbe25f6ccf8f3cc7c33b67f94029d8643c9622cb5a1f42b933ef785bae7ba548652aa851b8dac4d4cbb5a7de0138c8f940edd17af6e081b5fb3048321b34ea75eabb72a35afe2d56e6b27ede671bbf1e1c86b7df858f73259f42d57d290e48f522788b9e4c66ae6c6b2218bd3cccaed2cc1f64076a4e5b40a130379ad528b06d4188a6a6d38bf2b43ff6a20bb2a8e95845bcd02844bda9869437766d53d4accd64e47ebcb3fd290652381eeef8f6ff427b89c643f2b1c4b00fbbdb2127dfce66c778254d8614f192ec3c2deba1777039968954433c1a6dc94c128c103204b4c026d4b9a44306907f2fc0eb4db761b9a71589d84b455f8eed523989e54bc06046c46ca3642b93e5f6f44640a5acb91e6b4fa3019c8fe556eccabd56a71483e03cb833284fc1ee181db08c64a05e4c727f8ceceef2acc18e51f6dc7d4ac9cb8354ee15c8e551ba4b2e0195b217f22b010dd569e59fd7995d3edb8345a0abe75a8781ca752f92a26ac31371840421941aa8650ca20cd424dfe4466631a7dea44af51a97b99177721bf605c5a9494f3b83256869d7ee8085a6e230207acf1acd332fbcd7ce8fb71040f111764ee814d10deb52050064d95b6f6fee51e3e94231497fdec704264ed9fd3ca38d8c78033abb9bf8d8757e33108364201a921971848726988e9cbcfcacb363a3c4bd73ce976f0b510ebf6066fb727ce4e460e64d1c44298cbf13c8c3b513d2540cc66c0a54f29482e71490456c1c95151f1f03d2c6195c1579292905b26e0dd270f62f57e205b1bf85a0f93ff5652fe442adf24e87326867d95a482ad9a686eaeaf31740199c135cdca7040f1ee0ee46fccb79934686e266e90024dd99afd82cfa4ab0b23049d0a2aa0546cb638bc744da116db289417412ac6db0a6e57770595a94aeb631bea7912b9d09ecea7eacd4aa33095e54f36e5d52af506d5bda3fad3b94f5e6d7de6785e5dcf7aed7941cbd2968d2d6a203e8b997184910a4c9a2402635cefac65caf82da5f739e82b0c0be85bf12db0d78e5acf815f9b3a04fdaa2facc3f4b286e08a3e69def380e2f9a557c9fa4501726d9bd86829b6403fef2e5f7aebb0e763af475c2a32f6f1450cde4ce8fd64e9b913ed5cd80cb91c2e2d148957a4c47eb34bf9a1931f525fc050694ee0e7cc7c63c71b3b7e961d2f6f7159ca7595a4830765d5e294526c051d21508733d7ba7d41a784aabbead165eab20b9f1c4a7211751014680d0dd49b65daf301203ac13d6a83c36b64fe5310dbfac80d6aaed2a29c8de8f43e523e5dd4123a0fb08194985a9dff248ebfcb298309f9cf8924a466d594fbdccedc38ff33d56816f7033a530468991fcd1322a2cba4a62c36d979c8597499ec2e119b852973adbb45162052dcb48e90d61f236d792005a6931c12934ae3d47dddd32d242f54afae769b6ed85f966e37350a456ecd89fb4d5dae0917acccfdbddfc0cd5c6e43771e9397682f240bfaeb51db6fe36c5dba606733debbedf4d7a50b76f22c78411fca250bfa59eeec57fe25132b68aed2ed05cd6a255bb0b19e9cbb2ddce5928b73e7bf91b39b85e58db46fa47d23ed8ab47f0f1f0eb977ff4f1dde8f988e99af840a6705b79f3131ae083ea6d3e871445ebfa01a3752829b988ea7bff71b4d3a8d7d9efaae04ba179aaf9abff6b13a5bff02fd8849b23a54e361c77ff29e7e2e233ee274deeb5d7620516216a3764f3c4c06eebd47e94469e6ded7e9b8af207bc676a20720b9c6316aa4fb42b1657c4e949fad5086afc9adead1e76b8d3f3efe05702e34a9', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137461, 3236, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c35cc310a02311046e1abfca5826216d122a92c2d44af3098d964303bc1cd68f0f6ae85edc7e35d48d45849ef0c9b996c62b50d6e57ccf565ec3138e7a6f4039318702ae671f8d3739fd1b31406757a305647c4dab8ed227dd601671dab8756c3d06c5b44972e2dff80246f4617cb186b8d5f750e2bf7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137462, 3236, 5.0, 5.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf3cc4b294d2ec9cccfb35230cd4dd7cf4e57f00c53283434ca50a830d73534514849ac2c0600dca20b5f', X'789ced58516fe23810fe2b239e7625288402dda5fb8260ef5ae9dab26db7d2e95821930c898563676da7855bf5bfdf3810209442cb9e4ea7bbbe25f6ccf8f3cc7c33b67f94029d8643c9622cb5a1f42b933ef785bae7ba548652aa851b8dac4d4cbb5a7de0138c8f940edd17af6e081b5fb3048321b34ea75eabb72a35afe2d56e6b27ede671bbf1e1c86b7df858f73259f42d57d290e48f522788b9e4c66ae6c6b2218bd3cccaed2cc1f64076a4e5b40a130379ad528b06d4188a6a6d38bf2b43ff6a20bb2a8e95845bcd02844bda9869437766d53d4accd64e47ebcb3fd290652381eeef8f6ff427b89c643f2b1c4b00fbbdb2127dfce66c778254d8614f192ec3c2deba1777039968954433c1a6dc94c128c103204b4c026d4b9a44306907f2fc0eb4db761b9a71589d84b455f8eed523989e54bc06046c46ca3642b93e5f6f44640a5acb91e6b4fa3019c8fe556eccabd56a71483e03cb833284fc1ee181db08c64a05e4c727f8ceceef2acc18e51f6dc7d4ac9cb8354ee15c8e551ba4b2e0195b217f22b010dd569e59fd7995d3edb8345a0abe75a8781ca752f92a26ac31371840421941aa8650ca20cd424dfe4466631a7dea44af51a97b99177721bf605c5a9494f3b83256869d7ee8085a6e230207acf1acd332fbcd7ce8fb71040f111764ee814d10deb52050064d95b6f6fee51e3e94231497fdec704264ed9fd3ca38d8c78033abb9bf8d8757e33108364201a921971848726988e9cbcfcacb363a3c4bd73ce976f0b510ebf6066fb727ce4e460e64d1c44298cbf13c8c3b513d2540cc66c0a54f29482e71490456c1c95151f1f03d2c6195c1579292905b26e0dd270f62f57e205b1bf85a0f93ff5652fe442adf24e87326867d95a482ad9a686eaeaf31740199c135cdca7040f1ee0ee46fccb79934686e266e90024dd99afd82cfa4ab0b23049d0a2aa0546cb638bc744da116db289417412ac6db0a6e57770595a94aeb631bea7912b9d09ecea7eacd4aa33095e54f36e5d52af506d5bda3fad3b94f5e6d7de6785e5dcf7aed7941cbd2968d2d6a203e8b997184910a4c9a2402635cefac65caf82da5f739e82b0c0be85bf12db0d78e5acf815f9b3a04fdaa2facc3f4b286e08a3e69def380e2f9a557c9fa4501726d9bd86829b6403fef2e5f7aebb0e763af475c2a32f6f1450cde4ce8fd64e9b913ed5cd80cb91c2e2d148957a4c47eb34bf9a1931f525fc050694ee0e7cc7c63c71b3b7e961d2f6f7159ca7595a4830765d5e294526c051d21508733d7ba7d41a784aabbead165eab20b9f1c4a7211751014680d0dd49b65daf301203ac13d6a83c36b64fe5310dbfac80d6aaed2a29c8de8f43e523e5dd4123a0fb08194985a9dff248ebfcb298309f9cf8924a466d594fbdccedc38ff33d56816f7033a530468991fcd1322a2cba4a62c36d979c8597499ec2e119b852973adbb45162052dcb48e90d61f236d792005a6931c12934ae3d47dddd32d242f54afae769b6ed85f966e37350a456ecd89fb4d5dae0917acccfdbddfc0cd5c6e43771e9397682f240bfaeb51db6fe36c5dba606733debbedf4d7a50b76f22c78411fca250bfa59eeec57fe25132b68aed2ed05cd6a255bb0b19e9cbb2ddce5928b73e7bf91b39b85e58db46fa47d23ed8ab47f0f1f0eb977ff4f1dde8f988e99af840a6705b79f3131ae083ea6d3e871445ebfa01a3752829b988ea7bff71b4d3a8d7d9efaae04ba179aaf9abff6b13a5bff02fd8849b23a54e361c77ff29e7e2e233ee274deeb5d7620516216a3764f3c4c06eebd47e94469e6ded7e9b8af207bc676a20720b9c6316aa4fb42b1657c4e949fad5086afc9adead1e76b8d3f3efe05702e34a9', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137463, 3236, 5.0, 5.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4eb55230cd4dd7cf4e57f00c53283432c9b05670cc29b15230830b9a56e89767030090ae0f64', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137464, 3236, 5.0, 5.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33cd4dd7cf4e57f00c53283432c900001ff00429', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137465, 3236, 5.0, 5.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf3cc4b294d2ec9cccfb35230cd4dd7cf4e57f00c53283434ca50a83034d13532544849ac2cb656f0cc4bcbb752c84dac54c8cc4b2e4a4d2c4e5548c9071225f90ae67aa81a01433519f5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137466, 3236, 5.0, 5.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4eb55230cd4dd7cf4e57f00c53283432c9b05670cc29b15230830b9a56e89767030090ae0f64', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137467, 3236, 6.0, 6.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33cb4dd7cf4e57f00c53283434ca50a8302bcf0600393505d7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137468, 3236, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Adult', X'789c65ce4b0ec2201405d0addc0594b6603191765607ba01e7449e48da4205ea67f7c618138de33339fb036258321570de2cc7ec82478ea4f3443e2bf4b11f216bb6de2888524eb61a2c2e5c9cdb3709c99a1f12cd8778cd44a3c04bf16f1dafbf6575af6e438bdd56c1ba2bc18444d0a74c11c6e9f1915c2ae003d232cf23bd664f8d213773', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137469, 3236, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Adult', X'789c6dce4d1282201806e0abbc0710450267c276b6a80bb467f2cb18010db09fdb57d3aaa9f5b379f607c469c954c01b1b3205138e841cc9644f216b74b173509c356b0d512a3f54e3808b90e7f6434231f9a2ba14bf567326a4062f9b3fb8a9f917adeed56d6cb1db6a0cf64ae8a74430a74c11bd35ee916c2a1026a4659e1dbd734f9d9938c7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137470, 3236, 1500.0, 1500.0, 'mg', 'PO', 1, 'Adult', X'789c6dcc4b0e82301485e1ad9c05d8708bd4c4e20c06ced425d4f44a1a8192b6a0ec5e7c8e9cfee7cb391e10fc9858a30a550b4562b3d5908aa86b326b66583739cb16a75a2467cb37cb95289e8cfeb1f38f491279a1f13a5b964fdd49fab6f53dbb5d4bec6b8dc64d0ceb23c35c1287e5d0b473747185de238ec3d072c77d7a00991434f8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137471, 472, 5.0, 5.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494cb2523055c84dd7513034005346c640ca5ac1df2504450200c5830f1b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137472, 472, 5.0, 5.0, 'mg', 'PO', NULL, 'Adult', X'789c3355c84d5708f05728cc2856a830d1352bcf060030b60566', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137473, 472, 10.0, 10.0, 'mg', 'PO', NULL, 'Adult', X'789cf3cc4b2e4a4d2c4e5528c957303450c84d5708f05728cc280600651807ce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137474, 472, 5.0, 5.0, 'mg', 'PO', NULL, 'Adult', X'789c3355c84d5708f05728cc2856a830d1352bcf060030b60566', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137475, 472, 10.0, 10.0, 'mg', 'PO', NULL, 'Adult', X'789cf3cc4b2e4a4d2c4e5528c9573034c84d5708f05728cc2856a830cecdd75128c948cd53c8445262640c5702003c901341', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137476, 621, 0.03, 0.07, 'mg/kg', 'IV', NULL, 'Adult', X'789c25cccb0980301045d1565e01f18788600769c07dd0991034198d2358be1137f7ee8e4d4183db27b475db572523a26f360f3b1b0446121033d3a206990e728ab3430c09f7011544f794a9dbb1ca4510fea0f127246388fe05d49d1ee0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137477, 621, 15.0, 375.0, 'mg', 'PO', 1, 'Adult', X'789cb3523034d5353637cd4d5708f0574849cccca954d0f0cb2f51707371d44d2c2828ca2f4b4dd10400ca3e0b6e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137478, 1928, 1.0, 1.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65230cc4dd75130ca4db75630d43755c8f50100973508f5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137479, 1928, 2.0, 2.0, 'mg', 'PO', NULL, 'Adult', X'789c33ca4d5708f05728482d5248c92f4e0500250b04f8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137480, 1928, 4.0, 4.0, 'mg', 'PO', NULL, 'Adult', X'789c0b2e492c2ab15230c94d5708f057a830d45128c948cd533082f013d34a528b14521393331472f2f38b53158a4bf2f373ac157c132bac140ccd72d3f553122b01da3215d2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137481, 1928, 4.0, 8.0, 'mg', 'PO', 1, 'Adult', X'789c33d1b5c84dd74f49ac5408f05748c92ccb4c494d510874d12dc94c0100751408b6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137482, 1928, 4.0, 4.0, 'mg', 'PO', NULL, 'Adult', X'789c25c8cb0980301005c0565e01a244c443ac4114ac60356b12c8079215b47b118f339b50118d215aac0b6ed5401c27f4bfe9142e603a1c42ce955125e7802b890f88e493b430df7315da83af8ecd84996e0d3546db197a5e30c520f8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137483, 1928, 1.0, 1.0, 'mg', 'PO', NULL, 'Pediatric', X'789c73c92f4eb55230cc4d5708f057a83054484c2b492d52484d4cce50c8c907ca291497e4e7e70000ecdc0ce9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137484, 1928, 3.0, 3.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230ce4dd74f49ac040018a603f5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137485, 1928, 1.0, 1.0, 'mg', NULL, NULL, 'Pediatric', X'789c0b2d4e55f00f715630cc4dd7375528cecf51c82f0273ccf54c15727d148a4b8b0b00c4fc0ade', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137486, 1928, 2.0, 2.0, 'mg', 'PO', NULL, 'Pediatric', X'789c73c92f4eb552282e492c2a5130ca4d5708f057a830d45128c948cd533084f013d34a528b14521393331472f281ca81aaf3f3730016d01317', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137487, 1928, 4.0, 4.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230c94dd74f49ac040018ad03f6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137488, 1928, 2.0, 2.0, 'mg', 'PO', NULL, 'Pediatric', X'789c73c92f4eb552282e492c2a5130ca4d5708f057a830d45128c948cd533084f013d34a528b14521393331472f281ca81aaf3f3730016d01317', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137489, 1928, 6.0, 6.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230cb4dd74f49ac040018bb03f8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137490, 1928, 4.0, 4.0, 'mg', 'PO', NULL, 'Pediatric', X'789c73c92f4eb552282e492c2a5130c94d5708f057a830d45128c948cd533082f013d34a528b14521393331472f281ca81aaf3f373001747131a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137491, 1928, 8.0, 8.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052b0c84dd74f49ac040018c903fa', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137492, 1928, 0.08, 0.24, 'mg/kg', 'PO', 2, 'Pediatric', X'789c33d033b0d035d03332c94dd7cf4ed74f49ac5408f05748c92ccb4c494d5148ca4cd12dc94c0100c3730b6f', X'789ced595b6fdb3614fe2b0706fa66d9f225a9a7ecc5b333b45b9b7a49fab04d85404bb444842205926ae216f9ef3b947ca3e3d4b1d1aec59637893ae73b577ee2913e371255a69120396d04d078230baa48ce12da6842a354dc2e66c6143a68b76fd90dcd5b52a5f68ab55d591d2b52d02422c6aa74fdeea9e777bc8e7fedbf0c4e4e83decbd64fbdeec9c969254b63c3a4d028f9b9314c722698368ad8b56ac9d0bb0ae57a5ed00086c2302f6144a98c12de0c852c98644928c6529394c2af52e53a804e9e36a19ba767d0699f40fe261497b23454839c816b2380c9bb508c649e4b01d78a24142e307ec4789dcb84957913c68ce0256d2e5760e88d9d1b38ff0b4619bdd5eeea05bdadfc293969c2ef447a13f2912a26aa9b02c3268642c71b575928a79b89b8c72543a69cdabbbf3fe01d67e2a6ba5967a40e7d7f6dded572f71f2cea3029b989305b4ca44e7e7778d118c698b468bc48b7238ec9c5cc01561d12a96928ae0c5126807ebd7ed76982c9a880851c991994a424ce804b94076da4e467f096dc61b54ef3b49d9079c38ddaba3bca94142cdeed43df1bd48ad642c23e62f725f0c7d833b6218ef1074a6c2f0e3961c2b4aab8806aeb11d3194df678fb859ad599fff793b95dcfff50367ff0509ebe9fab68261439cd281bcf213b73498451d76d27ef04e6b2099d9ed7f5e126add89156ac5887fc4894a1a8e2e8d56184e23d3e78773db27ac8a21ad3205575f3b265491574a98b509c7a83ca5ad7f77a9bd6b4cdf332adab3477be94e68503fda50303afd3a9b07bbed7ff3ad8a74bec4e1791818804244fa872910f6a8e05f2602f893d522ebfe50f3cbfd5b561df3c68db294beabead8c74ad11b47c1cf93cf7cb8fd92f8ff1f4776c986fe4c281bc7885c72446783491059ea2d6095aba3151341544c473b8c4a702eb1dc02fa17843ece10aa541317d6317274a4ed1ce1c3499ed72a4714905dad9c1bed58129d8b1ab5fd1026dec64ec4aa7bd22f5002e6952c698981953da7805d11a728a78125f20391e3f2faec0c83b163373c88bf0f13cec3f148eed49bf16d61113d10aa18106d7c06e269f30072ce5232b1fc578c44da562e87c7dfc7c429ab72bf3fdf3fcadcb7de0a6184981c30b13098b776c8921e754a57334003147cb6d3bd385e2f50c52f611a9e996992c0845210d3eb4a30a8959024526759161b5369fc419c7da25ee1ab38393b3b4d23d229661822391a6d12592e4c35876b5c3158e50b274e5d6d3e72aafa1a8ae30ef29892597023d268af039d61018a7a50eb1dd532669427362af4991cd39b963f8a0bdbc8b0d4e4ea016ce2d31698196544e38081a2bc9e7da2a5d198af9d5de6f32131a378c9e8b44c91c5345d51cdf0a39011c050d9be148888b254e8244cd11dc5051a323cd1a7c452879f380aeabb2db19d5893bc6a41856905a5d9052531bca349138e2a27b3886e705ba96b04f9f98a05a1f452e3bb27bc8078168a5e430cb5679f6235e5b8568ade0a0ad4bb91f68b896ddc258b5c05340d6c23be2dad5224f0d71a51b6de83a361e6bb5fd16b634a395a683bfa361f7439f2f94a20d2507f541c7efc77c5fab446b1507716bc37c19eb150a470b6107657317ed87196d4a3b38f5fedb8f7051cbb9bdb7b5679fd0804b8d68a1e1e0393b7ecf4960255abfa2ff3f04fbe0d8fdccb0cf0cfbccb0cf0cfb8d19f66bf1cc313f0d9e4be194629211e4014b77e9dc29c82bc2671e67331ac0c665c76f0db250bc5d0d7301709caad4198cfe9cf44ffc00baa341137ac33ed8e254a3d219bc163319c0c44b8bcdd5beff0269451b9a239b91a996aaa8ab7f7e17e36eacfe4dcd684c35f4fc174db07b9bc2cfdd17474c596f699c1181ee4672160de307ffd6a6384c6a484b03b78473a87f2c218bc4b430523581898c4d99fd5660ff51306d0847c63cc375f494687491d86ae214882ba8816f3171d4e71e4aa321d772dfd9e3d8e6ff7aefd9c5c78c195554c4d43d2c9d1732b625d6016cfd163d201bf7f7ff004b2f0cb2', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137493, 1928, 2.0, 2.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230ca4dd74fc92f4e05001d160461', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137494, 18342, 650.0, 650.0, 'mg', NULL, 1, 'Adult', X'789c333335c84d57305628c9cc4d2d564849cccca954484c2b492d52c84d4dcc295648cb2f523032004a5416030032fe0e56', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137495, 18342, 1.95, 1.95, 'g', NULL, 1, 'Adult', X'789cf3cb2f5128c95748ad484e4d4d5130d4b3345548574849cccca9040072f7086a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137496, 18342, 30.0, 40.0, 'mg/kg', 'IN', 1, 'Pediatric', X'789c73cec8cc49294acdb3523036d03531c84dd7cf4e574849cccca954d0c84dacc8cc2dcdb5523033054a2814a41629a4e417a76a2a64e629182ba4649665a6a4a680858a15d2f28b148c0c803a2b8b016ade1b25', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);